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Native 5-haemolysin of Staphylococcus aureus was poorly immuno­
genic in the mouse, inducing low anti-5-haemolysin antibody titres in 
only 50% °f immunised animals. Treatment of 6-haemolysin with formal­
dehyde at pH 5 or pH 7*5 caused a rapid loss of haemolytic activity and, 
on treatment for 7 days at pH 5» gave a product of higher immunogenicity 
than the native material.
Treatment of 5-haemolysin with formaldehyde at pH 9*5 f°r 7 days 
reduced the haemolytic activity by 9 7% Hut failed to enhance the immuno­
genicity.
Antisera to formaldehyde-treated 5-haemolysin contained antibodies 
directed against antigenic sites not present on the native molecule.
Formaldehyde-treated 5-haemolysin had an increased electrophoretic 
mobility and a reduced isoelectric point but there was no evidence of 
polymerisation. The enhanced immunogenicity may be due to a reduced 
affinity for phospholipids, resistance to enzymic digestion, increased 
rigidity and/or the masking of a suppressor determinant on the molecule.
Treatment of 5-haemolysin with glutaraldehyde under acid, 
neutral or alkaline conditions produced a rapid loss of haemolytic and 
immunogenic activities.
High doses of 5-haemolysin (62.5 - 1000 pg) gave enhanced 
vascular permeability (EVP) when injected intradermally in the rabbit.
The response was obtained at a critical time of 1 h between injection of 
sample intradermally and of Pontamine Sky Blue Bye intravenously. The 
EVP activity was resistant to heating at 100°C. Treatment of the 
haemolysin with lecithin or formaldehyde reduced, but did not eliminate,
i i i
this activity. Tryptic digestion studies indicated that the EVP 
activity was associated with fragments which lacked both haemolytic and 
antigenic activities, and suggested that the various biological activities 
of the molecule may not be mediated by a common site or mechanism.
Several strains of S. aureus were screened for haemolysin 
production. The majority of human and animal strains produced high 
titres of a- and 6-haemolysins but little or no (3-haemolysin. The 
antigenic reactivity of the crude culture supernates with rabbit anti-5- 
haemolysin antisera indicated that all animal strains and all but one of 
the human strains produced a haemolysin which was antigenically identical 
to purified 5-haemolysin from strain NCTC 10545* The human strain,
LS26, produced a 5-haemolysin which precipitated with antibodies against 
purified 5-haemolysin and which carried specificities directed against 
determinants not exposed on the native molecule. These results 
suggested that "hidden" antigenic determinants may be "exposed" during 
immunisation with 5-haemolysin which induce specific antibody formation. 
Production of 5-haemolysin by strain LS26 may expose these "hidden" 
antigenic determinants which would therefore be free to precipitate with 
the specific antibody.
Several of the crude delta-haemolysin preparations had very 
similar isoelectric points to that of purified 5-haemolysin. Only two 
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1The occurrence of staphylococci in human pus was first described 
by Robert Koch in 1878. Pasteur (1880) successfully cultivated the 
organism in liquid media and Ogston (1882) later showed it to be patho­
genic for mice and guinea pigs.
Staphylococcus aureus, as well as occurring as a harmless 
commensal in the nose and on the skin of many healthy persons, is also 
the cause of a diverse array of both superficial and systemic infections 
(Table 1).
Although strains of high virulence can occasionally cause out­
breaks of infection in certain human populations, S. aureus is more 
frequently an opportunistic pathogen in the sense that it causes infection 
most commonly in tissues and sites of lowered host resistance. Table 2 
lists the many factors and conditions which may lead to the establishment 
of a staphylococcal infection.
Staphylococcal infections have been reviewed by Shulman and 
Nahmias (1972) and Musher and McKenzie (1977)- The skin is the most 
common site of infection and, once virulent staphylococci have gained a 
foothold in deeper tissues of the body, their multiplication causes 
necrosis and eventual abscess formation.
In severe infections the organisms may break through the localised 
barrier of the lesion(s) and invade the lymphatics and bloodstream. If 
bacteraemia becomes established, metastatic foci frequently develop 
(Table l).
The gastrointestinal tract is also a frequent site of infection. 
The most commonly found staphylococcal enteritis is food poisoning 
mediated by an enterotoxin formed by certain staphylococci during
^ a ^ h ^ o c ^ c c ^ ^ I ^ e c t i o n ^










carbuncles, boils, abscesses, 








bones and joints 
lungs
skin and muscle 
heart









intra-abdominal visceral abscesses 
spleen, liver, pancreas.
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4multiplication in foodstuffs. A quite different entity is staphylococcal 
enterocolitis in which the organisms multiply in the lumen of the gut.
This most commonly occurs in patients who receive antibiotic therapy and 
may have their normal bowel flora suppressed; the ensuing overgrowth of 
antibiotic-resistant staphylococci may result in enterocolitis.
This review shall be primarily confined to discussing the extra­
cellular products of S. aureus, in particular the haemolysins, and their 
role in virulence. However, initially, the immunity to staphylococcal 
infections will be reviewed, and the factors affecting the immune response 
generally will be outlined in a later section.
Immunity to staphylococcal infections
Since all species of animals used for experimentation show a high 
degree of resistance to staphylococcal infection and yet also show very 
little resistance to superficial colonisation by these organisms, the 
study of immunity to staphylococci has proved very difficult.
The interaction of staphylococci with phagocytic cells plays an 
extremely important role in the host's "immune" response to staphylococcal 
infection (Koenig, 1972). This non-specific cellular immunity is 
primarily a function of polymorphonuclear leukocytes and macrophages and 
defects in these systems can lead to increased susceptibility to staphylo­
coccal infections. When chemotaxis is impaired or when leukocytes are 
incapable of responding to chemotactic and phagocytic stimuli, recurrent 
staphylococcal infections may occur (Mandell, 1972; Clark et al., 1973). 
Efficient phagocytosis of staphylococci by neutrophils is dependent on 
bacterial opsonisation by serum factors including specific antibody 
(Wheat, Humphreys and White, 1974) as well as components of the classical 
(Forsgren and Quie, 1974) and alternative (Jason, 1972) complrnent pathways.
5However, different strains can exert a heterogeneity in opsonic require­
ments possibly due to cell wall protein A (Verhoef _et al•, 1977; Verhoef, 
Peterson and Verbrugh, 1979).
Virulent staphylococci generally resist phagocytosis or intra­
cellular killing by phagocytes. Immunisation with surface components 
which have antiphagocytic activity protected mice against challenge with 
staphylococci (Morse, 1962; Fisher, Devlin and Erlandson, 1963; Ekstedt, 
1966; Easmon and Glynn, 1976). Recently, two surface components, an 
acid polysaccharide and a strain-specific mucopeptide complex, have been 
purified and implicated as inhibitors of in vitro opsonisation of 
organisms by leukocytes (Karakawa, Young and Kane, 1978).
Specific cellular immunity (cell-mediated immunity) does not 
appear to be of prime importance in protecting against staphylococcal 
infections since individuals with defective cell-mediated immunity do not 
normally suffer from severe staphylococcal infection. Indeed, cell- 
mediated immunity can be harmful rather than beneficial (Easmon and Glynn, 
1975*0 there is evidence that it is an important contributing factor 
in recurrent staphylococcal infections (Mudd, Taubler and Baker, 1970)•
Since patients with deficiencies in humoral immunity are more 
susceptible than normal subjects to infection by staphylococci, it is 
probable that humoral immunity is important. The role of both antitoxic 
and antibacterial humoral immunity to staphylococcal infections has been 
reviewed by Ekstedt (1972). Immunisation with a-haemolysin toxoids 
(Goshi et al., 1961, 1963a,b; Taubler, Kapral and Mudd, 1963), leucocidin 
(Souckova-Stepanova, Gladstone and Vanecek, 1965; Ward, 1979), whole 
cells (Brodie, Guthrie and Sommerville, 1958; Agarwal, 1967a,b,c;
Yoshida, Ichiman and Ohtomo, 1975; Hasegawa and San Clemente, 1978; 
Yoshida and Ichiman, 1978) as well as surface antigens (Morse, 1962;
6Fisher et al., 1%3; Ekstedt, 1966; Yoshida, Ichiman and Ohtomo, 1976) 
has given protection against subsequent challenge with viable staphylococci.
Antibacterial antibodies, as opposed to antitoxin antibodies, 
appear to act by promotion of phagocytosis and therefore may be useful in 
preventing establishment of staphylococcal infection (Ekstedt, 1972).
Since a-haemolysin, as well as other extracellular products, are produced 
late in the growth cycle of staphylococci (Elek, 1959; Gladstone and 
Glencross, I960; Coleman and Abbas-Ali, 1977) it is probable that anti­
toxic immunity is only effective once an infection is established.
Indeed, it has been suggested that antitoxic immunity can only alter the 
development of infection (Ekstedt, 1972) and may only prevent more acute 
symptoms and have little effect on established or chronic infections 
(Adlam et al., 1977; Anderson, 1978).
The main defence mechanism against staphylococcal infections, 
however, appears to be an inflammatory response (Easmon and Glynn, 1975a; 
Anderson, 1978). Anti-inflammatory substances of staphylococci have 
contributed to an increased infectivity (Hill, 1968, 1969; Easmon,
Hamilton and Glynn, 1975). Easmon and Glynn (1975a) concluded that 
a-antitoxin immunity was protective against the dermonecrotic effects of 
staphylococci not only because of its specific neutralising power, but 
also because the antigen/antibody reaction, taking place locally in the 
tissue, elicited a brisk inflammatory response which proved protective. 
Non-specific acute inflammation also protected against dermonecrosis.
Extracellular products of SJLjaureu3
Staphylococci produce a large number of extracellular toxins and 
enzymes during growth (Table 3)> although the number and quantity may 
• vary. Bernheimer and Schwartz (1961) detected 12-14 different proteins
7
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8by analytical starch gel electrophoresis; more recent studies by iso­
electric focusing in polyacrylamide gels have shown that certain strains 
of S. aureus give as many as 25 to 50 bands while others give only 4 to 
10 bands (Wadstrom, Thelestam and Mollby, 1974)* Excellent reviews on 
the extracellular products of S. aureus are by Bernheimer (1965, 1968,
1970), Gladstone (1966), Jeljaszewicz (1967, 1972), Bergdoll (1967, 1970, 
1972), Arbuthnott (1970), Wiseman (1970, 1975), Woodin (1970, 1972),
Abramson (1972) and Kwarecki et al, (1973)*
1. Staphylococcal haemolysins
The effect of diffusible products of staphylococci on mammalian 
tissues, notably red blood cells and leukocytes, was first detected 
nearly 100 years ago by several workers (Von Leber, 1888; De Christmas,
1888; Brieger and Fraenkel, 1890; Van de Velde, 1894» Neisser and 
Wechsberg, 1901). Work on these "toxic" substances was greatly stimulated 
in 1928 by a tragic accident in Bundaberg, Australia. Sixteen out of 
twenty-one children died after being inoculated with diphtheria toxin- 
antitoxin from a single rubber capped vial which had been kept at room 
temperature in subtropical heat for several days. Burnet (1929, 1930) 
concluded that the deaths were due to a soluble toxin elaborated by the 
staphylococci cultured from the vial.
Since then it has been established that S. aureus produces several 
distinct toxins. From the haemolytic spectra and serological 
specificities four haemolysins (alpha, a-; beta, |3-; gamma, y- and 
delta, 6-) have been resolved. The existence of a further haemolysin 
(Epsilon, e-) has been postulated (Elek and Levy, 1950) but not definitely 
identified because of the complexities created by the multiple molecular 
forms of a-, [3- and 6-haemolysins and absence of a purified preparation. 
Indeed, a postulated e-haemolysin was shown to be identical to 6-haemolysin
9by Kleck and Donahue (1968). A further haemolysin, which lyses horse 
erythrocytes, has recently been reported by Turner and Pickard (1979)•
The purification and properties of staphylococcal haemolysins 
have been reviewed by Wiseman (l975)»
(i) Alpha-haemoly sin
Rabbit erythrocytes are highly susceptible to a-haemolysin while 
the erythrocytes of other species are less so (Bernheimer, 1968; Chao 
and Birkbeck, IJ'JS'b). The production of a-haemolysin is frequently 
found in strains from human origin (Elek and Levy, 1950; Fraser, 1964; 
Jeljaszewicz, 1972) whereas strains of canine origin produce very little 
of this haemolysin (Fraser, 1964).
Alpha-haemolysin has been separated into four different forms by 
sucrose gradient electrophoresis (Bernheimer and Schwartz, 1963), iso­
electric focusing (Wadstrom, 1968; McNiven, Owen and Arbuthnott, 1972) 
or hydroxylapatite chromatography (Dalen, 1975) (Table 4)* In contrast, 
Six and Harshman (1975a,b) only found two molecular forms of a-haemolysin 
on ion exchange chromatography while Watanabe and Kato (1974) found only 
one component on isoelectric focusing. Recent studies by Cassidy and 
Harshman (1976b) and Fhimister (1979) revealed only a single form of 
a-haemolysin after purification by glass bead chromatography. The 
different forms of a-haemolysin, although varying in charge properties, 
possess similar biological activities (Wadstrom, 1968; Bernheimer, 1970; 
McNiven et al., 1972).
Alpha-haemolysin occurs as a soluble inactive aggregated form 
(12S) as well as the active monomeric (5s) form (Arbuthnott, Freer and 
Bernheimer, 1967). Dissociation of this 12S component in 8M urea yielded 
the active 3S form supporting the contention that 12S was an inactive 
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immunological characteristics to the biologically active form and has 
therefore been regarded as a toxoid.
As well as being lytic towards erythrocytes, a-haemolysin is
reported to be toxic towards cultured cells (Nogrady and Burton, 1961;
Madoff, Artenstein and Weinstein, 1963; Korbecki and Jeljaszewicz, 1964,
1965; Hallander and Bengtsson, 1967; Galanti et al., I968; Thelestam,
Mollby and Wadstrom, 1973; Paradisi et al., 1976). However, release of 
3H-nucleotides from human diploid embryonic lung fibroblasts only occurred 
when high concentrations of a-haemolysin were incubated for several 
hours with the culture cells (Thelestam et al.t 1973; Thelestam, 1976).
On the other hand, 5-haemolysin caused rapid and massive release of these 
markers (Thelestam et al., 1973) and. it has therefore been suggested that 
the earlier reports of cytotoxicity of a—haemolysin for cells in tissue 
culture may be due to contamination by 5-haemolysin since, in most cases, 
only crude or partially purified preparations were used (Thelestam,
1976).
In vivo, a-haemolysin causes necrosis when injected subcutaneously 
into rabbits (Watanabe and Kato, 1974) or injected into the lactating 
mammary tissue of rabbits (Ward et al., 1979)* Alpha-haemolysin is also 
lethal in both rabbits and mice in small intravenous (Lominski, Arbuthnott 
and Spence, 1963) and intraperitoneal (Fackrell and Wiseman, 1976b) doses 
and it inhibits the infiltration of leucocytes (Takeuchi et al., 1978).
The pharmacological effects of a-haemolysin in vivo have been reviewed by 
Jeljaszewicz, Szmigielski and Hryniewicz (1978); the peripheral 
circulation, heart and central nervous system are the main areas affected 
(Arbuthnott, 1970).
The mode of action of a—haemolysin on cell membranes is still 
unclear. Bernheimer (1974), Wiseman (1975)» Freer and Arbuthnott (1976)
12
and McCartney and Arbuthnott (1978) have reviewed this topic and two 
mechanisms have been postulated. These are that a—haemolysin causes 
membrane damage due to its surface active properties or secondly by 
enzymic activity. The surface activity of a-haemolysin has been 
investigated in detail by Buckelew and Colacicco (l97l)» Colacicco and 
Buckelew (l97l)> Bernheimer ert al. (1972), Arbuthnott, Freer and McNiven 
(1973) and Freer, Arbuthnott and Billcliffe (1973) and it has been 
suggested that the mode of action might involve penetration and dis­
organisation of the hydrophobic region of the cell membrane (McCartney 
and Arbuthnott, 1978). However, experimental evidence has not been 
produced to explain the high specificity of a-haemolysin for rabbit 
erythrocytes (Freer and Arbuthnott, 1976).
Wiseman (1975) has reviewed the evidence supporting the possible 
enzymic activity of a-haemolysin. It has been postulated that a- 
haemolysin is activated by a membrane-bound protease to become itself a 
proteolytic enzyme (Wiseman and Caird, 1970; Wiseman and Caird, 1972; 
Wiseman, Caird and Fackrell, 1975)* This has not been confirmed by 
others (Freer et al., 1973). The finding that a-haemolysin activity was 
associated with cholesteryl esterase has suggested a different enzymic 
mechanism (Harvey, 1974)• However, these two entities have now been 
separated by isoelectric focusing (McCartney et al., 1977; Harvey, 1977). 
More recent studies have attempted to find a specific receptor for a- 
haemolysin on erythrocyte membranes (Cassidy and Harshman, 1976a), 
however, the involvement of specific high affinity membrane receptors in 
the lytic mechanism of a—haemolysin has been disputed (Phimister and 
Freer, 1979).
(ii) Beta-haemolysin
Glenny and Stevens (1935) first showed p-haemolysin to be
13
serologically distinct from a-haemolysin. A characteristic phenomenon 
of this haemolysin is its "hot-cold11 haemolytic action on sheep erythro­
cytes (Walbum, 1921; Bigger, Boland and 0*Meara, 1927). That is, 
haemolysis is greatly enhanced if incubation at 37°C is followed by a 
period of incubation below 10°C. Although various hypotheses have been 
offered, the nature of the reaction is still not fully understood 
(Wiseman, 1970; Meduski and Hochstein, 1972; Bernheimer, 1974;
Mollby et al., 1974? Mollby, 1976). However, Smyth, Mollby and Wadstrom 
(1975) bave shown that divalent cations are important for the stability 
of sphingomyelin-depleted membranes and have suggested that "hot-cold" 
haemolysis may be a consequence of the temperature dependence of divalent 
ion stabilization.
It is now well established that |3-haemolysin is a sphingomyelin­
ase C having a substrate range confined to sphingomyelin and lysophospha- 
tidylcholine (Doery et_ al., 1963* 1965? Maheswaran and Lindorfer, 1967; 
Wiseman and Caird, 1967; Wadstrom and Mollby, 1971a,b). Erythrocytes
of the sheep, goat and cow are highly sensitive to (3-haemolysin and 
correlation between the sphingomyelin content of erythrocytes of different 
species and their sensitivity to (3-haemolysin has been shown by Wiseman 
and Caird (1967). The substrate specificity of 3-haemolysin has made it 
a particularly useful agent in the study of biological membranes (Low 
et al., 1974; Mollby, 1976; Avigad, 1976).
Beta-haemolysin is a protein (Jackson, 1963; Wiseman, 1965; 
Maheswaran, Smith and Lindorfer, 1967; Haque and Baldwin, I969) with a 
disputed molecular weight. This topic has been reviewed by Wiseman
(1975) and a molecular weight of 33*000 and isoelectric point of 9*3 for 
the major form of 3“baemolysin bas recently been reported by Low and 
Freer (1977b).
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The toxicity of |3-haemolysin both in vivo and in vitro has also 
been disputed (Elek, 1959; Wiseman, 1965* 1970; Wadstrom and Mollby, 
1972). However, the cytopathic effect of partially purified (B-haemo- 
lysin reported for various cell lines (Korbecki and Jeljaszewicz, 1965; 
Wiseman, 1968) has been confirmed using highly purified preparations 
(Wadstrom and Mollby, 1972; Mollby and Wadstrom, 1975; Kwarecki et al., 
1975; Thelestam et al., 1975; Thelestam and Mollby, 1975^;
Szmigielski et al,, 1976). As well as tissue culture cells, (3-haemolysin 
damages leukocytes (Gladstone and Van Heyningen, 1957; Szmigielski et al., 
1976), macrophages (Chesbro et al., 1965) and blood platelets (Wadstrom 
and Mollby, 1972).
Mollby and Wadstrom (1975) reported that intraperitoneal or 
intravenous injection of highly purified (3-haemolysin into mice or 
rabbits was lethal within a few minutes. Similarly, Gow and Robinson
(1969) showed (3-haemolysin to be toxic but this has not been confirmed 
in other investigations (Wiseman, 1965; Fackrell and Wiseman, 1976b;
Low and Freer, 1977a). Similarly, the previously reported dermonecrotic 
activity of p-haemolysin (Wiseman, 1965; Wadstrom and Mollby, 1972) has 
not been confirmed (Fackrell and Wiseman, 1976b; Low and Freer, 1977a).
(iii) Gamma-haemolysin
The existence of y-haemolysin was first described by Smith and 
Price (1958)» Later Smith (1956) isolated a "rough11 variant known as 
strain 5R which produced large amounts of this haemolysin. Purified 
y-haemolysin (strain 5R) consists of two factors of pi 9*8 and 9*9 
(Taylor and Bernheimer, 1974) which act synergistically (Guyonnet,
Plommet and Bouillanne, 1968; Guyonnet and Plommet, 1970). Separation 
of these proteins was obtained using hydroxylapatite chromatography but
15
not by isoelectric focusing (Taylor and Bernheimer, 1974)* which may 
account for the single component found by other workers (Mollby and 
Wadstrom, 1971; Fackrell and Wiseman, 1976a).
Rabbit, human and sheep erythrocytes are sensitive to the 
haemolytic action of y-haemolysin while those of the horse are resistant 
(Guyonnet and Plommet, 1970). Very little is known about the mode of 
action of y-haemolysin. Haemolytic activity is inhibited by EDTA 
(Fackrell and Wiseman, 1976b), phospholipids and sterols (Taylor and 
Bernheimer, 1974; Fackrell and Wiseman, 1976b) and also by sulphated 
polymers such as agar, dextran sulphate and heparin (Mollby and Wadstrom,
1971). This inhibition by agar precluded its detection by blood agar 
haemolysis by Elek (1959) who regarded alpha-2, delta- and gamma-haemolysins 
as being identical. Since sodium ions are required for lysis the action 
may be enzymic (Wiseman, 1975).
In vitro, y-haemolysin was reported to be cytotoxic for human 
leucocytes and lymphoblast cells (Fackrell and Wiseman, 1976b) and also 
for rabbit peritoneal granulocytes (Szmigielski et al., 1976). Other 
workers failed to detect liberation of labelled nucleotides after incubation 
of the haemolysin with human fibroblast and HeLa cell cultures (Thelestam 
et al., 1973).
In vivo, y-haemolysin was not lethal for mice although intra- 
cardial injection of 50 |ig was fatal for guinea pigs (Fackrell and 
Wiseman, 1976b).
(iv) Delta-haemolysin
In 1947 Williams and Harper first observed that various strains 
of S. aureus, grown on sheep blood agar, produced a haemolytic agent 
which was not neutralised by either a- or [B-antitoxins. This agent was
16
termed 6-haemolysin and has provided an interesting area of research for 
more than 30 years,
a) Production: The production of 6-haemolysin was first described 
by Marks and Vaughan (1950) who used the dialysis membrane technique 
devised by Birch-Hirschfeld (1934)• The 6-haemolysin produced was 
retained on top of these membranes, separating it from the non-dialysable 
components of the medium. Since then many workers have employed this 
technique with some variations in the medium (Jackson and Little, 1958; 
Hoffman and Streitfeld, 1985? Murphy and Haque, 1967; Wiseman and Caird, 
1968; Kleck and Donahue, 1968; Murphy and Haque, 1974)*
More recently, a semi-defined fluid medium (Gladstone and Van 
Heyningen, 1957; Bernheimer and Schwartz, 1963) comprising protein 
hydrolysate and diffusate of yeast extract has been employed (Yoshida,
1963; Heatley, 1971; Kreger et al,, 1971; Kapral and Miller, 1971; 
Kantor, Temples and Shaw, 1972) for production of large volumes of high 
potency crude toxin. Williams and Harper (1947) reported that 6-haemo- 
lysin production did not occur in fluid medium, but the importance of 
adequate aeration may have been overlooked (Yoshida, 1963; Turner, 1978b). 
Other factors which are important for maximum 6-haemolysin production 
in liquid media are l) the concentration of yeast diffusate, 2) the 
volume of the medium and 3) the strain of S. aureus (Turner, 1978b).
b) Purification: Marks and Vaughan (1950) partially purified 
6-haemolysin by extraction of the crude supernate with ethanol in which 
6-haemolysin was soluble. Jackson and Little (1958) recovered partially 
purified 6-haemolysin from heated (60°c/l0-15 min) crude culture 
supernates by precipitation with ethanol at pH 4 and. -5°C.
More recently, Heatley (l97l) purified 6-haemolysin by ammonium
sulphate precipitation of heated (60°c/l h) crude culture fluids of 
strain 186X, followed by chloroform-methanol extraction and cyclic 
transfer between organic and aqueous phases of a two phase system 
(chloroform/methanol/water) by adjustment of the pH. A single poly- 
disperse peak (4-9S) was observed on ultracentrifugation of the purified 
haemolysin while on PAGE at pH 4*6 or pH 8.4 a main diffuse band with a 
faint diffuse secondary band was shown.
Hallander (1968) purified 6-haemolysin by gel filtration, 
preparative electrophoresis and chloroform/methanol (2:1) extraction. 
Immunodiffusion against antisera to 6-haemolysin yielded a single 
precipitin line.
The use of ion exchange chromatography as a step in purification 
of 6-haemolysin has been employed by several workers. Yoshida (1963) 
obtained a crystalline preparation of 6-haemolysin produced by strain 
Poggie by chromatography of concentrated, heated culture supernates on 
calcium phosphate gel and DEAE-cellulose. The haemolytic fraction was 
lyophilised and recrystallised 2-3 times by dissolution in Tris buffer 
and dialysis against water. A sedimentation coefficient of 6.1S was 
obtained by ultracentrifugation. However, Gladstone and Yoshida (1967) 
subsequently showed this preparation to be contaminated with significant 
quantities of ribonuclease and (3-haemolysin.
Caird and Wiseman (1970) purified 6-haemolysin of strain E-delta 
by isoelectric precipitation (pH 4)» ammonium sulphate precipitation and 
DEAE-cellulose chromatography. Purified haemolysin, obtained in a 16% 
yield with a 32-fold increase in specific activity, yielded a single 
precipitin line on immunodiffusion or immunoelectrophoresis against 
antiserum to 6-haemolysin. A single protein band was noted on PAGE 
(pH 9,5) but ultracentrifugation revealed two components (2.8S and 9*8S).
17
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More recently, Kreger _et al. (I97l)» using a mutant strain of 
Wood 46 which produced very little a-haemolysin (W46M), purified 5-haemo­
lysin by adsorption to hydroxylapatite and elution with phosphate buffers 
of increasing molarity. After dialysis against water both soluble and 
insoluble forms were recovered. The soluble haemolysin was heterogeneous 
by gel filtration, sucrose density gradient centrifugation, ion exchange 
chromatography, PAGE and isoelectric focusing. Two bands were obtained 
in PAGE at pH 4*3 and pH 9*5 and, on isoelectric focusing, two protein 
bands (pi 9*5 and 5*0)> corresponding to the peaks of haemolytic activity, 
were found. Refocusing of the basic haemolysin yielded additional 
acidic haemolysin but the converse did not apply. Electron microscopy 
of fractions of purified haemolysin showed two forms, one a fibrous high 
molecular weight (ll.9S) fraction of pi 5*0 and a second granular lower 
molecular weight fraction (4«9S) with a pi of 9«5« Unlike the preparation 
of Yoshida (1963), Kreger et al. (1971) stated that their preparation was 
free of ribonuclease and (3-haemolysin as well as other haemolysins and 
enzymes. However Fackrell and Wiseman (1974) found the preparation of 
Kreger ejt al. (1971) to be contaminated with a- and y-haemolysins and 
concluded that this method of purification was no more satisfactory than 
that of Yoshida (1963).
Kantor jet al. (1972) achieved a 20-fold purification of 5-haemo­
lysin (strain W46M) by adsorption to aluminium hydroxide gel and elution 
with 0.5M phosphate buffer pH 7*2. Delta-haemolysin was homogeneous by 
PAGE, isoelectric focusing in the presence of 0.1% Tween 80 (pi 5*2) and 
gel filtration in 6M guanidine hydrochloride.
Recently the efficacy of three of these procedures (Wiseman and 
Caird, 1968; Kreger jet al., 1971; Kantor et_ al., 1972) as purification 
techniques for 5-haemolysin was disputed by Lee et. al• (1976). They
19
claimed, that none of these methods yielded pure preparations of 6- 
haemolysin of S. aureus strain I46P.
c) Physiochemical properties: Table 5 summarises the findings on the
isoelectric point of 6-haemolysin. There are also various conflicting 
reports of the molecular weight of 6-haemolysin (Table 6). However, by 
gel filtration and sedimentation velocity centrifugation in increasing 
concentrations of Tween 80, Kantor et al. (1972) proposed a model to 
explain these variations in molecular weight, sedimentation coefficient 
and isoelectric points. They suggested that 6-haemolysin consists of 4 
individual polypeptide chains of molecular weight 5100 bo 5200 daltons 
which form a basic subunit of 21,000 daltons. Association of five or ten 
of these basic subunits would then yield polymers of molecular weights 
consistent with those determined in the absence of Tween 80 by sucrose 
gradient centrifugation, analytical ultracentrifugation and gel filtration.
Amino acid analyses of 6-haemolysin consistently show lysine, 
aspartic acid and isoleucine present in high amounts, with histidine, 
arginine, proline, cysteine and tyrosine absent or present as traces 
(Table 7)» Caird and Wiseman (1970), however, found the N-terminal 
amino acid of 6-haemolysin (strain E-delta) to be proline. It is never­
theless agreed that 6-haemolysin is a simple protein containing less than 
1.5% lipid, phosphorus or carbohydrate (Yoshida, 1963? Kreger et al.,
1971> Heatley, 1971? Turner, 1978a) which is sensitive to various 
proteolytic enzymes (trypsin, chymotrypsin, pronase, papain and pepsin) 
(Kreger et al,, 1971? Kantor et al., 1972).
Delta-haemolysin differs from the other haemolysins of S. aureus 
in being relatively thermostable (no loss of activity after 80°C for 1 h; 
Kreger et al., 1971), highly surface active (Colacicco et al•, 1977) and
20
Table 5. Isoelectric point of Staphylococcal 6-haemolysin
_ P i Reference
5.52; 5.75; 8.45 Maheswaran and Lindorfer, 1970.
9.6 Mollby and Wadstrom, 1970.
5.0; 9.5 Kreger et al.. 1971.
10.01 McNiven et al•, 1972.
5.2 Kantor ejt al. , 1972.
4.45 Chao, 1976.
9.6 Fackrell and Wiseman, 1976b.
4.5 Whitelaw, 1978.
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adsorbing quickly and strongly to glass and polypropylene (Heatley,
1971)* In addition, 6-haemolysin is amphipathic, from its ability to 
dissolve in both organic (Marks and Vaughan, 1950; Jackson and Little,
1958; Heatley, 1971; Kreger et al., 1971; Colacicco £t al., 1977)
and aqueous (Heatley, 1971; Kreger et al., 1971; Colacicco, 1972) media.
d) Biological properties: Delta-haemolysin has a wide haemolytic
spectrum (Wiseman, 1970; Jeljaszewicz, 1972). Gladstone (1966) stated 
that all erythrocytes tested were susceptible to 6-haemolysin. Human 
erythrocytes have generally been used to detect haemolytic activity, but 
recent work in this laboratory (Chao and Birkbeck, 1978t>) has shown that 
cod erythrocytes are more sensitive than mammalian erythrocytes to the 
action of 6-haemolysin (Table 8). Synergistic action between (3- and 6- 
haemolysins has been shown with both sheep (Williams and Harper, 1947;
Marks and Vaughan, 1950; Kreger et al., 1971) and human (Heatley, 1971) 
but not fish (Chao and Birkbeck, 1978b) erythrocytes.
In vitro, 6-haemolysin exerts a strong cytopathic effect on various 
cell lines (Gladstone and Yoshida, 1967; Hallander and Bengtsson, 1967; 
Thelestam et al., 1973)» leucocytes (Jackson and Little, 1957; Gladstone 
and Yoshida, 1967; Hallander and Bengtsson, 1967) and bacterial protoplasts 
and spheroplasts (Bernheimer, Avigad and Grushoff, 1968; Kayser, 1968; 
Kreger et al., 197l)« Cellular organelles such as lysosomes and mito­
chondria (Bernheimer and Schwartz, I964; Gladstone and Yoshida, 1967;
Evans and Lack, 1969; Kreger et al., 1971; Kantor et al,, 1972; Rahal,
1972) and lipid spherules (Freer, Arbuthnott and Bernheimer, 1968;
Kreger et al,, 1971) are also disrupted by 6-haemolysin. Delta-haemolysin 
also prevented growth of certain bacterial species for up to 4 days 
(Kreger et al,, 1971)• In addition to being cytotoxic, 6-haemolysin can 
also inhibit water absorption (Kapral _et al., 1976) and increase cyclic
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Table 8 Relative Sensitivity fo 6-haemolysin of Erythrocytes
of Different Species



















Human 100 100 100 100 100
Rabbit 25 25 200 50 60
Sheep 25 12.5 40 50 20
Horse 5 6 100
Guinea Pig 6 12.5 50
Pig 40







AMP (cAMP) levels (O'Brien and Kapral, 1976) in the guinea pig ileum.
The haemolysin also increases the vascular permeability in guinea pig 
skin (O'Brien 'and Kapral, 1976). The mechanism by which 6-haemolysin 
produces these effects is different from that initiated by cholera toxin 
(O'Brien and Kapral, 1977) but may be due to its ability to augment 
intercellular movement of ions across the mucosa rather than the stimu­
lation of transcellular processes (O'Brien, McClung and Kapral, 1978).
The toxicity of delta-haemolysin in vivo has been studied by 
several workers (Table 9). For example, Marks and Vaughan (1950) 
injected 6-haemolysin intradermally in man and observed slight erythematous 
lesions which disappeared within 48 h. Larger amounts injected into 
rabbit or guinea pig skin induced indurated lesions which, in the guinea 
pig, became necrotic. Similar findings were reported by Kreger et al. 
(1971). It must,however, be emphasised that the lethal and dermonecrotic 
effects observed with the large doses shown in Table 9 could well be due 
to contamination with a-haemolysin which is considerably more toxic than 
6-haemolysin,
e) Mode of action: Wiseman and Caird (1968) proposed that 6-haemolysin
possessed phospholipase C activity since the purified haemolysin was shown 
to release acid-soluble phosphorus from phospholipid extracts of erythro­
cytes in direct proportion to their haemolytic sensitivity. However, 
other workers failed to detect phospholipase C activity in their 
preparations (Kreger et al., 1971; Heatley, 1971; Kapral, 1972; Rahal,
1972) and the kinetic studies on 6-haemolysin were not consistent with 
an enzymic mode of action (Marks and Vaughan, 1950; Jackson and Little, 
1958; Bernheimer, 1970; Kapral, 1976).
Recently, Low and Finean (1976, 1977) purified a phosphatidyl 
inositol-specific phospholipase C from S. aureus which had no detectable
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Table 9 Effects of 5-haemolysin in animals





Mouse 110 (MLD) Kreger et al. (1971)
10 (ed50) - Gladstone (1966)
> 4 (1®50) > 0.1 Fackrell and Wiseman
(1976b)
Rabbit - 0 •rH1LPv.o Kreger et al. (1971)
- < 1 II
. - 0.005 - 0.5 Gladstone (1966)
5000 (U)50) Wadstrom and Mollby
(1972)
Guinea pig JO (MLD) 0.5 - l.o Kreger et al. (1971)
- <_i II
> 4 ( M 50) > 0.1 Fackrell and Wiseman
(1976b)
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haemolytic activity. The phosphatidyl inositol in erythrocyte ghosts 
was readily hydrolysed by this phospholipase C but was not hydrolysed in 
intact erythrocytes. This suggested that at least 75-80% of the 
phosphatidyl inositol was located in the inner leaflet of the membrane 
and therefore would render it inaccessible for the hydrolytic action of 
Wiseman's preparation. Thus,the activity of Wiseman's preparation may 
be due to contamination by this enzyme.
The high surface activity (Colacicco et al., 1977) and the high 
content of hydrophobic amino acids (Table 7) of 5-haemolysin have led to 
the suggestion that 5-haemolysin affects membranes by a detergent-like 
action (Kreger et al., 1971; Bernheimer, 1974; Alouf, 1977)- Evidence 
for this detergent-like action has been shown in kinetic studies in which 
lysis of cells occurred rapidly without a lag period (Wadstrom and Mollby, 
1972; Thelestam et al., 1975; Kapral, 1976) although the temperature 
dependence of the reaction has been disputed (Thelestam e_t al., 1975 5 
Kapral, 1976). The lytic activity (Thelestam and Mollby, 1975a,b) and 
the metabolic changes in rabbit liver mitochondria (Rahal, 1972) caused 
by 5-haemolysin have been compared to the non-ionic detergent Triton X-100 
The principal toxin of bee venom, melittin, has similarly been compared 
with 5-haemolysin (Thelestam and Mollby, 1975a,b; Freer and Arbuthnott, 
1976). Lee and Haque (1976) have recently suggested that only super­
ficial contact between 5-haemolysin and erythrocytes is required for lysis
f) Inhibition by normal sera and by phospholipids: Neutralisation of
5-haemolysin by normal serum from various animals was first reported by 
Marks and Vaughan (1950)• Formation of a precipitin line has also been 
found between normal serum and 5-haemolysin on immunodiffusion (Gladstone 
and Yoshida, 1967) and immunoelectrophoresis (Kantor et al., 1972). 
Identification of the inhibitory components by serum fractionation has
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been attempted by several workers (Marks and Vaughan, 1950» Jackson and 
Little, 1958; Gladstone and Yoshida, 1967; Kantor et al., 1972) and 
recent work has identified a- and (3-lipoproteins as the inhibitory factors 
to 6-haemolysin present in normal serum (Whitelaw and Birkbeck, 1978).
The lipoproteins were purified by zonal ultracentrifugation of serum in 
potassium bromide density gradients and were shown to inhibit 6-haemolysin 
and give a precipitin line on gel diffusion. Fractions,which, by poly­
acrylamide gel electrophoresis were shown to be devoid of such lipoproteins, 
were non-inhibitory (Whitelaw, 1978)*
In addition to neutralisation by normal serum, 6-haemolysin is 
neutralised by many phospholipids, although conflicting reports are found 
in the literature (Table 10). Recently, Kapral (1976) found that C ^  to
C-^ 2 saturated fatty acids potentiated the haemolytic activity of
6-haemolysin and that fatty acids with longer chain lengths inhibited 
haemolytic activity. This action was thought to occur by influencing 
the binding of 6-haemolysin to the erythrocyte membrane.
g) Immunogenicity: The production of specific antibodies to 6-haemo­
lysin has been reported by McLeod (1965), Kayser and Raynaud (1965), Caird 
and Wiseman (1970) and Lochman and Vymola (1974)• Also, Rusakova (1970) 
reported the production of an antigenic toxoid of 6-haemolysin by formol- 
isation which induced a specific antibody to the haemolysin. However, 
there was no evidence that non-specific lipoprotein inhibitors had been 
removed from the sera. The failure to detect an elevated neutralising 
capacity or additional precipitin lines on gel diffusion of sera after 
immunisation with 6-haemolysin led to the view that 6-haemolysin was not 
antigenic (Gladstone and Yoshida, 1967; Kleck and Donahue, 1968;
Hallander, 1968; Kantor et al., 1972).
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Gladstone and van Heyningen, 1957 > 
Caird and Wiseman, 1970*
Kreger et al., 1972; Kapral, 1972; 
Whitelaw and Birkbeck, 1978*
Kreger et; al., 1971; Kapral, 1972; 
Whitelaw and Birkbeck, 1978*











Phosphatidyl choline (synthetic) 
Phosphatidyl choline (egg,
catalytically reduced) 
Phosphatidyl ethanolamine (synthetic) 
Cardiolipin (synthetic)
Albumin (human sera)
Gladstone and Yoshida, 1967;
Kreger _et al., 1971; Kapral, 1972 
Kapral, 1972.
Inhibitory agents : 
Stimulatory agents ;
21-23C fatty acids Kapral, 1976 
13-198 fatty acids 11 11
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Fackrell and Wiseman (1974) obtained specific anti-5-haemolysin 
antibodies in sera of rabbits immunised intensively with increasing 
concentrations (200 |ig - 2 mg) of 5-haemolysin. Precipitinogenic 
activity resided in an IgG fraction prepared by ammonium sulphate 
fractionation and ion-exchange chromatography. The purified anti-5- 
haemolysin gave a single line on gel diffusion and immunoelectrophoresis 
with purified 5-haemolysin and, unlike Gladstone and Yoshida (1967), the 
line of precipitation also coincided with the zone of haemolysis caused by 
5-haemolysin in blood-agarose gel diffusion tests. Kapral (1976) argued 
that Fackrell and Wiseman's findings did not prove the antigenicity of 
5-haemolysin. Preimmune sera will precipitate 5-haemolysin (Kantor 
et al., 1972) and, since this reaction results from the combination with 
a substance other than globulin, Kapral maintains that no proof was given 
that the precipitate consisted of 5-haemolysin and specific antibody.
Further work has, however, also shown 5-haemolysin to be immuno­
genic in rabbits (Birkbeck and Whitelaw, 1976, 1979)* Rabbits were 
immunised subcutaneously with 5-haemolysin emulsified in Freund's Complete 
Adjuvant (FCA). High neutralising titres were found in these immune sera 
and, on immunodiffusion, they gave two precipitin lines with purified 
5-haemolysin while only one precipitin line was present with pre-immune 
sera. After removal of lipoproteins by zonal centrifugation in potassium 
bromide density gradient, the immune sera, unlike the pre-immune sera, 
retained their precipitinogenic and neutralising activities.
The immunogenicity of 5-haemolysin has also been shown by Heatley 
(1977)» Immunoglobulin G fractions from the sera of rabbits immunised 
with either "insoluble" or "solvent-transferred" 5-haemolysin precipitated 
with and neutralised both forms of the haemolysin. This did not occur 
with pre-immune sera. By an affinity chromatography technique the
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antigenicity of 5-haemolysin was confirmed (Heatley and Gladstone, 1977)-
Comparative studies of 5-haemolysins produced by different 
strains of S. aureus have recently indicated that antigenic differences 
may occur between these haemolysins (Turner, 1978a).
2. Role of Extracellular Products in Virulence
Studies of the pathogenesis of S. aureus and the role of various
factors in virulence has been greatly hampered by the lack of suitable
experimental models. Laboratory animals are very resistant to infection 
by staphylococci and staphylococcal abscesses can be produced in mice only 
by subcutaneous injection of large numbers ( >10^) of organisms (James and
MacLeod, 1961; Fisher and Robson, 1963; Takeuchi and Suto, 1976;
Musher and McKenzie, 1977; Takeuchi et_ al., 1978). However, in the 
presence of a foreign body such as a suture (James and MacLeod, 1961) or 
cotton-dust (Noble, 1965; Hill, 1968, 1969) subcutaneous abscesses can be 
produced with as few as 100 viable organisms. Table 11 reviews various 
animal models which have been developed to study staphylococcal infections.
Three main approaches have been used to study the possible 
virulence factors in staphylococcal infections:
1) Purification of extracellular products and investigation of 
their effects in vitro and in vivo.
2) Investigation of the protective effect of active or passive
immunisation with extracellular products.
3) Comparison of mutants of a strain of known virulence.
The role of several staphylococcal extracellular products shall be 
individually discussed.
(i) Alpha-haemolysin: The majority of strains of S. aureus excrete
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of a-haemolysin in vivo has “been shown in rabbits, mice and guinea pigs 
(Gladstone and Glencross, i960; Kapral, Keogh and Taubler, I9655 Poster, 
1967; Bartell et al., I968; Takeuchi and Suto, 19745 Anderson, 19745 
Takeuchi e_t al., 1978). Tissue necrosis has been linked directly and 
indirectly with a-haemolysin production in vivo (Foster, 19675 Goshi 
et al., 1961, 1963a,b) as has increased invasiveness (Kimura, 1971; 
Takeuchi and Suto, 1974)*
Alpha-haemolysin deficient mutants had either a completely (Van 
der Vijver, Van Es-Boon and Michel, 1975a,b) or partially (Taubler et al., 
1963) reduced ability to cause dermonecrosis in mice and had a reduced 
ability to multiply in the kidneys of mice challenged intravenously (Van 
der Vijver e_t al•, 1975L) • Also, the lethal dose for mice of such 
mutants on intraperitoneal injection was higher than that of the wild 
type (Kapral, 1965).
(ii) Beta-haemolysin; Beta-haemolysin is produced mainly by strains 
of S, aureus of animal origin (Elek and Levy, 1950; Fraser, 1964).
Kimura (1971) showed that mutant strains of S. aureus producing p-haemo- 
lysin, but not a-haemolysin, were lethal but less invasive in mice 
challenged intraperitoneally than mutants producing a-haemolysin. 
Production of p-haemolysin during experimental infection in mouse skin was 
shown by Takeuchi and Suto (1974) and. a p-haemolysin producing strain of
S. aureus caused cutaneous changes in mouse skin (Takeuchi et al., 1978)* 
However, a strain of S. aureus that produced p-haemolysin but not a- 
haemolysin failed to cause clinical mastitis when injected into the udder 
of cows (Slanetz and Bartley, 1953) and anti-p-haemolysin did not protect 
rabbits against mastitis after intramammary challenge with staphylococci 
(Adlam et al., 1977)*
(iii) Delta-haemolysin: The production of 5-haemolysin correlates as
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well with potential pathogenicity of strains of S. aureus as does a- 
haemolysin (Elek and Levy, 1950* Jeljaszewicz, 1960a,b). Kapral (1974) 
reported that lethal doses of 5-haemolysin (200 were produced in
the peritoneal cavity of mice and rabbits within 2 h of inoculation if 
the inoculum was large enough (2 x 10 or more) and 5-haemolysin was of 
prime importance in infection if a-haemolysin was not produced. Mutant 
strains of S. aureus lacking 5-haemolysin had reduced dermonecrotic activity 
in local lesions which developed after subcutaneous injection (Van der 
Vijver et al., 1975a,b).
A role for 5-haemolysin in staphylococcal enteritis has been 
postulated by O’Brien and Kapral (1976). This is based on the evidence 
that 5-haemolysin inhibits water absorption in the guinea pig and rabbit 
ileum (Kapral et al., 1976), causes increased cAMP levels in the guinea 
pig ileum and increased vascular permeability in guinea pig skin (O’Brien 
and Kapral, 1976). These results are comparable with the enterotoxin of 
V. cholerae which is solely responsible for clinical cholera (Hendrix,
1971)• However, unlike cholera enterotoxin, 5-haemolysin did not cause 
spindling of Chinese hamster ovary cells, rounding of Y-l adrenal cells 
nor promote steroid production by these cells (O’Brien and Kapral, 1977) 
all of which are related to an elevation of intracellular cAMP content. 
Delta-haemolysin did, however, lyse both Chinese hamster ovary and Y-l 
adrenal cells but the increase in cAMP levels caused by 5-haemolysin may 
be mediated through a mechanism different from that initiated by cholera 
toxin (O'Brien et al., 1978)*
(iv) Gamma-haemolysin: Studies on antibodies induced during staphylo­
coccal osteomyelitis in humans indicate that y-haemolysin is produced 
in vivo since elevated titres of specific antibodies have been found in 
nearly all osteomyelitic subjects (Taylor and Plommet, 1973; Taylor et al.,
1975)* Similarly Kurek et al. (1977) Pound synthesis of antibodies 
against y-haemolysin in rabbits with experimental staphylococcal osteo-
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myelitis and they have proposed a role for y-haemolysin in the pathogenesis 
of osteomyelitis.
(v) Epidermolytic toxin: Toxic epidermal necrolysis (TEN) or 
Staphylococcal Scalded Skin Syndrome is a disease of infants and children 
characterised by intra-epidermal splitting and extensive exfoliation of
the epidermis. The epidermolytic toxin of S. aureus has been unequivocally 
shown to be responsible for these symptoms. On subcutaneous injection of 
purified toxin or of strains producing this toxin into neonatal and adult 
mice, the symptoms mimic those found in humans (Melish and Glasgow, 1970; 
Melish et al., 1972; Arbuthnott et al., 1972; Kapral and Miller, 1971; 
Elias jet al., 1974a,b; Elias, Fritsch and Epstein, 1977)* Because of 
the role of epidermolytic toxin in TEN it can be recognised as a major 
virulence determinant in this syndrome.
(vi) Enterotoxins: Five serologically distinct enterotoxins (A, B, C,
D and E) have so far been recognised (Bergdoll, 1972). The enterotoxins 
are produced in some foods by staphylococci (mainly phage group III 
strains) and the ingestion of toxin leads to staphylococcal food poisoning 
with classical symptoms of diarrhoea and vomiting 1-6 h after ingestion 
(Dack, 1956). Various animals have been used to study the effects of the 
enterotoxin, including rhesus monkeys, cats, dogs, rabbits, rats and mice 
(Bergdoll, 1972) but they are less sensitive to the enterotoxin than man. 
Besides their known role in food poisoning, enterotoxins may also figure 
in cases of enterocolitis. However, enterocolitis cannot be connected 
with the consumption of food since it occurs sporadically, has a more 
prolonged course (Bergdoll, 1972) and usually occurs in patients on anti­
biotic therapy in which resistant staphylococci develop (Matthais, Shooter 
and Williams, 1957)* Although there is indirect evidence that staphylo­
cocci produce enterotoxin while growing in the intestinal tract 
(Bergdoll, 1972) there is no direct proof that the toxin is involved in
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entercolitis. Indeed, as stated earlier, O'Brien and Kapral (1976) have 
suggested that 6-haemolysin may play a role in entercolitis.
(vii) Coagulase: The production of coagulase has been considered as 
a protective mechanism for staphylococci against phagocytosis (Hale and 
Smith, 1945) "but this has not been confirmed by other workers (Cowdery 
et al,, 1969; Foster, 1962a,b; Anderson and Chandler, 1975)* An 
alternative role for coagulase has been proposed by Ekstedt (1956) who 
suggested that coagulase may protect the organism against the antibacterial 
activity of human serum since coagulase negative strains, suspended in 
partially purified coagulase and injected intracerebrally, caused 
significant mortality (Ekstedt and Yotis, i960). Injection of the 
organisms or coagulase alone at the same dose level was innocuous.
Coagulase negative mutant strains were as virulent in experimental 
animals as parent strains (Kapral and Li, i960). Also, coagulase 
negative strains have been implicated in various infections including 
endocarditis (Brandt and Swahn, i960), wound infections (Wilson and Stuart, 
1965) and urinary tract infections (Mitchell, 1964; Mortensen, 1969).
This is therefore an indication that coagulase production may not be 
necessary for virulence of staphylococci. Gemmel, Thelestam and Wadstrom
(1976) suggest that the possession of multiple toxins and enzymes by 
staphylococci rather than the mere possession of coagulase determines 
pathogenicity.
(viii) Leucocidin: Panton-Valentine leucocidin comprises two 
components known as F (fast) and S (slow) components which act synergistic- 
ally to produce their cytotoxic effect. The leucocidin specifically kills 
polymorphonuclear leucocytes and macrophages but no other cell type 
(Woodin, 1972).
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Gladstone and Glencross (i960) showed that leucocidin was 
produced in vivo in experimental infection and, in humans, raised levels 
of anti-leucocidin were associated with infection (Gladstone et al.,
1962). Large doses of leucocidin injected into rabbits caused a marked 
but brief granulocytosis (Gladstone, 1966) and, measured in this way, 
leucocidin was relatively non-toxic. Also, mutants lacking leucocidin 
did not differ in virulence from the wild type when injected subcutaneously 
or intravenously into mice (Van der Vijver jet al., 1975b)• However, it 
has recently been shown that the leucocidin can produce dermonecrosis in 
rabbits and pre-immunisation with the F component or both F and S 
components inhibited this dermonecrosis (Ward, 1979)*
A role in pathogenicity has also been suggested for many of the 
extracellular enzymes produced by staphylococci (Abramson, 1972) but, as 
concluded by Anderson (1976), they may only be secondary factors in host 
damage and may be more important in facilitating the growth of the organism 
in vivo. Indeed, all of the products discussed above may favour 
multiplication of the organism which, in turn, may explain its patho­
genicity (Anderson, 1976). However, the existence of an unidentified 
"virulence factor” produced only in vivo cannot be dismissed (Abramson,
1972).
The Immune Response
The ability of a protein to elicit an immune response reflects a 
complex series of factors such as the structural properties of the 
immunogen, the immunisation schedule and the genetic features of the 
species and strains to which the studied animals belong. Excellent 
reviews on all aspects of the immune response are by Abramoff and La Via 
(1970), Sela (1974) and Hobart and McConnell (1975).
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1. Factors affecting the immune response
(i) Structural properties of the immunogen
The study of synthetic polypeptides has led to some understanding 
of the role which amino acid composition, disposition of groups, conform­
ation of the molecule, charge and other factors may play in determining 
immunogenicity (Crumpton, 1974> de Week, 1974)•
a) Physical state: Particulate antigens as a class, have been regarded
as being more immunogenic than soluble antigens (Wossal, Ada and Austin, 
1964; Draper and Hirata, 1968; Katsura, 1972) possibly due to a more 
efficient uptake of the particulate antigens by macrophages (Draper and 
Hirata, 1968). However, Rabin and Rose (1973) found no evidence for 
different processing mechanisms by macrophages dependent on the physical 
state of the antigen.
b) Foreignness: In order to be immunogenic, molecules must, in
general, be foreign to an organism and the more foreign, the more immuno­
genic the molecule is likely to be. Burnet and Fenner (1949) based their 
discussion on the mechanism of antibody formation on the ability of the 
antibody producing mechanisms to distinguish ’self1 from ’non-self'.
That is, antibodies are formed against only those areas of a foreign 
protein which are not shared by the animal's own proteins. For example, 
the N-terminal, non helical segments of collagen al chains from different 
vertebrates show a closer similarity in amino acid sequence than a2 chains 
and are less immunogenic than a2 chains in rabbits (Lindsley, Mannik and 
Bornstein, 1971)• The apparent relationship between immunogenicity and 
the degree of foreignness may, in part, explain why proteins of similar 
size, shape and overall amino acid composition differ so markedly in their 
immunogenicities (Prager and Wilson, 1971).
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in controlling the induction of an immune response has been shown in 
various studies in which there was a progressive rise in protein immuno­
genicity with increasing size and aggregation (Dresser, 1962; Nossal 
et al., 1964; Revchlin, Nisonoff and Margoliash, 1970» Parish and Ada, 
1972; Warren, Spero and Metzger, 1973)*
Although the reason for the enhancement of the immunogenicity of 
proteirs by polymerisation is not known several plausible hypotheses have 
been suggested. Dresser (1962) and Frei, Benacerraf and Thorbecke (1965) 
have suggested that antigens in an aggregated form are required for phago­
cytosis by macrophages which facilitate a more efficient antigen 
presentation to lymphocytes (Unanue, 1970, 1972, 1978). Reichlin et al.
(1970) postulated that retardation of renal excretion may increase the 
immunogenicity of polymers. Differences in the quaternary structure 
and/or conformational alterations that occur during polymerisation have 
also been proposed to explain the increase in immunogenicity (Crumpton, 
1974)> such changes influencing the T- and B-cell co-operation. However, 
Feldman and Basten (1971) have suggested that it is the lack of a 
requirement for T helper cells by the polymers which gives them an 
enhanced immunogenicity due to the possession of multiple and identical 
antigenic sites available to interact with B cells.
A number of attempts have been made to determine the minimum 
molecular size that is conducive with good immunogenicity. However, 
recent studies (Dintzis, Dintzis and Vogelstein, 1976) have suggested that 
a minimum number of antigenic receptors, probably 10-20, must be connected 
together in a spacially continuous cluster before an immunogenic signal 
is delivered and an immune response only occurs when a sufficient number 
of such signals per cell has been delivered.
c) Molecular size: The importance of the physical state of a protein
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d) Molecular Rigidity: A rigid structure of the determinant groups
has been suggested as a prerequisite for immunogenicity (Haurowitz, 1952; 
de Week, 1974)• For example, gelatin is feebly immunogenic and, due to 
its amino acid composition, free rotation occurs around the longitudinal 
axis and therefore the molecule has no fixed conformation. However, 
attachment of tyrosine, tryptophan or phenylalanine converted gelatin 
into a relatively powerful immunogen (Haurowitz, 1950; Sela, 1966) by 
increasing its rigidity.
(ii) Immunisation procedure
As well as the physical state of the antigen, the mode of 
administration to the animal can affect the resulting immune response.
a) Route of Injection: Several workers have found that intravenous,
intraperitoneal and subcutaneous injections were in descending order of 
efficiency for immunisation of rabbits (Webster, 1965» 1968) or mice 
(Katsura, 1972). Similarly, the intra-lymph node route of injection was 
reported to be superior to other routes (Newbold, 1965) "but this claim was 
rejected by other workers (Horne and White, 1968; Birkbeck and Stephen,
1971).
b) Dose of immunogen: The dose of antigen injected into an animal
may be extremely important in the induction of antibody production. For 
example, Mitchison (1968) found that mice given either high or low doses 
of BSA failed to respond to a later challenge dose of the antigen.
However, injection of intermediate doses induced a high antibody response 
after injection of the challenge dose. Such unresponsiveness or 
"immunological tolerance" may occur at either the T- or B-cell although 
the dose of antigen required for induction as well as the duration of
the tolerant state differs in these two types of lymphocyte (Weigle, 1975;
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Howard, and Mitchison, 1975)* The mechanism of immunological tolerance 
is at present unresolved although several proposals have been suggested 
(Humphrey, 1976). These include, the blockage of B-cell receptors by 
antigen (Borel, 1976) or the irreversible modulation of these receptors 
(Klaus and. Abbas, 1977» Klaus, 1979)* Suppression by T-cells has also 
been proposed as a mechanism for B-cell tolerance (Taylor and Basten,
1976) although Parks and Weigle (1979) failed to show a major role for 
suppressor cells in inducing or maintaining a tolerant state. However, 
recent reviews by Fernandez et al. (1979), Kettman £t al. (1979) and 
Marshall-Clarke and Playfair (1979) have further discussed the mechanisms 
of B lymphocyte tolerance.
c) Antigenic competition: The term antigenic competition has been 
used to describe the phenomenon whereby an animal, immunised with two 
antigens either simultaneously or in close sequence manifests a decreased 
response to one or both antigens (Adler, 1964)* Liacopoulos and Ben- 
Efraim (1975) proposed that competition may be due to l) obliteration of 
the ’handling’ of antigens by macrophages through some defect of antigen 
'processing' which interferes with the various functional properties of 
the cells or 2) inhibition of antigen-specific T- or B-cells by other 
cells, either directly or indirectly, via inhibitory factors.
d) Adjuvants; An adjuvant is a substance which is able to
1) convert an apparently non-immunogenic material into an 
effective immunogen
2) increase the levels of circulating antibody to an antigen
3) induce delayed type hypersensitivity or its increase, and
4) lead to the production of certain disease states (White, 1967). 
The most widely used adjuvant is Freund’s adjuvant which is a water-in-oil 
emulsion either with(Freund's complete adjuvant, FCA) or without (Freund's
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incomplete adjuvant) mycobacteria. Various other microbial products have 
adjuvant activity (Corynebacterium parvum. Bordetella pertussis, E. coli, 
Salmonella) and also nucleic acids, mineral substances, emulsions, 
organic compounds and vitamins (joll&s and Paraf, 1973)-
The general mode of action of adjuvants has been reviewed by 
numerous workers (Munoz, 1964? Neter, 1971j Jolles and Paraf, 1973>
White, 1976; Frost and Lance, 1978)* The mechanisms reported (which may 
not apply to all adjuvants) are:-
1) Adjuvants have an effect on antigen stimula either by its 
slow release from a depot or its protection from destruction and rapid 
excretion, thus improving its distribution through the body.
2) Antigen processing may be affected by adjuvants by the 
mobilisation of operative cells or by the facilitation of the interaction 
of antigens with cell membranes.
3) Antibody producing cells may be stimulated to proliferation 
with an alteration in protein synthesis, e.g. a general effect on control 
mechanism of the body.
4) Adjuvant may affect cells not involved in the immune process
so that breakdown products are released which affect immunocompetent cells.
(iii) Animals
The choice of animal for use in immunological studies is of great 
importance since there are differences in the abilities of various 
species to induce humoral and/or cell-mediated immune responses (Laky,
1978). For example, Kondo, Sakurai and Sarai (1976) have shown that 
staphylococcal exfoliatins A and B are immunogenic in the rabbit but not 
in the mouse. Similarly, it has been demonstrated that various strains 
of animals of the one species show constant differences in response to 
the same dose of antigen (Buschmann et al., 1972; Silver, McKenzie and
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Winn, 1972; Nutt, Grossberg and Pressman, 1974) while Ipsen (1959) found 
that up to 10-fold differences occurred in the response of inbred strains 
of mice to tetanus toxoid.
The recognition of specific antigens as immunogens by individual 
animals and inbred strains is governed by the products of individual 
dominant immune response (ir) genes which are linked to genes of the 
major histocompatibility complex (Benacerraf and Katz, 1975? Munro, 1975 > 
Benacerraf and Germain, 1978; Fudenberg et al., 1978). These genes 
have been termed histocompatibility or H-linked Ir genes. Although the 
relevant gene products and their cellular site of action have not been 
fully characterised, it has been shown that subsets of T cells with 
helper or suppressive activities are major factors in the control and fine 
tuning of the immune responsiveness (Gershon, 1974; Feldman et al.,
1977! Tada, 1977).
Two models have been proposed to account for the function of 
specific H-linked Ir genes (Benacerraf and Germain, 1978). The first 
model postulates that Ir genes are primarily expressed on T cells and are 
concerned with the production of specific helper and suppressor factors. 
The second model postulates that Ir genes control the immune response by 
coding for cell surface antigens on macrophages and B cells. Several 
workers have shown the importance of determinant selection by macrophages 
in controlling the immune response (Rosenthal, Barcinski and Blake, 1977; 
Niederhuber, 1978; Rosenthal, 1978; Schwartz, Yano and Paul, 1978). 
Recent work by Yowell _et al. (1979) has indicated that the presentation by 
macrophages of a specific suppressor determinant on the antigen molecule, 
may determine the immune responsiveness of an animal by the preferential 
stimulation of suppressor T cells.
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Under a variety of conditions bacterial exotoxins lose their 
toxicity without losing antigenicity and Ehrlich introduced the term 
"toxoid" to name such pharmacologically inactive toxin preparations.
The use of formaldehyde to convert these bacterial toxins into non-toxic 
derivatives appears to have its origin in the work of Lowenstein (1909)» 
who rendered tetanus toxin atoxic in this way. Glenny and Sudmerson 
(1921), Glenny and Hopkins (1923) and Ramon (1923) reported a similar use 
of formaldehyde to convert diptheria toxin into a non-toxic material.
The general subject of formaldehyde reactivity is reviewed by 
French and Edsall (1945) and subsequent studies by Fraenkel-Conrat,
Branson and Olcott (1947) and Frankel-Conrat and Olcott (1948) has extended 
the investigation of formaldehyde as a cross-linking reagent both in 
model systems and with proteins. The primary reaction with many proteins 
is the formation of aminomethyol derivatives with the e-amino groups of 
lysyl residues (Fig l). The cross-linking reaction involves the conden­
sation of this group with an active hydrogen on primary amides, guanidyl, 
phenolic, indole, and imidazolyl groups to form a methylene bridge. In 
addition, these and other side chain groups (e.g. aliphatic alcohols and 
thioalcohols) are potentially capable of initiating the crosslinking 
reaction (French and Edsall, 1945)*
Various factors may influence methylene bridge formation and the 
subsequent polymerisation of toxins. The concentration of formaldehyde 
and toxin in the reaction mixture may not only influence the size and 
number of polymers obtained (Murphy, 1967) but also the rate at which the 
reaction occurs (Wadsworth, Quigley and Sickles, 1937)* The pH of the 
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formaldehyde (French and Edsall, 1945) and, in alkaline conditions, 
formaldehyde fails to induce any polymerisation of staphylococcal entero­
toxins while, at pH 5 or pH 7*5* polymerisation is extensive (Warren 
et al., 1975, 1975).
Formaldehyde treatment has been reported to produce little or no 
change in the antigenic specificity of proteins (Habeeb, 1969, Kondo 
et al., 1976), however, high concentrations of formaldehyde have also 
been reported to lead to a marked decrease in the antigenicity of toxoids 
(French and Edsall, 1945). Gill et al. (1968) suggested that the 
formation of methylene bridges may give rise to new antigenic determinants 
depending on the degree of cross-linking. However, Rittenberg, Finney 
and Iglewski (1976) concluded that formaldehyde treatment is more apt to 
destroy antigenic determinants rather than create new ones and Warren 
et al. (1973, 1975) found that this destruction of native determinants 
was influenced by the pH of the reaction. Similarly, the immunogenicity 
of formaldehyde-treated toxins is dependent on the pH of the system 
(Eaton, 1937; Moroz-Perlmutter et al., 1963; Warren et al., 1973, 1975)and 
also on the animal used for immunisation (Kondo et al., 1976). Loss of 
immunising power of some preparations of staphylococcal toxoids has been 
reported (Fisher, 1957)*
Nevertheless, formaldehyde treatment does not involve extensive 
conformational alterations (Habeeb, 1969; Robinson, Picklesimer and 
Puett, 1975) and renders proteins relatively inert to tryptic digestion 
(French and Edsall, 1945), urea (Habeeb, 1969) and acid hydrolysis 
(Fraenkel-Conrat and Olcott, 1948). This increased stability and 
resistance to proteolysis of toxoids compared with toxin have been 
attributed to the cross-linking effects of the formaldehyde treatment 
(Bazaral, Goscienski and Hamburger, 1973; Pappenheimer, Uchida and 
Harper, 1972).
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There is evidence that formalinised toxins may reactivate both 
in vivo and in vitro. This has been shown with diphtheria (Wadsworth
et al,, 1957; Linggood et al•, 1965; Scheibel and Christensen, 1965; 
Stanier, 1968; Relyveld, 1969; Akama et al., 1971t>), tetanus (Akama 
et al., 1971a) and cholera (Northrup and Chisari, 1972; Rappaport et al,, 
1974) toxins. This reversion can be inhibited either by heating the 
toxin prior to formaldehyde treatment (Germanier et al,, 1976) or by the 
addition of certain amino acids during the detoxification process 
(Linggood et al., 1965; Scheiber and Christensen, 1965; Stanier, 1968; 
Relyveld, 1969; Northrup and Chisari, 1972; Saletti and Ricci, 1974k>). 
However, reversion to a toxic preparation was not always found with 
formaldehyde-treated toxins (Warren et al., 1975)*
Glutaraldehyde has been employed as a substitute for formaldehyde 
by several workers for the toxoiding of cholera (Rappaport e_t al., 1974) 
and other toxins (Relyveld, Girard and D6sormeau-Bedot, 1975)* The 
efficiency of glutaraldehyde as a toxoiding agent has been attributed to 
the stability of the reaction products (Habeeb and Hiramoto, 1968;
Richards and Knowles, 1968; Korn, Feairheller and Filachione, 1972). 
However, Saletti and Ricci (1974a) have shown that highly purified 
cholera toxin detoxified with glutaraldehyde lost its immunising capacity.
The use of other agents in detoxifying bacterial toxins has been 
varied both in the chemicals used and the results obtained. Carbamylation 
(Robinson et al.. 1975)» maleylation (Bizzini, Turpin and Raynaud, 1975) 
and dinitrophenylation (Raynaud, Blass and Turpin, 1957) all produced an 
atoxic, non-immunogenic derivative while methylation only reduced the 
toxicity (Robinson et al., 1975; Beugnier and Zanen, 1977)* However, 
tetranitromethane has been successfully used for the highly selective 
nitration of tyrosyl residues yielding a product that was atoxic but still
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immunogenic (Bizzini et al., 1973; Kondo et al., 1978; Beugnier and 
Zanen, 1977)* The properties of the atoxic derivatives depended on the 
degree of nitration of the tyrosine residues, too much and both immuno­
genicity and toxicity were destroyed. Employment of these methods of 
detoxification, which are specific for certain amino acids, has indicated 
that particular amino acid residues are involved in toxicity and immuno­
genicity (Robinson et al,, 1975 > Kondo et al,, 1978).
Object of Research
The immunogenicity of staphylococcal 6-haemolysin has been well 
established in the rabbit but not in the mouse. Since large numbers of 
animals are readily available, the mouse is a more convenient system for 
immunological studies. The mouse has also been employed as an animal 
model for several experimental staphylococcal infections and therefore 
induction of anti-6-haemolysin antibodies in the mouse might be useful in 
determining a role for the haemolysin in the virulence of the organism.
The primary objective of this research was therefore to establish 
conditions necessary for the induction of an immune response to staphylo­
coccal 6-haemolysin in the mouse. Since induction of an effective 
immune response might require chemical modification of 6-haemolysin, the 
effect of treatment with formaldehyde and glutaraldehyde on both the 
immune response and some ir vivo and in vitro biological properties of the 
haemolysin was considered necessary.
Finally, it was intended to screen several strains of S. aureus 
from various sources for the production of 6—haemolysin which might vary 
in their haemolytic, antigenic and other biological properties.
MATERIALS AND METHODS
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1. Strains of S. aureus
S. aureus strain NCTC 10545 was used throughout this investigation 
for large-scale production of 6-haemolysin. Other strains were obtained 
through the courtesy of Professor J.P. Arbuthnott, Trinity College,
Dublin (JK128, JK152, JK159); Dr. S. McKay, Royal Infirmary, Glasgow 
(SM14); Dr. D. Taylor, Veterinary School, University of Glasgow (canine, 
bovine and mouse strains) and Mr. W. Irving, Department of Bacteriology, 
Law Hospital, Carluke (LS human isolates). These strains and their 
source are listed in Table 12.
2. Maintenance of cultures
On receipt, all cultures were plated on to 5% washed horse blood 
agar to examine the haemolysis zones surrounding the colonies, with 
routine gram staining to confirm culture purity. Freeze-dried samples 
were reconstituted in sterile saline before plating out on to blood agar 
plates. Cultures were maintained by lyophilization or by passage on 
freshly prepared nutrient agar slopes.
3. Production of crude culture supernates
All strains were subcultured from nutrient agar slopes and 
inoculated on to 5% washed horse blood agar. After 24 h incubation at 
37°C plates were checked for culture purity and organisms from isolated 
colonies, which showed large haemolytic zones, were inoculated on to agar 
slopes and incubated overnight at 37°C. The resulting confluent growth 
was resuspended in 2 ml of sterile saline. One ml of this suspension 
was seeded into 50 ml °D pre-warmed Bernheimer diffusate medium (Appendix 
I) contained in a 250 ml flanged Erlenmeyer flask and incubated at 37°C
A. Production of 5-haemolysin
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in an orbital shaking incubator operating at 150 rpm. This was used as 
a starter culture for strain NCTC 10345* ln all other cases the crude 
culture supernates were obtained by centrifugation at 17,000 £ for 20 min.
One ml of starter culture NCTC 10345 was inoculated into 500 ml 
of pre-warmed medium in a 2 1 Erlenmeyer flask. One ml of a sterile 
solution of antifoam (Appendix i) was added to prevent excessive foaming 
during the subsequent overnight incubation. A total of six such 2 1 
flasks were processed at any one time, yielding 3  1  o f crude haemolysin. 
Crude culture supernatant fluids were obtained by centrifugation at 
17,000 £  for 20 min.
4* Purification
This was based on the method of Kreger et al. (1971)* The crude 
culture supernates were stirred for 48 h with hydroxylapatite (200 g/3000 
ml) at 4°C and unadsorbed material removed after centrifugation (300
10 min). The haemolysin/hydroxylapatite mixture was washed five times
with 400 of 0.01M phosphate buffer pH 6.8 and then washed six times
with 500 ml of phosphate buffer (pH 6.8, 0.4M). The mixture was stirred
for 30 min each time and then centrifuged at 300 g for 10 min to separate 
hydroxylapatite from the supernatant fluid. Delta-haemolysin was 
recovered from the hydroxylapatite by washing for 30 min with 200 ml 
phosphate buffer (pH 7»4, 1M). Five such washes were carried out after 
which the supernates (containing the eluted 6-haemolysin) were bulked and 
centrifuged (12,000 £, 10 min) to remove traces of hydroxylapatite. 
Following overnight dialysis against running water, haemolysin was 
recovered from the dilute solution by lyophilisation. The freeze-dried 
preparation was redissolved in approx. 250 ml distilled water and dialysed 
for a further 72 h against distilled water with frequent changing of the
water. At this stage, any insoluble material was removed by 
centrifugation at 47,000 g for 20 min. The supernates, containing 
purified soluble 6-haemolysin, were lyophilized.
B. Assay for 5-haemolysin
1. Haemolytic assay
(i) Erythrocytes: Horse blood was obtained from Gibco-Bio-Cult
Diagnostics Ltd., Paisley. Human blood was obtained from the Haematology 
Department, Western Infirmary, Glasgow. Rabbit blood was collected by 
bleeding from the marginal ear vein of stock animals housed in this 
department. Sheep blood was removed by jugular venepuncture from sheep 
from the grazing stock of the Veterinary School, University of Glasgow.
Cod blood was obtained by bleeding from the dorsal aorta of freshly 
caught fish. These were obtained from the Firth of Clyde by the
R.V. Leander, by courtesy of the University Marine Biological Station, 
Millport. In all cases sodium citrate (3.8% w/v) was used as an anti­
coagulant.
Cod blood was stored in liquid nitrogen as described by Chao and 
Birkbeck (1978a) and, when required, pellets were removed, thawed and 
washed 4 times in 12.5% DMSO/CDS (v/v). All other blood samples were 
stored at 4°C and washed 4 times in PBSA.
(ii) Standardization of erythrocyte suspensions: One ml of washed
packed erythrocytes was added to 100 ml CDS (for cod erythrocytes) or 
PBSA (for all other erythrocytes) to make an approx. 1% suspension. This 
suspension was standardized by haemolysing an aliquot with a few grains
of saponin. The amount of haemoglobin in the lysate was measured on a 
Pye Unicam SP500 spectrophotometer at A 1% suspension of




(iii) Doubling dilution titration: Doubling dilutions (0*5 nil volumes)
of samples were made in CDS (for cod erythrocytes), PBSA (for rabbit,
2 •horse or human erythrocytes) or PBSA containing 0*001M Mg (for sheep 
erythrocytes) in 100 mm x 12 mm test tubes. Equal volumes of a 1% 
erythrocyte suspension were added to each dilution and tubes were incubated 
for 50 min at 57°C, except for tubes containing cod blood which were 
incubated at room temperature for 30 min. The 50% end-point (hU^q ) was 
measured visually. To test for (3-haemolysin when using sheep erythrocytes, 
tubes were incubated at 4°C for a further 1 h. Any increase in haemo­
lytic titre after this incubation period was taken to indicate the 
presence of 3-haemolysin.
2. Vascular Permeability enhancement
This test was based on the method of 0*Brien and Kapral (1976).
(i) Animals; HAMl/CR mice were originally used but, for reasons given 
elsewhere, rabbits were employed in later experiments. White rabbits 
were obtained by cross-breeding New Zealand White and Dutch rabbits in 
this department.
The backs of the rabbits were shaved using Oster Professional 
(Model A-5) Animal Grooming Clippers. Spots were marked on the backs (to 
indicate injection sites) using a felt tip pen. A maximum of 80 spots 
per rabbit was obtained.
(ii) Procedure; The skin sites were intradermally inoculated with
0.1 ml volumes containing various doses of 5-haemolysin (l jig - 1000 jig) 
or other test preparations. After various intervals (30 min - 24 h)
3-4 ml of 5% (w/v) Pontamine Sky Blue in 0.85% NaCl was given intra­
venously. One hour later the animals were sacrificed by intravenous 
injection of Nembutal at a concentration of 35 mg per Kg of body weight.
The average diameter of responses was measured with Vernier Calipers.
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The antigenic activity of test preparations was examined by the 
double diffusion technique of Ouchterlony (1958)* Rabbit anti-6-haemo- 
lysin antisera (Birkbeck and Whitelaw, 1979) were kindly donated by 
Dr. T.H. Birkbeck. Rabbit anti-a-haemolysin (Wellcome Reagents Ltd., 
Beckenham, England) and a-haemolysin were donated by Mr. G.M. Phimister.
A microscope slide (previously cleaned in absolute alcohol) was 
covered with 2 ml of 0.75% agarose (BDH Chemicals Ltd., Poole, England) 
in PBSA. Wells (2 mm diameter) were cut in the agar with a punch and 
Perspex template with well centres spaced 6 mm apart. Wells were filled 
with either antigen solutions, diluted to approx. 62.5 [ig/nd. protein, or 
antiserum. Plates were incubated in a moist atmosphere (sandwich box 
containing dampened filter paper) at room temperature for 24-48 h.
Staining of plates: The slides were washed in saline and then distilled
water to remove unreacted protein and then pressed for 10 min, to remove 
excess water, by covering with dampened Whatman No. 1 filter paper plus 
several layers (2-5 cm) of soft blotting paper and finally a weight of 
2-4 Kg. Two such pressings were carried out followed by two washings of 
the slides in saline and distilled water. Slides were dried thoroughly 
at 37°C after which time they were stained for 2 min with Nigrosine 
(saturated solution in 2% acetic acid). Destaining in 2% acetic acid 
was followed by drying at 37°C.
2• Immunoelectrophoresis
A glass plate (ll cm x 8 cm) was covered with 15 ml molten 0.75% 
agar (Oxoid L12 purified agar) in barbitone buffer (pH 8.6, I = 0.05).
When the agar had set, 2 mm wells were cut 2 cm apart at a distance of
C.___Immunological Studies
1. Double Diffusion tests
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5 cm from the end of the slide. The wells were filled with samples 
which had been dialysed against barbitone buffer. Bromophenol Blue 
tracking dye was added to one well. Electrophoresis was performed at 
100V until the dye was 15 mm from the anodal end of the plate. For the 
development of antigen-antibody precipitin arcs, troughs (8 cm x 0.5 cm) 
were cut parallel to the direction of migration, between the wells, and 
filled with antiserum.
5* Rocket Immunoelectrophoresis (RIE)
This test was based on the method of Laurell (1966). Rabbit 
anti-6-haemolysin serum (0.15 ml) was mixed with 4*85 ml double strength 
barbitone buffer (pH 8.6). An equal volume of molten 2% agarose (BDH 
Chemicals Ltd., Poole, England) was added and the molten solution poured 
onto a 5 cm x 12.5 cm glass plate. When the gel had set, wells (2 mm 
diam.) were cut 5 mm apart along the cathode end of the slide. Each well 
was filled with 5 |H- of standard 6-haemolysin solution (25 pg - 200 pg) 
or other test samples. Electrophoresis was carried out at 48 mA for 2 h 
after which time the slides were stained in Coomassie Brilliant Blue dye 
(Weber and Osborn, 1969) destained in a methanol : acetic acid ; water 
(l : 1 : 5) solution. The height of the resulting precipitin peaks was 
measured and the concentration of antigen present in each sample was 
calculated from the standard graph.
D. Chemical modification of 5-haemolysin
1. Treatment with formaldehyde
A modification of the method of Warren £t al. (1973) was 
employed. Delta-haemolysin was exposed for various periods (0-50 days) 
to aqueous formaldehyde (Analar grade, BDH Chemicals Ltd., Poole, England);
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at pH 5, pH 7«5 or pH 9»5» I*1 these experiments, lyophilized haemolysin
was added to a formaldehyde-free buffer (0.15M phosphate, pH 5 or pH 7*5?
0.05M sodium carbonate/bicarbonate, pH 9*5) to a concentration of 1 or 
2 mg/ml. Reagent grade 36% formaldehyde was diluted 1:6 (v/v) in the 
appropriate buffer and a measured volume pipetted into the haemolysin 
containing solutions to give a final formaldehyde concentration of 1%. 
Control samples contained no formaldehyde. In initial experiments the 
formaldehyde solutions were placed into Visking dialysis tubing, immersed 
in the haemolysin solutions and allowed to equilibrate for 16 h before 
removing the bags. However, simple mixing of haemolysin and formaldehyde 
solutions was found to be just as effective in toxoiding the 6-haemolysin.
The solutions were incubated at 37°C in a water bath after which 
time the reaction was terminated by dialysis against a large volume of 
formaldehyde-free 0.01M phosphate buffer (pH 6.8) containing 1:10,000 
merthiolate as a preservative. Any precipitate was removed from the 
solutions by centrifugation (10,000 £ for 20 min) and the preparations 
were stored at 4°C.
Such formaldehyde-treated preparations were denoted by the 
symbols F5, F7.5* F9*5 to indicate 6-haemolysin that had been treated with 
formaldehyde at pH 5> pH 7*5 and. pH 9.5 respectively. Similarly, control 
samples were denoted by the symbols C5» 07.5» 09.5. Untreated 6-haemolysin 
was termed native 6-haemolysin.
2. Treatment with glutaraldehyde
Purified 6-haemolysin was treated with 1% (v/v) glutaraldehyde 
(25% Aqueous Solution, TAAB Laboratories, Reading, England) in the same 
way as with formaldehyde for up to 7 days at 37°C. The preparations 
obtained at pH 5* pH 7*5 or pH 9.5 were denoted by G5, G7.5 and G9.5 
respectively.
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Delta-haemolysin was treated for 7 days at 37°C with 1% (v/v) 
formaldehyde and one of three amino acids, glycine, leucine, or tyrosine 
(BDH Chemicals Ltd., Poole, England). The first two amino acids were 
added to a final concentration of 0.1M. Tyrosine, which is only slightly 
soluble in water, was added at a concentration of 0.0026M. All reactions 
were done at pH 5f pH 7*5 pH 9*5 and the reaction was terminated as 
for preparations treated with formaldehyde alone.
E. Properties of native and formaldehyde-treated 5-haemolysin
1. Protein estimation
Protein estimations were done by the method of Lowry et al.
(1951) using bovine serum albumin (Fract. V, Sigma Chemical Co., St.
Louis) as a standard.
2. Nitrogen determination
This was done by Kjeldahl digestion and Nesslerisation. Samples 
of 0.5 ml were digested for 8 h with 0.2 ml acid A in boiling tubes 
using a Gallenkamp digestion rack. A few carborundum chips were added 
to prevent bumping. The cooled digested samples were diluted with 2.8 ml 
and 1 ml of this was mixed with 9 ml H^O and 1 ml of Nessler's
reagent. The absorbance was read at using an SP500 spectrophoto­
meter. The nitrogen content of each sample was estimated from the 
standard curve of a standard solution of ( ^ 4)2 ^ 4 similarly treated.
3. Heat stability of 6-haemolysin
A solution of 5-haemolysin in PBSA (l or 2 mg/ml) was immersed
in a boiling water bath for up to 10 h. Aliquots of the haemolysin were
removed at various times and titrated for haemolytic, enhanced vascular 
permeability and antigenic activities.
3« Treatment with formaldehyde/amino acids mixtures
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4. Spectral analysis
The ultraviolet adsorption spectrum was determined with a Pye 
Unicam SP800 spectrophotometer in 10mm path length silica cells.
5. Isoelectric focusing
(i) Equipment: A horizontal trough zone convection isoelectric 
focusing apparatus designed by Talbot and Caie (1975) was used with an 
LKB 5371 DC power supply.
(ii) Procedure: All procedures were done at 4°C and the total power 
was restricted to a maximum of 0.5W. All samples were first dialysed 
against 1% glycine. The apparatus was allowed to equilibrate at 4°C,
56 ml of 1% ampholines (pH 5*5 “ 10 > 1KB Instruments, London) was added, 
and a pH gradient established by isoelectricfocusing for 24 h at a 
potential of 600V using 1% (v/v) phosphoric acid and 1% (v/v) TEMED for 
the anode and cathode electrode solutions respectively.
From each of the five central troughs 0.1 ml of ampholines was 
removed and replaced with 0.2 ml of sample (i.e. a total of 1 ml of 
sample was added). Focusing was continued at a potential of 800V for 
18 h and finally at 1000V for a further 24 h. After focusing was 
completed, fractions, including any precipitated material, were removed 
with Pasteur pipettes and retained for analysis.
(iii) Analysis of fractions: The pH of each fraction was measured with
a Pye Model 46A Vibret Lab pH meter with the samples kept cold in an ice 
bucket.
The optical density of each fraction was measured at 280 nm using 
a Pye Unicam Model SP500 spectrophotometer with silica micro cells of 10mm 
light path. To detect the presence of haemolysin, doubling dilution 




(i) Procedure: Solutions of native 5-haemolysin (2 mg/ml in PBSA),
HCHO treated 5-haemolysin and their controls (approx. 62.5 dg/nO-) were 
placed in bijou bottles. Trypsin (2 mg/ml solution in 0.001N HCl) was 
added in the ratio of 0.1 ml per ml of test solution. Buffer containing 
trypsin or 5-haemolysin alone served as controls. Samples were incubated 
at 37°C for 2 h.
(ii) Separation of tryptic peptides: A 15 mg/ml solution of 5- 
haemolysin was treated overnight with trypsin as described above; 10% 
Tween 80 was added to a final concentration of 0.1% and the sample was 
sonicated for a few minutes using a Polaron sonicating bath. The 
addition of Tween 80 was required to dissolve 5-haemolysin which is 
insoluble in 0.1M acetic acid (T.H. Birkbeck, unpublished observation). 
Tryptic peptides were separated on a Sephadex G25 (Pharmacia Fine 
Chemicals Ltd., Uppsala, Sweden) column (60 x 1.8 cm) and fractions of 
5 ml were collected. The optical density of each fraction at 280 nm 
and 250 nm was measured on a Pye Unicam Model SP500 spectrophotometer 
with silica micro cells of ]Dmm light path. Haemolytic, antigenic and 
vascular permeability enhancing activities of each fraction were measured 
as described previously.
7. Inhibition by lecithin
The inhibitory effect of lecithin was tested using a 0.5 ml 
solution in chloroform containing 50 |ig, 500 |ig or 5 mg lecithin. This 
was evaporated to dryness under a stream of nitrogen and the lipid was 
dispersed in PBSA to a final concentration of 2.5 mg/ml or 250 ng/ml.
The sample was then vortexed, put in the dark at room temperature for 1 h 
to swell after which time it was sonicated for a few minutes to form
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liposomes. Porified 6-haemolysin was added to the lipid dispersion to 
a final concentration of 62,5 hS or 1 mS protein per ml of liposomes. 
Formaldehyde treated samples and their controls were similarly processed.
All samples were incubated at 37°C for 45 nm1 after which time they were 
tested for haemolytic, antigenic and vascular permeability enhancing 
activities.
8. Adsorption to cod erythrocytes
Suspensions of cod erythrocytes in CDS (50% and 10% (v/v)) were 
mixed with 200 (ig of sample (native or formaldehyde treated 6-haemolysin 
in CDS) in a 3si volume ratio in 100 mm x 12 mm test tubes. Samples 
were incubated at room temperature for 30 min, centrifuged (500 g for 5 min) 
to remove erythrocytes, and the supernates tested for unbound antigen 
by double diffusion.
9. Polyacrylamide gel electrophoresis
(i) Gels; Polyacrylamide gels were prepared according to the method 
of Laemmli (1970).
(ii) Samples; A standard solution was prepared from four proteins 
(HSA, ovalbumin, myoglobin and cytochrome c) at 200 |ig/ml each in 0.5M 
Tris HC1 buffer pH 6.8. Test preparations (F5, F7*5» F9»5» C5> C7*5>
09*5) were dialysed against 1% ammonium acetate and then lyophilised.
Each freeze-dried preparation (10 mg) was dissolved in 2 ml Tris HC1 
buffer pH 6.8.
(iii) Procedure: Solubilising buffer (0.1 ml) was mixed with 0.1 ml 
of sample and heated at 100°C for 5 min. Samples (25 |jil) were applied 
to the gel and electrophoresis was performed at 20 mA per gel. Gels 
were stained overnight in Coomassie Brilliant Blue and then destained in 
acetic acid/methanol/water solution (Appendixix).
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1. Injection mixtures
HAMl/CR mice were injected with 0.05 ml volumes containing equal 
amounts of sample and Freund1s Complete Adjuvant (FCA) or saline.
2. Time Schedules
Mice were given either 1 or 3 intraperitoneal priming injections 
in FCA followed by 1 or 3 intraperitoneal booster injections in saline 
given 3 or 5 weeks later. Mice were killed in ether 7 days after the 
final injection and bled by cardiac puncture.
3* Rabbit immunisation
A single rabbit was immunised with F5 6-haemolysin at a concen­
tration of 100 (ig/ml protein. Intramuscular injections of 0.5 ml of 
sample in FCA were given every second day for 5 days followed by a fourth 
priming injection 5 days later. Three booster injections in saline were 
given intravenously 5 weeks later. The rabbit was test bled from the 
ear. Rabbit antisera to native 6-haemolysin (Birkbeck and Whitelaw,
1979) was provided by Dr. T.H. Birkbeck.
4* Collection of Sera
All blood samples were allowed to clot at 4°C overnight after 
which time they were centrifuged to remove free erythrocytes and the sera 
collected.
5. Analysis of Sera
(i) Passive haemagglutination (PHA): Doubling dilutions of serum
samples (0.05 ml volumes) were made in microtitre trays and 0.05 ml of 
tannic acid-treated sheep erythrocytes (coated with heated-6-haemolysin) 
(Appendix X ) added. Mixtures were shaken and the results were read
F. P rep a ra tion  and a n a ly s is  o f  a n t is e ra
after incubation at 37°C for 1 h. The highest dilution showing complete 
agglutination of the tanned erythrocytes was taken as the end point.
(ii) Counter immunoelectrophoresis (CIE); Fifteen ml of 0.75% (w/v) 
purified agar in barbitone buffer was poured on to an 11 cm x 8 cm glass 
plate. Parallel rows of wells, 2 mm in diameter, were cut 3 nun apart.
The anodal wells were filled with serum samples and the cathodal wells 
with purified 6-haemolysin (200 pg/ml in barbitone buffer). Electro­
phoresis was carried out for 30 min at 100V and plates examined for the 
presence of precipitin lines.
(iii) Haemolysin inhibition: Before this test was performed it was
necessary to remove lipoproteins from the serum samples.
Each serum sample was mixed with NaBr in a 12 ml polycarbonate 
centrifuge tube to give a final concentration of 40% (w/v) NaBr. Two ml 
each of 30%, 20% and 10% NaBr in 350 pM EDTA (w/v) were carefully and 
sequentially layered on top of the serum sample. The tubes were finally 
filled with 350 pM EDTA. The samples were centrifuged in an MSE 65 
superspeed centrifuge at 29,000 £ for 24 h at 18°C in a 3 x 25 ml swingout 
rotor with 12 ml adaptors. Fractions (l ml) were collected using an
MSE tube piercer. The refractive index of each fraction was measured
10mmwith an Abbg refractometer and the E was also measured. Peak280 nm
fractions, containing serum proteins except lipoproteins, were pooled and 
tested by the haemolysin-inhibition titration.
The inhibitory titre of serum samples was determined by making 
serial doubling dilutions in 0.5 ml amounts in CDS in 100 mm x 12 mm 
test tubes and adding an equal volume of a standard haemolysin preparation 
containing 4 HU^Q. After incubation at 37°c for 30 min, tubes were 
cooled to room temperature and 0,5 ml of a 1% suspension of cod erythro­
cytes was added to each tube. After a further 30 min at room temperature 
the 50% inhibition end-point (hIj-q) was assayed visually.
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(iv) Radial immunodiffusion: The antibody content of anti-ovalbumin
sera was measured by a modification of the method of Mancini, Carbonara 
and Heremans (1965). Serum samples (15 M-l) were applied to 3 mm diameter 
wells cut in 2 mm deep 0.75% agarose (BDH Ltd., Poole, England) containing 
50 (Jig/ml ovalbumin on 75 nm x 100 mm glass plates. After 24 h 
incubation at 22°C in a humid chamber the diameter of zones of precipi­
tation were measured with an eyepiece containing a millimetre graticule.
Sera giving the maximum zones of precipitation were pooled and 
analysed for antibody content by the quantitative precipitin test (Smith 
et al., 1962). The antibody content of the other sera was determined by 
comparison with this pooled antiserum.
(v) Absorption of sera: Absorption of antisera was done by mixing 
either equal volumes of serum and a 1 mg/ml solution of 6-haemolysin or 
by mixing serum and crude canine staphylococcal culture supernatant fluids 
in a volume ratio of 5*1* Mixtures were briefly allowed to react at 
room temperature after which time they were tested by double diffusion and 
counter-immunoelectrophoresis.
G. Comparison of 5-haemolysins produced by different 
strains of S^__aureu£
1• Production of crude culture supernates
Small batches (50 ml volumes) of each strain were grown in 
Bernheimer diffusate medium as described for strain NCTC 10345. Crude 
supernates thus obtained were stored at -20°C. Selected strains were 
grown in CCY medium under the same conditions.
2. Isoelectric focusing in polyacrylamide gels
(i) Concentration of culture supernates: Before electrofocusing was
carried out in both the Talbot and Caie apparatus and in polyacrylamide
gel slabs, selected crude culture supernates were first concentrated 
with ammonium sulphate.
Crude supernates were mixed with ammonium sulphate to 70% (w/v) 
saturation and stirred at 4°C overnight. Precipitates were collected 
by centrifugation at 12,000 £ for 15 min. Each precipitate was dissolved 
in 4 ml PBSA and then dialysed overnight against PBSA.
(ii) Apparatus: Electrofocusing was performed with the LKB 2117 
Multiphor apparatus.
(iii) Procedure: A special template was placed on the cooling plate
and the gel plate placed on top using a detergent solution to improve 
thermal contact. Samples were applied to the gel surface at the cathode 
end in 5 mm x 10 mm strips of filter paper (Whatman 3MM, Whatmans Ltd., 
Kent) soaked in a solution of sample (10 mg/ml purified 6-haemolysin or 
ammonium sulphate concentrated crude supernates. Spacing between
adjacent samples was at least 5 Electrofocusing strips of filter
paper were soaked in the appropriate electrode solution (1M phosphoric 
acid; 1M sodium hydroxide), applied to the surface of the gel and the 
protruding ends cut off. An initial voltage of 600V was applied but, 
since the current dropped rapidly, the voltage was increased every 1 0  min 
until a maximum of 1000V had been reached. Focusing was continued until 
the current ceased to drop - about 3“4 h. After termination of focusing, 
the pH gradient was determined immediately with an antimony surface 
electrode (Beeley, Stevenson and Beeley, 1972) (Activion Ltd., Kinglassie, 
Fife).
(iv) Blood overlay: The haemolytic activity of bands was determined 
by a blood agar overlay technique. A 10% or 20% (v/v) suspension of 
washed cod erythrocytes in CDS was mixed with a 1% agarose solution in 
CBS at 56°C giving a final erythrocyte concentration of 2% or 5% (v/v).
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The mixture was carefully poured on top of the gel which was surrounded 
by a wall of plasticine to prevent overflow. When the agar had solid­
ified, the gel was placed in a humid chamber and incubated at 4°C 
overnight.
5* Formaldehyde treatment of crude culture supernates
Crude culture supernates from seven selected strains were dialysed 
against phosphate buffer (0.15M ; pH 5 ) after which time formaldehyde was 
added to give a final concentration of 1% (v/v). Samples were incubated 
at 37°C for 7 days and the reaction terminated as previously described 
for purified 6-haemolysin.
4 . Purification with an immunosorbent
(i) Separation of y-globulin from serum; Equal volumes (20 ml) of 
rabbit anti-6-haemolysin serum and 3 2% (w/v) sodium sulphate solution 
were mixed and stirred for 20 min at room temperature. The resulting 
precipitate was collected by centrifugation at 10,000 £ for 10 min at 
20°C and re-dissolved in half the original volume (10 ml) of distilled 
water. An equal volume of 3 2% (w/v) sodium sulphate solution was added 
and re-precipitation was carried out as before. This second resulting 
precipitate was dissolved in 5 ml PBS2 and dialysed against 1 1 PBS2«
(ii) Immunosorbent preparation: The reaction was performed such that 
the thiolated y-globulin contained 6 to 10 -SH groups per molecule. The 
Y-globulin concentrate was mixed with N-acetyl-DL-homocysteine thio- 
lactone (NAHTL ; 20 mg/ml in distilled water) to a ratio of 5 si. Bicarbo­
nate buffer (2 . 5  ml > pH 1 0 .6 ) was added and the mixture was flushed
with nitrogen. The reaction was allowed to proceed at 0°C for 1 h and 
the thiolated Y“gl°bulin fraction was recovered by precipitation with 
an equal volume of 3 2% (w/v) Na2S0 .^
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The precipitate obtained above was mixed with 2 ml of cross­
linking reagent and allowed to react at 0°C for 1 h. The polymer was 
homogenised, washed 6 times in PBS2 and twice with glycine/HCl buffer 
pH 2.2. The mixture was left overnight at 4°C and the volume of the 
settled precipitate was noted.
(iii) Preparation of column: Sephadex G15* 5 S (Pharmacia Fine
Chemicals Ltd., Uppsala, Sweden), was allowed to swell overnight in PBS2*
Ten ml of the Sephadex slurry was mixed thoroughly with 3 nil of the poly­
merised immunosorbent and poured into a column 1 cm x 15 cm diam. When 
the mixture had settled a 2 cm layer of Sephadex was placed on top and 
the column was equilibrated with PBS2 at a flow rate of 1 4  ml/h.
(iv) Procedure: After equilibration, 2 ml of sample (purified 6-haemo­
lysin or ammonium sulphate concentrated crude culture supernates) was 
applied to the column and eluted with PBS2 overnight. Fractions (2 ml) 
were collected using an LKB 2200 Ultrorac and the elution profile monitored 
using a Uvicord UV spectrophotometer and an LKB 2560 Chart Recorder. 
Adsorbed material was eluted by running glycine/HCl buffer through the 
column. After the second elution peak was recorded (approx 8 fractions) 
the column was re-equilibrated with PBS2* The absorbance of fractions 
was measured at 280 nm using a SP 500 Spectrophotometer. Peak fractions 
were pooled and examined for protein content and haemolytic and antigenic 
activities.
5. Purification with hydroxylapatite
Selected strains were grown in large batch cultures (500 ml) of 
Bernheimer's diffusate medium and purified as previously described for 
strain NCTC IO3 4 5 .
RESULTS
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1. Selection of strain
Staphylococcus aureus strain NCTC 10345 was used in this work as 
Chao (1976) showed, that, with this strain, large quantities of 6-haemo­
lysin could be prepared and purified by the method of Kreger et al. (1971)*
2. Preparation of S. aureus 5-haemolysin
Delta-haemolysin was purified from ) 1 of crude culture supernate 
according to the method of Kreger et al. (1971) using hydroxylapatite.
The supernates from each washing step were titrated for haemolytic 
activity against cod erythrocytes (Table 13)• The hydroxylapatite 
removed all haemolytic activity against cod erythrocytes. Thirty seven 
per cent of 6-haemolysin was recovered by washing the hydroxylapatite 
with 1M phosphate buffer. A final lyophilised product (34%) of 1*019 mg 
of soluble 6-haemolysin with a specific activity of 1024 HU^/mg was 
obtained. Six such preparations (denoted by 76/1 ; 77/1 ; 77/2 ; 77/5 » 
78/1 ; 78/2) were made over the period of this research work and all gave 
similar results although the specific activity was occasionally lower.
3. Properties of purified 5-haemolysin
(i) Haemolytic spectrum; The specific activity and haemolytic 
spectrum of purified 6—haemolysin (Table 14) were similar to those 
described by Chao (1976) and Whitelaw (1978) except that the haemolytic 
activity against horse, human and sheep erythrocytes was somewhat lower 
than found by Chao (1976).
(ii) Ultra-Violet spectrum: The UV spectrum of purified 6-haemolysin,
with absorption maxima at 280 nm and 291 nm and a minimum at 247 nm 
(Pig 2), was similar to that found by other workers (Kayser and Raynaud,
A. Preparation of purified. S. aureus 6-haemolysin
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Table 13» Haemolysin activity in supernates from the purification


















apatite 3 , 0 0 0 < 2
0.01M PB
washings 1 4 0 0 2 800
2 4 0 0 2 800
3 4 0 0 2 800
4 4 0 0 < 2
5 4 0 0 < 2
0.4M PB
washings 1 5 0 0 16 8 , 0 0 0
2 5 0 0 32 1 6 , 0 0 0
3 5 0 0 1 6 8 , 0 0 0
4 5 0 0 1 6 8 , 0 0 0
5 5 0 0 32 1 6 , 0 0 0
6 5 0 0 1 6 8 , 0 0 0
1M PB
washings 1 2 0 0 2 0 4 8 4 0 9 , 6 0 0
2 2 0 0 2 0 4 8 4 0 9 , 6 0 0
3 2 0 0 512 1 0 2 , 4 0 0
4 2 0 0 512 1 0 2 , 4 0 0
5 2 0 0 512 1 0 2 , 4 0 0
Total 1M washings 1,126,400
Final lyophilised product : 1019 mg @ 1024 HU^Q/ mg
= 1,043,000 hu50














Figure 2 Ultraviolet absorption spectrum of 5-haemolysin
The absorption spectrum of purified soluble 5-haemolysin 
(500 (ig/ml) was measured in the Pye Unicam SP 800 spectrophoto­












W A V E L E N G T H  ( n m )
(iii) Isoelectric focusing: When 6-haemolysin was subjected to
isoelectric focusing in a broad pH gradient (pH 3*5 “ 10,0) all haemolytic 
activity was found in a single peak (pi 4«9) which corresponded to the 
major peak of E28Q-absorbing material (Fig 3)*
(iv) Heat stability: In preliminary experiments different preparations
of 6-haemolysin varied in their sensitivity to heating at 100°C. The 
time taken for the haemolytic activity of 6-haemolysin (preparation 76/l) 
to decrease by half, after heating at 100°C, was 2,7 h. However, using
a different preparation of 6-haemolysin (preparation 78/1) no loss of 
haemolytic activity occurred even after 6 h at 100°C. In subsequent 
experiments, the half-life of 6-haemolysin (preparation 78/2) was 1 h and 
complete loss of activity was not obtained until after 10 h incubation. 
Delta-haemolysin remained antigenically active against anti-6-haemolysin 
antibody even after 10 h incubation at 100°C (Fig 4).
B. Immunisation of mice with purified 6-haemolysin
1. Preliminary experiment
In an initial experiment eight groups of five mice were given
three intraperitoneal priming injections, at two day intervals, of 0 . 0 5  ml
containing 50 |ig 6-haemolysin in FCA (groups 1-4) or saline (groups 5-8). 
Six of the eight groups were given three intraperitoneal booster 
injections of 6-haemolysin (50 |ig in 0.05 ml of FCA, groups 2-4, or 
saline, groups 6-8) 1 week (groups 2, 3 , 6, 7) and/or 2 weeks (groups 3,
4, 7, 8) later. Sera, collected 6 days after the final injection, did 
not contain detectable levels of antibodies against 6-haemolysin when 
tested by CIE.
2. Variation of time schedules
Immunisation of mice with purified 6-haemolysin was further
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1965; Kreger et al., 1971, Chao, 197^ 5 Whitelaw, 1978)*
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Figure 3 Isoelectric focusing of 6-haemolysin
Purified 6-haemolysin (4 mg) was analysed by 
isoelectric focusing using the apparatus of Talbot and 




□---□ - haemolytic activity against
1% cod erythrocytes
3 5  7 9 11 13 15 17 19 21 23 25 27 29 31 33 351
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Figure 4 Antigenicity of heated 5-haemolysin
Purified 6-haemolysin was heated for 1-10 h at 
100°C in a water bath and antigenic reactivity with anti-6- 
haemolysin tested by double diffusion.
Nos. 1-10 - 6-haemolysin heated for 1-10 h 
C - unheated 6-haemolysin 
Centre
wells - rabbit anti-6-haemolysin.
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investigated, by expanding the initial experiment above to include various 
time schedules. Groups of 5 mice were given one or three (days 1, 3 
and 5) primary injections of 50 dg 6-haemolysin in FCA followed by 
either one or three (at 2-day intervals) boosting injections of 50 \ig of 
haemolysin in saline after a further 3» 5 or 6 weeks. Sera obtained 7 
days after the final injection were pooled and tested by CIE and haemo­
lysin inhibition. The presence of anti-6-haemolysin antibodies, 
indicated by a strong precipitin line on CIE and an increase in haemo­
lysin inhibition titre when compared with normal serum, was found only 
in the sera of mice which had received three priming and three boosting 
injections after an interval of 5 weeks (Table 15).
93. Variation of injection mixtures
Improvement of the response obtained previously was attempted by 
varying the quantity of antigen and adjuvant in the injection mixture.
Mice were immunised with 3 priming injections of 6-haemolysin (6.25 dg - 
100 |ig/0.05 ml) in FCA containing 1.25 dg - 5 dg Mycobacterium 
tuberculosis. Three booster injections of 6-haemolysin (6.25 dg - 
100 dg/0«05 ml) i-n saline were given 5 weeks later. However, out of 
the 15 serum pools tested, only three gave a faint precipitin line on CIE, 
none of which had an increased haemolysin inhibition titre when compared 
with normal serum (Table 16).
4. Anti-ovalbumin sera
The reasons for the poor responses obtained on immunisation with 
purified 6-haemolysin were not evident. It may be that 6-haemolysin is 
indeed very poorly immunogenic in the mouse. However, other factors such 
as the mice, timing of injections, quantity or batch of adjuvant or the 
quantity of antigen used may be the primary cause(s). Investigations 
were therefore made to determine the efficacy of the immunisation schedule 
previously employed.
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Table 15 Immunisation of mice with purified 6-haemolysin -
Variation of Time Schedules
Analysis of sera**by;-
Timing of injections (days) 









1 36 - 8
1 43 — 32
it 5, 5 22 - 32
It 5, 5 36 - 8
1, 5, 5 43 — 32
1 22,24,26 - 128
1 36,38,40 — 64
if 3, 5 22,24,26 - 256
1. 3, 5 36,38,40 + 256
Normal mouse serum - 32
* + - precipitin line formed
- - no precipitin line
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Groups of four mice were injected with 5 l-ig ovalbumin in
0.05 ml of FCA (containing 5 Hg Mycobacterium tuberculosis) on days 1,
3 and 5 and in 0,05 ml saline on days 36, 38 and. 40* Sera were 
collected 1-10 days after final injection and individually analysed for 
anti-ovalbumin antibodies by CIE and radial diffusion. All sera 
contained anti-ovalbumin antibodies and a maximum antibody titre of
2.5 mg per ml was obtained seven to eight days after the final injection 
(Fig 5).
Therefore, by employing the same mice, adjuvant and immunisation 
schedule as for purified 6-haemolysin, high anti-ovalbumin antibody 
titres could be induced, especially seven to eight days after the final 
injection. It was therefore concluded that purified 6-haemolysin was 
very poorly immunogenic in the mouse.
C. Treatment of 6-haemolysin with formaldehyde
The objectives of these investigations were two-fold. First, 
the effects of formaldehyde on the toxicity, antigenicity and other 
biological properties of 6-haemolysin during the production of toxoids 
was monitored. Second, the immunisation of mice with formaldehyde- 
treated 6-haemolysin was investigated with the aim of enhancing immuno­
genicity by modulation of the antigenic determinants.
1. Haemolytic activity
Purified 6-haemolysin was treated with formaldehyde under acid, 
neutral or alkaline conditions using a modification of the method of 
Warren et al. (1975)* In preliminary experiments, haemolytic activity 
was lost after incubation for as little as 1 day under acid or neutral 
conditions whereas, at pH 9«5» loss of activity was not complete even
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Figure 5 Immunisation of mice with ovalbumin
Mice were given three primary intraperitoneal 
injections of 5 jxg ovalbumin in FCA followed by three 
booster intraperitoneal injections of 5 Jig ovalbumin in 
saline 5 weeks later. Individual sera were analysed for 
anti-ovalbumin antibody concentration by radial diffusion. 
The mean antibody concentration of four sera is shown at 
each time and the results of each individual serum is 
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after 6 days. Subsequent experiments indicated that, after an initial 
loss of 25% of activity within 1 h at 37°C, all activity was lost at 
pH 5 or pH 7.5 within 24 h (Fig 6). At pH 9«5» however, this initial 
loss of activity was not followed by any further decrease until after 
24 h incubation, and some activity remained after 7 days. When 6-haemo- 
lysin was incubated for up to 7 days at 37°C in the absence of 
formaldehyde there was no loss of haemolytic activity.
2. Antigenic activity
Treatment of 6-haemolysin with formaldehyde did not alter its 
reactivity with rabbit anti-6-haemolysin antibody; a line of identity 
was shown between each treated preparation and purified 6-haemolysin 
(Fig 7).
3. Protein and nitrogen estimations
A gradual loss in protein concentration of 6-haemolysin solutions 
was found after incubation with formaldehyde at pH 5 or pH 7.5; only 
27% and 40% respectively of original protein being retained after 7 days 
(Fig 8). This loss was not so apparent after incubation of 6-haemolysin 
and formaldehyde under alkaline conditions, only 20% of original protein 
was lost after 7 days incubation.
These protein losses occurred during the incubation period since 
it was shown that there was no significant decrease in the protein 
concentration of preparations before or after the dialysis and 
centrifugation steps. Since formaldehyde reacts with tryptophan residues 
(French and Edsall, 1945) and,since this amino acid is involved in the 
protein assay of Lowry £t al. (1951)^ it seems likely that reaction with 
formaldehyde influenced the reactivity of proteins in the Lowry assay.
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Figure 6 Haemolytic activity of 5-haemolysin treated with 
formaldehyde
The haemolytic activity of purified 6-haemolysin was 
assayed with 1% cod erythrocytes after incubation with
formaldehyde at 57°C at pH 5 (  • ), pH 7.5 (-■-----a )
or pH 9.5 ( A ▲ ). Delta-haemolysin, incubated at
pH 5 ( O O ), pH 7.5 ( □----- □ ) and pH 9.5 ( A-----A )
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Figure 7 The antigenic activity of formaldehyde-treated
5-haemolysin
Delta-haemolysin, incubated at 57°C at pH 5t pH 7»5 
or pH 9.5 for 7 days with formaldehyde, was tested for 
antigenic reactivity with rabbit anti-5-haemolysin 
antibody by gel diffusion.
D - 6-haemolysin
F5 - 6-haemolysin treated at pH 5 with
f ormaldehyde 
F7*5 - 6-haemolysin treated at pH 7*5 with
formaldehyde 
F9*5 “ 6-haemolysin treated at pH 9*5 with
f ormaldehyde 
AD - rabbit anti-6-haemolysin antiserum.
/D F5 ;
F 9 '5 ’ A D j D •
D F 7-5
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Figure 8 Lowry Reactivity of 6-haemolysin solutions treated 
with formaldehyde
Delta-haemolysin incubated at 37°C with formal­
dehyde at pH 5, pH 7*5 or pH 9*5 was assayed for protein 
concentration by the method of Lowry et al. (1951).
•------• - 6-haemolysin treated at pH 5 with
f ormaldehyde
■------■ - 6-haemolysin treated at pH 7*5 with
formaldehyde
A------▲ - 6-haemolysin treated at pH 9*5 with
formaldehyde
II






In order to investigate this, 6-haemolysin, treated for 7 days at pH 5» 
pH 7*5 or pH 9*5 with or without formaldehyde, was analysed for nitrogen 
content and the results were compared with the protein determinations of 
the same preparations. From Table 17 it is evident that incubation of 
6-haemolysin with formaldehyde under acid or neutral conditions caused a 
loss of nitrogen in addition to a loss of measured protein. At pH 9*5* 
as well as with control samples, there was little or no loss of nitrogen. 
Comparison of both protein and nitrogen results indicated that the 
loss was greater with the former, and therefore formaldehyde might be 
having an influence on the assay system. However, since there was also 
a loss of protein in control samples there might be some other factor 
involved, for example, adsorption of 6-haemolysin to glass (Heatley, 1971)*
4. Immunisation of mice
In preliminary experiments,twelve groups of 5 mice were immunised 
with 6-haemolysin treated for various times with formaldehyde at pH 5, 
pH 7.5 or pH 9.5 with the most successful time schedule found with native 
6—haemolysin. Pooled sera were tested by CIE. The immunising ability 
of each antigen increased with the increased time of incubation with 
formaldehyde (Fig 9)> samples incubated in the absence of formaldehyde 
failed to stimulate detectable anti-6-haemolysin antibodies.
In subsequent experiments, mice were immunised,using varying 
time schedules,with 6-haemolysin treated with formaldehyde for 7 days at 
pH 5, pH 7*5 or pH 9*5» In 2 experiments, the percentage of pooled sera 
giving positive results on CIE (over the range of time schedules employed) 
was 100% (8/8 pooled sera), 63% (5/8 pooled sera) and 25% (2/8 pooled 
sera) for mice immunised with F5, F7.5 and F9*5 6—haemolysin respectively. 
To determine whether this increase was due to increased antibody titres 
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Figure 9 Immunogenicity of formaldehyde-treated. 5-haemolysin 
in mice
Groups of five mice were immunised on days 1, 3> 5> 
36, 38, 40 with 6-haemolysin which had been treated with 
formaldehyde for various times at pH 5, pH 7.5 or pH 9*5• 
The sera from mice in each group were pooled and analysed 
by CIE and the results of two experiments were expressed as 
a percentage of the total number of sera giving a positive 
result for each incubation time (i.e. the results of 
animals immunised with each immunogen which had been 
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mice, groups of 8 to 13 mice were immunised with each antigen with 
varying time schedules. Individual sera were analysed for anti-6- 
haemolysin antibodies. The proportion of mice responding to 5-haemo- 
lysin increased with the number of injections of antigen and with the 
interval between primary and boosting injections (Fig 10, Table 18). Of 
the total mice treated with each immunogen, 23% responded to native- 
haemolysin and to F9*5 haemolysin; the responses to 5-haemolysin treated 
with formaldehyde at pH 5 or pH 7*5 were 62% and 39% respectively. 
Analysis of these results using the chi-squared test ( x ) confirmed
that the difference in percentages obtained between native and F7.5
2 2 haemolysin (x = 4*9) and between native and F5 haemolysin (x = 23*2)
were significant at the 5% and 0.5% probability levels respectively
(Appendix XI). In addition to an increase in the number of responding
mice, immunisation of both mice and rabbits with F5 haemolysin also
produced an increase in anti-5-haemolysin antibody titre, assayed by PHA
(Table 19)* The discrepancies found between the PHA and CIE results may
be due to the production of low avidity antibodies (Steward, Gase and
Petty, 1974) which were only detected by CIE because high concentrations
of antigen and antibody are focused in one specific area.
All mouse antisera to formaldehyde-treated 6-haemolysin reacted 
with both native and formaldehyde-treated haemolysin on CIE, although on 
immunodiffusion only antisera with high PHA titres gave a pronounced 
precipitin line with both native and formaldehyde-treated haemolysin. 
Antisera with low PHA titres failed to precipitate with native haemolysin 
on immunodiffusion (Fig 11). This substantiates the above hypothesis 
that the antibody to native 6-haemolysin in these antisera, with low PHA 
titres, may be of low avidity.
The precipitinogenic activity of the mouse antisera was 
associated with the gamma-globulin fractions as shown by immunoelectro-
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individual mice
Figure 10 Immunogenicity of formaldehyde-treated 6-haemolysin in
The sera of mice immunised with 6-haemolysin treated 
with formaldehyde at pH 5 (a) or pH 7«5 (B) for 7 days were 
analysed individually by CIE for anti-6-haemolysin antibodies.
A Anodal wells - a(i) - (v )
b ( i )  - (iv)
o(i) - (v )
d ( i )  - (v)
b ( v i )
v nine mice immunised on 
] days (1 ,22,24,26)
} ten mice immunised on 
) days (1,5,5,22,24,26)
- Rabbit anti-6-haemo- 
lysin antiserum
B Anodal wells - a(iii) - (vii) 
b(iii) - (vii)
c(i) - (vii) 
d(i) - (vi)
d(vii)
) ten mice immunised on 
] days (1,22,24,26)
} thirteen mice immunised 
) on days (1 ,3,5,22,24,26)
- Rabbit anti-6-haemo- 
lysin antiserum
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The activity of "both mouse (A) and rabbit (B) anti­
formaldehyde-treated 6-haemolysin antisera with native and 
formaldehyde-treated 6-haemolysin was tested by double 
diffusion.
Figure 11 Immunodiffusion analysis of anti-formaldehyde-treated
Wells 1,3,5,7,8,10,12,14 - purified 6-haemolysin
Wells 2, 4, 6
Wells 9, 11, 13
Centre wells
- formaldehyde-treated 6-haemolysin 
at pH 5 (2), pH 7.5 (4) or
pH 9.5 (6).
- Control samples of 6-haemolysin 
at pH 5 (9), pH 7.5 (11) or
pH 9.5 (13).
a - rabbit anti-6-haemolysin
b - mouse anti-pH 5 formaldehyde-
treated 6-haemolysin antiserum 
with low PHA titre (a )
- rabbit anti-pH 5 formaldehyde- 
treated 6-haemolysin antiserum 
(B).
1 2 3 4 5 6 7
a b a  b a  b a  b
14 13 12 11 10 9 8
__ _____________________________
1 2 3 4 5 6 7
\  ' ^
a b a b a b a b
14 13 12 11 10 9 8
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phoresis (Fig 12). Absorption of such sera with native 6-haemolysin 
did not remove all precipitinogenic activity against formaldehyde-treated 
haemolysin. (The figure is not illustrated as results were more 
clearly defined with rabbit antiserum.) Rabbit antiserum to pH 5“ 
formaldehyde-treated 6-haemolysin reacted more strongly on immunodiffusion 
with native 6-haemolysin than did mouse antisera (Fig ll) and also 
contained antibodies to formaldehyde-treated haemolysin which were not 
removed by absorption with native 6-haemolysin (Fig 13)•
5. Ultra-Violet spectrum
Formaldehyde treatment altered the UV-absorption spectrum of 
6-haemolysin with loss of the 291 nm peak (Fig 14)» This loss occurred 
within 24 h incubation under acid, neutral or alkaline conditions; 
haemolysin incubated for the same time in the absence of formaldehyde 
retained the 291 nm peak.
6. Immunoelectrophoresis
Reaction of 6-haemolysin with formaldehyde gave an increased 
electrophoretic mobility at pH 8.6 (Fig 15)* Samples incubated in the 
absence of formaldehyde were electrophoretically similar to native
6-haemolysin.
7- Isoelectric Focusing
Delta-haemolysin treated with formaldehyde was subjected to 
isoelectric focusing in a broad pH gradient (pH 3.5-10.0) and all E280~ 
absorbing material was found in single peaks corresponding to pi of 
4«5» 4*1 and 4*2 for F5-, F7#5“* and F9 ^ -haemolysin respectively. Native 
6-haemolysin, however, had a pi of 4.9 (Fig 16).
Figure 12 Immunoelectrophoresis of mouse anti-formaldehyde'
treated 6-haemolysin sera
Wells 1, 5 ” normal mouse serum
Well 2 - normal mouse serum minus lipoproteins
Well 3 - mouse anti-formaldehyde-treated
6-haemolysin
Well 4 - as for well 3 only minus lipoproteins,
Troughs a, c - purified 6-haemolysin
Troughs b, d — goat anti-mouse antiserum.
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Figure 13 Antigenic reactivity of formaldehyde-treated
6-haemolysin with absorbed rabbit anti-F5 serum
The antigenic reactivity of formaldehyde-treated. 
6-haemolysins (F5» F7*5> F9*5) with rabbit anti-F5-serum 
absorbed with purified 6-haemolysin was tested by gel 
diffusion -
D - purified 6-haemolysin
F5 - 6-haemolysin treated at pH 5 with formaldehyde
F7*5 “ 6-haemolysin treated at pH 7*5 with formaldehyde
F9.5 ~ 6-haemolysin treated at pH 9*5 with formaldehyde
C5 - 6-haemolysin treated at pH 5 without formaldehyde
C7*5 - 6-haemolysin treated at pH 7*5 without formaldehyde
C9.5 - 6-haemolysin treated at pH 9«5 without formaldehyde
Centre wells - rabbit anti-formaldehyde treated (pH 5) 
6-haemolysin antiserum absorbed with purified 6-haemolysin.
D F 5 F 75 F 9 5
A  A A  A A
C 9 5 C 7 5 C  5
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Figure 14 Ultraviolet absorption spectrum of formaldehyde-
treated. 5-haemolysin
The absorption spectrum of 6-haemolysin treated 
with formaldehyde at pH 5 (F5), pH 7*5 (*7.5) or pH 9.5 
(F9.5) for 7 days was measured in the Pye Unicam SP800 
























W A V E L E N G T H  (nm)
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Figure 15 Immunoelectrophoresis of formaldehyde-treated
5-haemolysin
F5 - 6-haemolysin treated at pH 5 with formaldehyde
F7.5 - 6-haemolysin treated at pH 7.5 with formaldehyde
F9.5 - 6-haemolysin treated at pH 9*5 with formaldehyde
C5 - 6-haemolysin treated at pH 5 without formaldehyde
C7.5 - 6-haemolysin treated at pH 7.5 without formaldehyde
C9.5 - 6-haemolysin treated at pH 9.5 without formaldehyde
D - 6-haemolysin
All troughs were filled with rabbit anti-6-haemolysin antiserum
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Figure 16 Isoelectric focusing of formaldehyde-treated
5-haemolysin
Delta-haemolysin treated with formaldehyde at 
pH 5 (F5), pH 7»5 (F7*5) or pH 9«5 (F9*5) f°r 7 days was 
analysed by isoelectric focusing using the apparatus of 
Talbot and Caie (1975) and. the E^qq and pH of each 
fraction measured.
* * “ E280
- pH
F R A C T I O N  NO.
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8. Inhibition by lecithin
Since formaldehyde had altered certain physical properties of 
6-haemolysin and increased its ability to stimulate the production of 
anti-6-haemolysin antibodies, it was of interest to investigate the 
possibility that formaldehyde may also have altered the ability of 6- 
haemolysin to bind to phospholipids and erythrocytes. Formaldehyde- 
treated 6-haemolysin preparations were incubated with liposomes of 
lecithin at 57°C for 45 min and then tested for antigenic activity by 
gel diffusion. The antigenic activity of formaldehyde-treated 6-haemo- 
lysin, whether under acid, neutral or alkaline conditions was not 
inhibited by lecithin at a concentration of 1 mg/ml. However, native 
6-haemolysin and haemolysin incubated in the absence of formaldehyde 
showed a much reduced gel diffusion reaction with anti-6-haemolysin after 
incubation with lecithin under the same conditions (Fig 17)*
9. Adsorption to erythrocytes
Incubation of formaldehyde-treated 6-haemolysin with cod 
erythrocytes for JO min at room temperature did not alter its ability to 
react with anti-6-haemolysin antibodies. This indicated the inability 
of the 1 toxoids* to adsorb to the surface of the erythrocytes. Native 
6-haemolysin and haemolysin incubated in the absence of formaldehyde, 
had a much reduced reaction with anti-6-haemolysin antibodies after 
incubation with cod erythrocytes. Most of these preparations had 
therefore been adsorbed onto the erythrocyte surface. (Figure not shown 
since results were similar to those in Figure 17).
10. Tryptic digestion
Formaldehyde-treated 6-haemolysin was resistant to proteolytic 
digestion by trypsin, its antigenic activity being retained after
98
Figure 17 Immunodiffusion analysis of native- and formaldehyde- 
treated. 6-haemolysin with anti-6-haemolysin serum 





5L, 7.5L, 9.5L -
rabbit anti-6-haemolysin antiserum 
purified 6-haemolysin 
6-haemolysin plus lecithin 
formaldehyde-treated 6-haemolysin 
at pH 5» pH 7.5, or pH 9.5 
plus lecithin
control 6-haemolysin treated at 
pH 5, pH 7.5, or pH 9.5 
plus lecithin.

incubation with the enzyme (Fig 18). Native 5-haemolysin and haemolysin 
incubated at pH 7*5 or pH 9*5 in ihe absence of formaldehyde lost all 
antigenic activity after incubation with trypsin. At pH 5» however, 
6-haemolysin incubated for 7 days at 37°C remained antigenically active 
after treatment with trypsin even when formaldehyde was absent during 
the incubation period.
11. Polyacryalmide gel electrophoresis
Contrary to the work of Warren £t al. (1973» 1975) there was no 
evidence for polymer formation of 6-haemolysin after treatment with 
formaldehyde at pH 5f pH 7*5 or pH 9*5 (Fig 19)• However, problems in 
staining 6—haemolysin in polyacrylamide gels were encountered, therefore 
the possibility of the presence of unstained polymers cannot be excluded.
D. Treatment of 5-haemolysin with glutaraldehyde or formal­
dehyde/amino acid mixtures
Since toxoiding of certain bacterial toxins has been successfully 
carried out with glutaraldehyde (Relyveld et al., 1973 > Rappaport £t al., 
1974) and also formaldehyde/amino acid mixtures (Linggood et al., 1963; 
Scheibel and Christensen, 1965; Stanier, 1968; Relyveld, 1969;
Northrup and Chisari, 1972; Saletti and Ricci, 1974)» 6-haemolysin was 
treated with these chemicals and comparisons were made between the reaction 
products and 5-haemolysin treated with formaldehyde alone.
1. Glutaraldehyde
Delta-haemolysin lost all haemolytic activity within 1 h incubation 
with glutaraldehyde at pH 5, pH 7.5 or pH 9.5. As with formaldehyde 
treated 6-haemolysin, there was a gradual loss in protein concentration of 
6-haemolysin at pH 5 and pH 7*5 "but little loss of protein at pH 9«5
99
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Figure 18 Immunodiffusion analysis of native- and formaldehyde- 
treated. 5-haemolysin after tryptic digestion
Wells 1,3,5*7*9,11,15 - samples before treatment
with trypsin.
Wells 2,4*6,8,10,12,14 - samples after treatment
with trypsin.




9,10 - C 5-8-haemolysin
11,12 - C7*5-8-haemolysin
15,14 - C9«5-8-haemolysin
Centre wells - rabbit anti—6-haemolysin antiserum.
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Figure 19 Polyacryalmide gel electrophoresis of formaldehyde-
treated 5-haemolysin
1 2 5  |ig of native- and formaldehyde-treated 
6-haemolysin were electrophoresed by the method of Laemmli
(1 9 7 0 ).
Standards (5 dg)
HSA - human serum albumin
0V - ovalbumin
Myg - myoglobin
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C7.5 
C9.5 n
6-haemolysin treated with formaldehyde 
for 7 days at pH 5 (F5), pH 7.5 (F7.5) 
or pH 9.5 (P9.5).
6-haemolysin treated for 7 days in the 
absence of formaldehyde at pH 5 (C5)» 
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(Fig 20). The reaction of these preparations with anti-6-haemolysin 
antibody on gel diffusion was very weak and, after incubation for 7 days, 
only the preparation treated at pH 9*5 retained its antigenic activity, 
giving a spurring reaction with purified 5-haemolysin (Fig 21).
Mice given three primary injections of toxoid in FCA followed by 
three boosting injections in saline 5 weeks later, failed to stimulate the 
production of anti-6-haemolysin antibodies.
2• Formaldehyde/amino acid mixtures
Incubation of 6-haemolysin for 7 days with formaldehyde plus one 
of three amino acids (tyrosine, glycine or leucine) produced a loss of 
haemolytic activity when reacted at pH 5 or pH 7«5 (Table 20). Similar 
results were obtained under alkaline conditions although, in the presence 
of tyrosine, some haemolytic activity was retained. All preparations 
retained their antigenic activity, and, when mice were immunised with 
these 'toxoids', only samples incubated at pH 5 °** pH 7*5 stimulated the 
production of anti-6-haemolysin antibodies.
E. Enhancement of Vascular Permeability in rabbit skin by
5-haemolysin
Enhanced vascular permeability (EVP) in the skin of guinea pigs 
has previously been shown (O'Brien and Kapral, 1976). The EVP activity 
of purified 6-haemolysin was studied in the rabbit and the effect of 
various treatments on this EVP activity was investigated.
Preliminary studies in mice had to be abandoned due to difficult­
ies in measurement of zones, inadequate numbers of injection sites per 
animal and general inconvenience.
1 0 5
Figure 20 Lowry reactivity of 5-haemolysin treated with
glutaraldehyde
Delta-haemolysin, incubated at 57°C with 
glutaraldehyde at pH 5» pH 7*5 pH 9«5 was assayed for 
protein concentration by the method of Lowry et al. (1951).
•----• - 6-haemolysin treated at pH
■— ' * - 6-haemolysin treated at pH
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Figure 21 Immunodiffusion analysis of 5-haemolysin treated with
glutaraldehyde for 7 days
D - purified 6-haemolysin (62.5 ng/ml)
G5 - 6-haemolysin treated at pH 5 with glutaraldehyde
G7«5 - 6-haemolysin treated at pH 7*5 with glutaraldehyde
09*5 ** 6-haemolysin treated at pH 9*5 with glutaraldehyde
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Table 20 Properties of 5-haemolysin treated with formaldehyde/
amino acid mixtures for 7 days








Tyrosine 5 < 0.1 + +
7.5 < 0.1 + +
9.5 5 + -
Glycine 5 < o.l + +
7.5 < 0.1 + +
9.5 < 0.1 + -
Leucine 5 < 0.1 + +
7.5 < 0.1 + -
9.5 < 0.1 + -
** Determined, by counter immunoelectrophoresis 
+ = precipitin line
- = no precipitin line
* Mice were immunised, on days lf3f5» with preparations in complete
Freund's Adjuvant followed by three boosting injections (days 
36, 38f 40) in saline. Sera were tested by counter iramuno- 
electrophoresis•
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1. Time of development of zones of enhanced vascular permeability
To determine the time required for maximum skin response,
6-haemolysin was injected at various times and dye was injected 50 min 
after the last injection of 6-haemolysin. A maximum skin response 
occurred within 1 h, the skin reaction fading with increased time until 
6 h or later when no dye was detectable and only hard erythematous lesions 
were present (Fig 22). The size of these swollen areas varied with the 
concentration of 6-haemolysin injected. When the experiment was repeated, 
virtually identical results were obtained. These results differ from 
the findings of O'Brien and Kapral (1976) who obtained maximum skin 
responses after 6 h. However, their experimental animal was the guinea 
pig and not the rabbit.
2. Dose response
Various concentrations of 6-haemolysin were injected intradermally 
and dye was administered 1 h later. The dose response was carried out in 
fifteen rabbits and, in all cases, high concentrations of 6-haemolysin 
(62,5 |ig-1000 |ig) were required to obtain a measurable result (Fig 25).
In addition to animal-to-animal variation, the size of the resulting 
zones also varied depending upon the location of the injection site.
This was investigated by injecting three rabbits with varying doses of
6-haemolysin at eight random sites per dose. The results obtained in a 
single rabbit are shown in Table 21 and are typical of those found in 
other rabbits. Figure 24 shows the range of variability found between 
rabbits, those giving high (El) and those giving lower (R2) dose responses. 
Although different preparations of 6-haemolysin were used in R1 (78/2) 
and R2 (78/l), the variabilities obtained cannot be attributed to the 
preparations themselves since the dose responses of nine rabbits all
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Figure Enhanced Vascular Permeability in the Rabbit - 
timing of injection of dye
The rabbit was injected intradermally with 
varying doses of 6-haemolysin at various times (30 min 
to 24 h) and Pontamine Sky Blue dye was injected intra­
venously 50 min after the final injection. The resulting 
zones measured 1 h later.




Figure 25 Enhanced Vascular Permeability in the Rabbit -
dose response
The rabbit was injected intradermally with 1000 (l), 
500 (2), 250 (3)t 125 (4) or 62.5 (5) dg 5-haemolysin.
After 1 h, Pontamine Sky Blue dye was injected intra­
venously and the resulting blue zones measured 1 h later.
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Figure 24 Animal-to-animal variation in the enhanced vascular 
permeability activity of 5-haemolysin in rabbit skin
For clarity only the highest ( •------ • ) and
lowest ( ■------ m ) responses obtained in the nine rabbits
tested are shown. In all other cases a straight line 
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fell within this range and were independent of the preparation used.
Despite these variations, a linear response was obtained in all 
cases. Therefore, to investigate the effect of various treatments on 
the EVP activity of 6-haemolysin, each test sample was administered in 
triplicate at random sites and the results expressed in fig equivalents 
of the dose response on each individual rabbit. In this way, the results 
obtained in different rabbits could be compared.
3» Effect of various treatments on the ability of 5-haemolysin to 
enhance vascular permeability
(i) Heat: Delta-haemolysin retained a substantial amount of EVP 
activity after incubation at 100°C (Fig 25). After 5 h at 100°C, 30% of 
EVP activity was retained compared with 6% of haemolytic activity. While 
longer incubation periods resulted in the complete loss of haemolytic 
activity, the EVP activity of 6-haemolysin was greatly increased. It 
must be noted that the antigenic activity of 5-haemolysin was retained 
after 10 h incubation at 100°C (Table 22).
(ii) Lecithin: The inhibitory effect of lecithin on the haemolytic
activity of 6-haemolysin has been well documented (Kreger £t al•, 1971; 
Kapral, 1972; Whitelaw and Birkbeck, 1978)* The effect of lecithin on 
the EVP activity of 6-haemolysin was therefore investigated. Incubation 
of 5-haemolysin with lecithin, at a concentration of 1,25 mg lecithin per 
mg of haemolysin, abolished haemolytic and antigenic activities but 61%
of EVP activity was retained (Table 22). At lower lecithin concentrations 
(125 |ig/mg haemolysin), haemolytic activity was reduced, antigenic activity 
was retained and 80% of EVP activity remained.
(iii) Trypsin: The EVP activity of 6-haemolysin was greatly increased
after incubation with trypsin (100 |ig/mg haemolysin) while the haemolytic
1 1 2
Figure 25 Effect of heat on the haemolytic and enhanced vascular 
permeability activities of 5-haemolysin
Purified 5-haemolysin was heated at 100°C for 1-10 h 
and assayed for haemolytic activity (l% cod erythrocytes) 
and EVP activity in rabbit skin.
0------• - EVP activity
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and enhanced vascular permeability activities of 6-haemolys:




Heating at 100°C for 10 h < 0.1 100 +
Lecithin
1.25 mg/mg haemolysin < 0.1 61 -
125 M-g/mg haemolysin 50 80 +
Trypsin
100 |ig/mg haemolysin < 0.1 244 -
Anti-6-haemolysin antibody
Neat/200 1ig 6-haemolysin 100 65 +
Neat/100 |ig 6-haemolysin 100 85 +
Neat/50 (j.g 6-haemolysin 100 126 +
Formaldehyde/7 days at 57°C
pH 5 < 0.1 52 +
pH 7.5 < 0.1 58 +
pH 9.5 5 69 +
+ = reacts with rabbit anti-6-haemolysin antibodies 
- = no reaction with rabbit anti-6-haemolysin antibodies.
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and antigenic activities of the haemolysin were destroyed (Table 22). 
These results suggested that tryptic fragments of 6-haemolysin were 
sufficient to induce EVP activity in the rabbit. Further investigations 
into the tryptic digestion of 6-haemolysin were therefore examined with 
a 15 mg/ml solution of the haemolysin. The tryptic peptides were 
separated by molecular exclusion chromatography and each fraction was 
analysed for haemolytic activity, antigenic activity by HIE and EVP 
activity in the rabbit.
Six tryptic peptides (D1 to D^), absorbing at E ^ q  nm* were 
consistently isolated, only four of which (D^, D2> D^, D^) absorbed at 
E280 nm 26). Peptides of high molecular weight (D^) contained all
haemolytic and antigenic activities and corresponded to either free or 
partially digested 6-haemolysin since untreated 6-haemolysin was eluted 
in a single peak at the same point as fraction Similarly, free
tryptophan could be eluted in fractions corresponding to Dg peptides.
The EVP activity of these tryptic fractions was shown in two experiments 
to be associated with a number of peptides which lacked both haemolytic 
and antigenic activities and which correlated well with the fragments 
absorbing at E ^  ^  and E2QQ ^  (D2, D^, D4> D^). Buffer containing 
10% Tween failed to induce an EVP response in rabbits.
(iv) Formaldehyde: Treatment of 6-haemolysin with formaldehyde
reduced, but did not eliminate, all EVP activity of the haemolysin (Table 
23). Even after incubation for 7 days, 52%, 58% and 69% of EVP activity 
was retained when 6-haemolysin was treated with formaldehyde at pH 5,
pH 7*5 °r pH 9*5 respectively (Table 22).
(v) Neutralisation by anti-5-haemolysin antibody: Complete neutral­
isation of EVP activity was not found after incubation of various
115
Figure 26 Tryptic Digestion of purified 5-haemolysin
Delta-haemolysin (15 mg/ml) was incubated overnight 
at 57°C with trypsin and peptides separated on Sephadex G25 
column.
-• — E^230
° ° -  E280
-a - Haemolytic activity (1% cod erythrocytes) 
41 - Antigenic activity (by RIE)
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concentrations (20Q, 100 or 50 |ig) of 6-haemolysin with a gamma globulin 
concentrate of rabbit anti-6-haemolysin (Table 22). There was, 
however, a decrease in EVP activity but this was associated with 
increasing concentrations of 6-haemolysin. Haemolytic and antigenic 
activities of 6-haemolysin were both retained. It is therefore 
probable that, due to the high concentrations of 6-haemolysin required to 
cause EVP, there was not sufficient antibody present to completely 
neutralise the haemolytic, antigenic and EVP activities of the haemolysin.
(vi) Serum proteins; To investigate the effect of other proteins on 
increasing the vascular permeability of rabbits, BSA and HSA (100 qg) 
were injected into rabbit skin. There was no visible blue zoning at 
injection sites indicating that neither of these proteins had the ability 
to cause EVP activity in the rabbit.
F. Comparison of 6-haemolysin from different strains of S. aureus
The aim of this section of the present study was the selection of 
different strains of S. aureus which produced a 6-haemolysin which 
differed in haemolytic spectrum and/or antigenic reactivities. Having 
selected various strains on this basis, various other biological properties 
were studied and compared with that of strain 10345*
1. Growth conditions
Several strains of S, aureus were grown in Bernheimer’s and/or 
CCY medium in approx. 50 ml volumes. Each culture supernate was collected 
after centrigugation and tested for haemolytic activity against cod, 
sheep, horse, human and rabbit erythrocytes (Tables 24, 25).
With the exception of five strains of S. aureus, all crude 
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Table 25 Haemolytic spectrum of crude culture supernates from 
various strains of S. aureus of human origin grown in 
Bernheimer's yeast extract medium
Haemolysin titre (HUj-q/ihI) with the following erythrocytes
Strain cod sheep* rabbit horse human
LSI 512 2 > 1024 64 256
2 2048 2 > 1024 128 256
3 512 < 2 32 16 64
4 2048 < 2 >_ 1024 32 32
5 256 < 2 64 16 16
6 2048 2 > 1024 128 256
7 512 < 2 16 8 8
8 2048 2 > 1024 64 128
9 2048 4 > 1024 128 256
10 <• 2 < 2 < 2 < 2 < 2
11 128 2 256 32 128
12 2048 < 2 64 16 32
13 < 2 < 2 < 2 < 2 < 2
14 2048 2 512 64 128
15 2048 2 > 1024 64 64
16 2048 16 > 1024 64 128
17 512 8 256 32 64
18 512 16 > 1024 64 128
19 64 < 2 128 16 16
20 512 < 2 64 16 16
21 2048 4 > 1024 64 128
22 256 < 2 32 16 32
23 < 2 < 2 < 2 < 2 < 2
24 2048 8 > 1024 32 64
25 2048 2 > 1024 256 512
26 64 < 2 512 < 2 < 2
27 256 < 2 32 16 16
28 2048 < 2 > 1024 16 16
29 512 < 2 > 1024 128 128
30 32 < 2 16 4 < 2
31 2048 4 512 128 256
32 . 2048 2 512 256 512
33 < 2 < 2 < 2 < 2 < 2
The recorded titre with sheep erythrocytes is the difference 
in titre obtained after incubation at 37°C followed by 
incubation at 4°C.
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erythrocyte types. In most cases, incubation with sheep erythrocytes 
was not associated with any significant difference in titre obtained 
after incubation at 37°C followed by incubation at 4°C. These results 
indicate that very little (if any) (3-haemolysin was produced under 
these growth conditions. High titres against rabbit erythrocytes showed 
high concentrations of a-haemolysin. Activity against cod, human and 
horse erythrocytes was variable but, in most strains of human origin, a 
high titre against cod erythrocytes was found, indicating high concen­
trations of 6-haemolysin were produced.
Only the canine strain 70671/L showed any increase in haemolysin 
production when grown in CCY medium as opposed to Bernheimer’s medium 
(Table 24).
2• Antigenic activity
The crude culture supernates were tested for antigenic reactivity 
with rabbit anti-6-haemolysin antiserum. Except for supernates with no 
haemolytic activity and that of strain LS26, a line of complete identity 
was shown between each crude supernate and purified (10345) b-haemolysin 
with anti-6-haemolysin antiserum (Fig 27). However a ’’split" precipitin 
line was found when 6-haemolysin (10345) was compared with the crude 
supernates of certain canine strains (70554» 70544 - grown in Bernheimer’s 
yeast extract medium - and 70671/L - grown in CCY medium) (Pig 28). When 
the anti-6-haemolysin serum was absorbed with either purified 6-haemolysin 
or crude 70544 culture supernate, neither purified 6-haemolysin nor crude 
supernates from these canine strains gave a precipitin line with the 
antiserum (Pig 28). These results therefore indicated that, despite the 
"split" line on immunodiffusion, these canine strains were antigenically 
identical to purified (10345) 6-haemolysin.
Only strain LS26 gave an atypical reaction with anti-6-haemolysin 
antibody (Pig 27, Slide C, well 12). Purified 6-haemolysin gave a line
1 2 1
Figure 27 The Antigenicity of crude culture supernates
Centre Wells - Rabbit anti-6-haemolysin antiserum 
Wells 1,3*5*7,9,11*13*15*17,19 - purified 6-haemolysin
Wells 2,4*6,8,10,12,14,16,18,20 - A, LSI-10 respectively
B, LS11-20 respectively
C, LS21-30 respectively
D, 10345(4), SM14 (6)
JK128 (8), JKL32(10) 
JK139(12), Wood 46(14).
A20 19 18 17 16 15 14 13 12 11
1 2 3 4 5  6 7 8 9  10
A
20 19 18 17 16 15 14 13 12 11
-
r 2 3 4 5 6 7 8 9 ro
C
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Figure 28 The antigenic reactivity of crude culture supernates
from S, aureus of canine origin
Wells 1,5*5 - purified 6-haemolysin
Wells 2 - 70544
4 - 70554
6 - 70671/L
Centre wells a - Rabbit anti—6—haemolysin antiserum
b - as for (a) and absorbed with purified 
6-haemolysin 




of partial identity with the crude culture supernate of this strain.
When anti-6-haemolysin antiserum was absorbed with purified 6-haemolysin, 
the homologous antibody still reacted with the crude supernate (Fig 29). 
Anti-5-haemolysin antisera produced in four different rabbits also 
precipitated with LS26 crude culture supernate on gel diffusion. The 
y-globulin fraction of one of these rabbit anti-6-haemolysin antisera 
also reacted with crude LS26, whereas other serum fractions failed to 
react with the crude supernate. Sera from ten mice and 1 rabbit not 
previously immunised with 6-haemolysin did not precipitate with the crude 
culture supernate of LS26 on gel diffusion. Only one electrophoretic 
form was found by immunoelectrophoresis (Fig 30).
Re-cultivation of this organism in Bernheimer's and CCY media 
yielded high concentrations of 6-haemolysin. Unfortunately, the 6-haemo- 
lysin produced did not react in a similar way with anti-6-haemolysin 
antisera - a line of complete identity with purified 6-haemolysin was 
obtained.
3. Immunoelectrophoresis
Several crude culture supernates were selected for further study 
based on their cod:human haemolytic titre ratios:- high, low or inter­
mediate. Seven of the fifteen strains tested had a greater electro­
phoretic mobility than purified 6-haemolysin (Fig 31).
4* Isoelectric focusing
Isoelectric focusing in the Talbot and Caie apparatus, as well as 
in polyacrylamide gels, was carried out on four selected crude culture 
supernates. The choice of these supernates was based on their haemolytic 
spectrum, electrophoretic mobilities and the animal from which each
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Figure 29 Reactivity of crude culture supernates on gel diffusion
with anti-6-haemolysin antiserum absorbed with purified
6-haemolysin




Centre Wells - A - rabbit anti-6—haemolysin antiserum 




Figure 50 Immunoelectrophoresis of the crude culture supernate
of strain LS26
Trough 2 - Rabbit anti—6-haemolysin antiserum
Trough 1,5 - as for (2) and absorbed with purified
6-haemolysin 
Well A - LS26
B - purified 6-haemolysin.
+»
1 2 6
Figure 51 Immunoelectrophoresis of crude culture supernates 
from different strains of S» aureus




respective strain had been isolated. The canine (70544) and ‘the mouse 
(ZM) strains had similar haemolytic spectra although they differed in 
their electrophoretic mobilities. The human strains, LS4 and LS28, were 
similarly chosen and they also differed from the two animal strains in 
their activity against horse and human erythrocytes.
(i) Zone convection isoelectric focusing: A major peak of E^qq
absorbing material was found at pi 4-75 (LS28), pi 5*1 (70544 and LS4)
and pi 5.2 (ZM) (Figs 32, 35* 54* 55) • Apart from strain ZM, all
haemolytic activity against cod, human and horse erythrocytes was found
in this major peak. Haemolytic activity against rabbit erythrocytes was
also found in fractions of pH 7 to 8. Since the principal form of
a-haemolysin has a pi of 8 (McNiven et al., 1972), it is probable that
these fractions contain this haemolysin. The antigenic activity of the
fractions, determined by RIE, was also found in the major Eoor.-absorbing<coU
peak although, with strain 70544* this was only detected by CIE in 
fractions 3 "to 11, and not by RIE. The mouse strain (ZM) differed from 
the other strains in that fractions of pi 7.6 to 8.1 also contained 
haemolytic activity (against cod erythrocytes) and antigenic activity.
(ii) Polyacrylamide gels: In preliminary experiments, with purified
6-haemolysin, it was found that a 10 mg/ml solution of haemolysin was 
required to give a distinct band on the gel; fixing in 1% glutar aldehyde 
did not improve the resolving power of the stain. Crude culture super- 
nates were concentrated by precipitation with 70% saturated ammonium 
sulphate and applied to the gels. Multiple bands were found with all 
supernates although the number detected varied. However, bands were 
found to be more distinct when electrofocusing was carried out in gels 
containing 9M urea (Fig 36). The multiple bands could be arranged
into groups of varying pi, ie l) pi 4*6 to 4.9, 2) pi 5 to 5*9 and 3)
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Figure 52 Isoelectric focusing of the crude culture supernate of
strain LS28
Crude culture supernate of strain LS28 were analysed 
by isoelectric focusing in the apparatus of Talbot and Caie 
(1975) and. the E^SO* HU,_q (cod, horse, human, rabbit 
erythrocytes) and antigenic activity by RIE measured.
0— “ °  280
... - pH
•— ---#  - Haemolytic activity, cod erythrocytes
■— ---■ - Haemolytic activity, rabbit erythrocytes
▲------▲ - Haemolytic activity, human erythrocytes
X------X - Haemolytic activity, horse erythrocytes
□— ---□ - Antigenic activity (by RIE).
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Figure 55 Isoelectric focusing of the crude culture supernate 
of strain 70544
Crude culture supernate of strain 70544 were analysed 
by isoelectric focusing in the apparatus of Talbot and Caie 
(1975) and. EgQQ, (cod, horse, human, rabbit erythrocytes)
and antigenic activity by RIE measured.
-O- E,280
-  pH
 •----#- Haemolytic activity , cod erythrocytes
* * - haemolytic activity , horse erythrocytes
▲----A- Haemolytic activity , human erythrocytes







Figure 34 Isoelectric focusing of the crude culture supernate
of strain LS4
Crude culture supernate of strain LS4 were analysed 
by isoelectric focusing in the apparatus of Talbot and Caie 
(1975) and E28q, HUj-0 (cod, horse, human, rabbit erythrocytes) 
and antigenic activity by RIE measured.
°  °  “ E280
- Haemolytic activity, cod erythrocytes
-X  - Haemolytic activity , horse erythrocytes
-A - Haemolytic activity, human erythrocytes
-41 - Haemolytic activity , rabbit erythrocytes




Figure 55 Isoelectric focusing of the crude culture supernate
of strain ZM
Crude culture supernate of strain ZM were analysed by 
isoelectric focusing in the apparatus of Talbot and Caie (1975) 
and ^280* ^ 5 0  (cod» horse» human, rabbit erythrocytes) and 
antigenic activity by RIE measured.
o--- ~"° 280
•— ---•  - Haemolytic activity, cod erythrocytes
X------X - Haemolytic activity, horse erythrocytes
▲------▲ — Haemolytic activity, human erythrocytes
■— ---■ - Haemolytic activity, rabbit erythrocytes
□— ---□ - Antigenic Activity (by RIE).
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pi 7 to 8. Purified 6-haemolysin had bands appearing in the last two 
of these categories.
Experiments with cod erythrocyte overlays were less clear and 
areas of lysis were found from the sample application point to the 
component with the lowest pi (Fig 57)•
5. Purification
(i) Immunoadsorbent: Purification of the crude culture superaates
was attempted.by adsorption chromatography. The adsorbing capacity of 
the column was determined by applying a 2 mg/ml solution of purified 
6-haemolysin and elution with PBS2. After the unadsorbed protein had 
been removed, the adsorbed material was eluted using 0.2M glycine HC1 
pH 2.2 buffer. Peak fractions were pooled and the pH adjusted to 7 with 
NaOH. Each sample was analysed for protein content and haemolytic 
activity.
Thirty-eight per cent of original protein sample was recovered 
from the column by elution at pH 2.2 out of a total of 70% protein 
recovered (Table 26). A loss of haemolytic activity was found after 
adsorption to the column. This loss was not due to acid inactivation by 
the buffer since a solution of 6-haemolysin, equilibrated against the 
buffer, did not lose any haemolytic activity. Similarly, equilibration 
against carbonate/bicarbonate buffer pH 11 did not decrease the haemolytic 
activity of 6-haemolysin.
Crude culture supernates of LS26, grown in Bernheimer's yeast 
extract or CCY medium were respectively eluted in glycine HC1 pH 2.2 and 
carbonate/bicarbonate buffer pH 11 (Stephen, Gallop and Smith, 1966)
(Pigs 36, 39).
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Figure 36 Isoelectric focusing of crude culture supernates in
polyacrylamide gels containing 9M urea
Crude culture supernatant fluids were analysed by 
isoelectric focusing in the LKB 2117 Multiphor apparatus and 
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Figure 37 Isoelectric focusing of crude culture supernates in 
polyacrylamide gels with a cod erythrocyte overlay
Crude culture supernatant fluids were analysed by 
isoelectric focusing in the LKB 2117 Multiphor apparatus and 
5% (v/v) cod erythrocytes/agarose overlay layered on top. 
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Figure 58 Adsorption chromatography of the crude culture 
supernate of LS26 - 
elution with glycine HC1 buffer
* “ ^80 
^ - pH
a




Figure 59 Adsorption chromatography of the crude culture 
supernate of LS26 
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Comparison of the two methods indicated that a greater recovery 
of desorbed protein was obtained after elution at pH 11 (Table 27). 
However, loss of haemolytic activity was still found. Immunoelectro­
phoresis (Fig 40) and gel diffusion of the desorbed material indicated 
the presence of 6-haemolysin. The adsorbing capacity of the column, 
however, decreased after continual use and therefore this method of 
purification had to be abandoned.
(ii) Hydroxylapatite: Several strains of S. aureus were grown in
500 ml volumes of Bernheimer's yeast extract medium. However, except for 
strain LS28, none produced high haemolysin titres. Strain LS28 gave a 
titre of 1024 (l% cod erythrocytes) and therefore purification of 6-haemo- 
lysin by hydroxylapatite, as employed for strain 10345t was attempted. 
Delta-haemolysin was not recovered after washing the hydroxylapatite in 
1M phosphate buffer pH 7*2 or with 1M Na^PO^ pH 4*5*
This purification method was therefore also abandoned.
6. Immunogenicity
Since purification of the crude culture supernates proved to be 
unsuccessful using the above methods, the immunogenicity of the 6-haemo- 
lysins was investigated using the crude preparations.
Seven selected crude culture supernates were treated with 
formaldehyde at pH 5 for 7 days at 37°C. In addition to loss of haemo­
lytic activity (Table 28), three of the seven formaldehyde-treated 
supernates also lost antigenic activity with rabbit anti-6-haemolysin 
antiserum (Fig 4l)« Groups of 9-10 mice were immunised and sera were 
tested individually by CIE. Antibodies to native 6-haemolysin (strain 
NCTC 10345) were present only in the sera from mice immunised with LS28 
or ZM antigens (Table 28). All sera gave multiple lines when tested
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Figure 40 Immunoelectrophoresis of peak fractions from adsorption
chromatography of strain LS26
All troughs contained rabbit anti-6-haemolysin 
antiserum.
S - Sample applied to column
PI - unadsorbed fraction
P2 - desorbed fraction
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Figure 41 Antigenic reactivity of crude culture supernates with 
anti—6-haemolysin antiserum after treatment with 
formaldehyde for 7 days at pH 5
Centre wells - rabbit anti-6-haemolysin antiserum 







Wells 1,3»5»7»9*11*13 “ purified 6-haemolysin.
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against homologous toxoids by CIE. Antisera containing anti-6-haemolysin 
antibodies gave multiple lines on gel diffusion with crude toxin and 
toxoid whereas only one line of identity was shown against purified 
6-haemolysin (Fig 42: Line of identity was clearly shown on original
slide although is difficult to see on figure shown). None of the mouse 
antisera reacted with purified a-haemolysin.
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Figure 42 Reaction of anti-ZM antiserum with crude toxin, toxoid 
and purified 6-haemolysin and a-haemolysin
Well 1, 3* 5 “ purified 5-haemolysin
Well 2 - crude culture supernate of strain ZM
Well 4 - crude formaldehyde-treated culture
supernate of strain ZM
Well 6 - purified a-haemolysin.




T h e  i m m u n o g e n i c i t y  o f  s t a p h y l o c o c c a l  6 - h a e m o l y s i n  i n  r a b b i t s  i s  
n o w  w e l l  e s t a b l i s h e d  b u t  t h e  i m m u n o g e n i c i t y  o f  t h i s  h a e m o l y s i n  i n  m i c e  h a s  
n o t  p r e v i o u s l y  b e e n  r e p o r t e d .  T h e r e  w e r e  tw o  r e a s o n s  f o r  w a n t i n g  t o  u s e  
m i c e :  f i r s t ,  w h e n  i n v e s t i g a t i n g  t h e  e f f e c t  o f  v a r i o u s  f a c t o r s  ( t i m e
s c h e d u l e s ,  c h e m i c a l  m o d i f i c a t i o n  e t c . )  o n  t h e  r e l a t i v e  i m m u n o g e n i c i t y  o f  
p r o t e i n s ,  m i c e  a r e  u s e f u l  s i n c e  t h e y  a r e  e a s y  t o  h a n d l e  a n d  l a r g e  n u m b e r s  
a r e  r e a d i l y  a v a i l a b l e .  S e c o n d l y ,  s i n c e  t h e  m o u s e  h a s  b e e n  u s e d  a s  a n  
a n i m a l  m o d e l  t o  s t u d y  v a r i o u s  s t a p h y l o c o c c a l  i n f e c t i o n s  ( T a b l e  1 1 ) ,  t h e  
p r o d u c t i o n  o f  a n t i - 6 - h a e m o l y s i n  a n t i b o d y  i n  t h e  m o u s e  m a y  p r o v e  
a d v a n t a g e o u s  i n  d e t e r m i n i n g  a  r o l e  f o r  6 - h a e m o l y s i n  i n  t h e s e  i n f e c t i o n s .
T h e  p r i n c i p a l  o b j e c t i v e  o f  t h i s  i n v e s t i g a t i o n  w a s  t h e r e f o r e  t o  
e s t a b l i s h  c o n d i t i o n s  f o r  i n d u c i n g  a n  im m u n e  r e s p o n s e  t o  6 - h a e m o l y s i n  i n  
t h e  m o u s e .  I n  p a r a l l e l ,  t h e  c h e m i c a l  m o d i f i c a t i o n  o f  6 - h a e m o l y s i n  w a s  
i n v e s t i g a t e d  a n d  a  l a r g e  p a r t  o f  t h e  s t u d y  i n v o l v e d  c o m p a r i s o n ,  b o t h  
i n  v i v o  a n d  i n  v i t r o , o f  t r e a t e d  a n d  u n t r e a t e d  6 - h a e m o l y s i n .  A l s o ,  a s  
p a r t  o f  a  p r o g r a m m e  t o  s e l e c t  v a r i a n t s  o f  6 - h a e m o l y s i n  w h i c h  m i g h t  b e  o f  
u s e  i n  d e t e r m i n i n g  t h e  m o d e  o f  e x p r e s s i o n  o f  t h e  b i o l o g i c a l  p r o p e r t i e s  o f  
6 - h a e m o l y s i n ,  a  n u m b e r  o f  d i f f e r e n t  s t r a i n s  o f  S .  a u r e u s  w e r e  s c r e e n e d  f o r  
a n t i g e n i c  r e a c t i v i t y  a n d  a l s o  o t h e r  p r o p e r t i e s .
P r e p a r a t i o n  a n d  p r o p e r t i e s  o f  5 - h a e m o l y s i n
T h e  p r e p a r a t i o n  o f  6 - h a e m o l y s i n  b y  t h e  p r o c e d u r e  o f  K r e g e r  £ t  a l .  
( 1 9 7 1 )  h a s  b e e n  u s e d  r o u t i n e l y  i n  t h i s  l a b o r a t o r y  f o r  a  n u m b e r  o f  y e a r s  
a n d  t h e  p r e p a r a t i o n  a n d  p r o p e r t i e s  o f  t h e  h a e m o l y s i n  h a v e  b e e n  d i s c u s s e d  
b y  C h a o  ( 19 7 6 )  a n d  W h i t e l a w  ( 1 9 7 8 ) •  T h e  s i x  p r e p a r a t i o n s  u s e d  i n  t h i s  
s t u d y ,  w i t h  a  s p e c i f i c  a c t i v i t y  o f  10 24  H U ^ / m g  w i t h  1 %  c o d  e r y t h r o c y t e s ,  
w e r e  e s s e n t i a l l y  s i m i l a r  t o  t h o s e  o f  C h a o  ( 1 9 7 6 )  a n d  W h i t e l a w  ( 1 9 7 8 )  i n  
s p e c i f i c  a c t i v i t y ,  h a e m o l y t i c  s p e c t r u m ,  u l t r a v i o l e t  s p e c t r u m ,  i s o e l e c t r i c
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f o c u s i n g ,  S L S - p o l y a c r y l a m i d e  g e l s  a n d  l a c k  o f  d e t e c t a b l e  a - h a e m o l y s i n  ( a s  
j u d g e d  b y  t h e  l o w  a c t i v i t y  a g a i n s t  r a b b i t  e r y t h r o c y t e s  a n d  t h e  l a c k  o f  
d e t e c t a b l e  a n t i - a - h a e m o l y s i n  a n t i b o d y  o n  i m m u n i s a t i o n ) .  T h e  o n l y  
d i f f e r e n c e  f o u n d  b e t w e e n  t h e  s i x  p r e p a r a t i o n s  i n  t h i s  s t u d y  a n d  t h a t  o f  
W h i t e l a w  ( 1 9 7 8 )  w a s  i n  t h e i r  s e n s i t i v i t y  t o  h e a t i n g  a t  1 0 0 ° C .  P r e p a r a t i o n  
7 8 / 1  r e t a i n e d  a l l  h a e m o l y t i c  a c t i v i t y  a f t e r  6  h  a t  1 0 0 °C  w h i l e  p r e p a r a t i o n  
7 8 / 2  h a d  l o s t  50% o f  i t s  a c t i v i t y  w i t h i n  1  h  a t  1 0 0 ° C .  T h e  r e s u l t s  o f  
t h e  l a t t e r  p r e p a r a t i o n  a r e  i n  a g r e e m e n t  w i t h  t h o s e  o f  K r e g e r  e t  a l .  ( l 9 7 l ) »  
h o w e v e r ,  W h i t e l a w  ( 1 9 7 8 )  r e p o r t e d  t h e  h a l f - l i f e  o f  5 - h a e m o l y s i n  t o  b e  4 lk  h  
a t  1 0 0 ° C .  T h e  r e a s o n  f o r  t h e  h i g h  t h e r m o s t a b i l i t y  o f  p r e p a r a t i o n  7 8 / 1  
i s  u n k n o w n .  W h e t h e r  t h e  d i f f e r e n t  p r e p a r a t i o n s  o f  5 - h a e m o l y s i n  e x i s t  i n  
v a r i o u s  a g g r e g a t e d  f o r m s  ( K a n t o r  ejb a l • ,  1 9 7 2 )  w h i c h  m a y  r e n d e r  th e m  
t h e r m o s t a b l e  t o  v a r y i n g  d e g r e e s  d e p e n d i n g  o n  t h e i r  s t a t e  o f  a g g r e g a t i o n ,  
r e m a i n s  t o  b e  i n v e s t i g a t e d .
A l t h o u g h  c o n t a m i n a t i o n  b y  o t h e r  s t a p h y l o c o c c a l  p r o d u c t s  w a s  n o t  
i n v e s t i g a t e d  i n  t h i s  s t u d y ,  i t  h a s  b e e n  s h o w n  p r e v i o u s l y  t h a t  p u r i f i c a t i o n  
b y  h y d r o x y l a p a t i t e  y i e l d s  a  p r o d u c t  t h a t  i s  f r e e  o f  m o s t  s t a p h y l o c o c c a l  
e x t r a c e l l u l a r  e n z y m e s  a n d  t o x i n s  ( K r e g e r  e t  a l . ,  1 9 7 1 ;  W h i t e l a w ,  1 9 7 8 ) .
T h e  o n e  k n o w n  c o n t a m i n a n t  i n  t h e  5 - h a e m o l y s i n  p r e p a r e d  b y  W h i t e l a w  ( 1 9 7 8 )  
w a s  a  p h o s p h a t i d y l  i n o s i t o l  s p e c i f i c  p h o s p h o l i p a s e  C (L o w  a n d  F i n e a n ,  1 9 7 6 ,  
1 9 7 7 ) >  p r e s e n t  a t  a  l e v e l  o f  0 .0 0 1 4 %  ( w /w )  (M .G .  L o w ,  p e r s o n a l  c o m m u n i c a t i o n ) .  
H o w e v e r ,  u n l i k e  5 - h a e m o l y s i n ,  t h i s  e n z y m e  h a s  l i t t l e  h a e m o l y t i c  a c t i v i t y  
( <  2% ) (L o w  a n d  F i n e a n ,  1 9 7 7 )  a n d  i i  h y d r o l y s e s  v e r y  l i t t l e  l e c i t h i n  i n  
e r y t h r o c y t e  g h o s t s  (L o w  & F i n e a n ,  1 9 7 6 ) .  T h e r e f o r e ,  i f  t h i s  e n z y m e  w a s  
p r e s e n t  i n  t h e  p r e p a r a t i o n s u s e d  i n  t h i s  s t u d y  i t  w o u l d  b e  u n l i k e l y  t o  
i n t e r f e r e  w i t h  t h e  r e s u l t s  o b t a i n e d .
I m m u n o g e n i c i t y  o f  n a t i v e  5 - h a e m o l y s i n
N a t i v e  5 - h a e m o l y s i n  w a s  p o o r l y  i m m u n o g e n i c  i n  t h e  m o u s e  i n d u c i n g
a  r e s p o n s e  i n ,  a t  m o s t ,  50%  ° f  im m u n is e d ,  a n i m a l s  ( T a b l e  1 8 )  w h e r e a s ,  i n  
t h e  r a b b i t ,  a n  im m u n e  r e s p o n s e  w a s  o b t a i n e d  i n  a l l  a n i m a l s  t e s t e d  b y  
B i r k b e c k  a n d  W h i t e l a w  ( 1 9 7 9 ) •  S i m i l a r l y ,  K o n d o  a t  a l .  ( 1 9 7 6 )  f o u n d  
s t a p h y l o c o c c a l  e x f o l i a t i n  A a n d  B t o  b e  im m u n o g e n i c  i n  t h e  r a b b i t  b u t  n o n -  
i m m u n o g e n i c  i n  t h e  m o u s e  a n d  L a k y  ( 1 9 7 ® )  r e p o r t e d  t h a t  t h e  r e s p o n s e  i n  
m i c e  t o  c h i c k e n  e r y t h r o c y t e s  w a s  l o w e r  t h a n  t h a t  o b t a i n e d  i n  r a b b i t s .
T h e s e  r e s u l t s  t h e r e f o r e  s u g g e s t  t h a t  g e n e t i c  f a c t o r s  a r e  
r e s p o n s i b l e  f o r  t h e  u n r e s p o n s i v e n e s s  o f  m i c e .  T h e  s t r u c t u r e  o f  6 - h a e m o -  
l y s i n  m a y  r e n d e r  t h e  p r o t e i n  m o r e  s u i t a b l e  f o r  i n d u c t i o n  o f  a n  im m u n e  
r e s p o n s e  i n  t h e  r a b b i t  t h a n  i n  t h e  m o u s e .  F o r  e x a m p l e ,  t h e  a m i n o  a c i d  
s e q u e n c e s  o f  t h e  p o l y p e p t i d e  c h a i n s  m a y  b e  m o r e  " f o r e i g n "  i n  t h e  r a b b i t  t h a n  
i n  t h e  m o u s e  ( B u r n e t  a n d  F e n n e r ,  1 9 4 9 )  a n d  t h e r e f o r e  m o r e  im m u n o g e n i c  i n  
t h e  f o r m e r  s p e c i e s .
G e n e t i c  u n r e s p o n s i v e n e s s  m a y  a l s o  b e  e x p l a i n e d  b y  l )  d i f f e r e n c e s  
i n  t h e  e a s e  a n d  s p e e d  w i t h  w h i c h  c e l l s  a r e  i n d u c e d  i n t o  s p e c i f i c  a n t i b o d y  
p r o d u c t i o n  ( i p s e n ,  1 9 5 9 ) »  2 )  t h e  n u m b e r  o f  i m m u n o c o m p e t e n t  B c e l l s  p r e s e n t
( S h e a r e r ,  M o z e s  a n d  S e l a ,  1 9 7 1 )  o r  3 )  g r e a t e r  s u s c e p t i b i l i t y  t o  t o l e r a n c e  
o f  h i g h  a f f i n i t y  c e l l s  a s  a  d i r e c t  r e s u l t  o f  d e f e c t i v e  m a c r o p h a g e  f u n c t i o n  
a t  t h e  l e v e l  o f  a n t i g e n  p r o c e s s i n g  a n d  p r e s e n t a t i o n  t o  im m u n o c o m p e t e n t  
c e l l s  ( S t e w a r d  e t  a l . ,  1 9 7 4 ) -  A f u r t h e r  p o s s i b i l i t y  m a y  b e  a  s u p p r e s s o r  
d e t e r m i n a n t  o n  t h e  h a e m o l y s i n  m o l e c u l e  w h i c h  s p e c i f i c a l l y  a c t i v a t e s  T -  
s u p p r e s s o r  c e l l s  i n  t h e  n o n - r e s p o n d i n g  m i c e  ( A d o r i n i ,  M i l l e r  a n d  S e r c a r z ,  
1 9 7 9 ) .  A s u p p r e s s o r  d e t e r m i n a n t ,  w h i c h  s p e c i f i c a l l y  i n d u c e s  s u p p r e s s o r  
T c e l l s  i n  n o n - r e s p o n d i n g  m i c e ,  h a s  r e c e n t l y  b e e n  i d e n t i f i e d  i n  h e n  e g g -  
w h i t e  l y s o z y m e  ( Y o w e l l  e t  a l . ,  1 9 7 9 ) *  W hen  t h i s  d e t e r m i n a n t  w a s  r e m o v e d ,  
t h e  m i c e  g e n e r a t e d  a  v i g o r o u s  T - c e l l  r e s p o n s e  d i r e c t e d  a g a i n s t  a  l a r g e  
f r a g m e n t  o f  t h e  a n t i g e n  a n d  t h e  a u t h o r s  s u g g e s t e d  t h a t  g e n e t i c  r e s p o n s i v e n e s s  
i s  c o n t r o l l e d  a t  t h e  l e v e l  o f  t h e  m a c r o p h a g e  i n  t h e  p r e s e n t a t i o n  o f  
d i f f e r e n t  d e t e r m i n a n t s  t o  t h e  c o m p e t i n g  s u b p o p u l a t i o n s  o f  r e g u l a t o r y  T c e l l s .
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I n  t h i s  s t u d y ,  t h e r e f o r e ,  i t  i s  p o s s i b l e  t h a t  " e x p r e s s i o n "  o f  a  
s u p p r e s s o r  d e t e r m i n a n t  m a y  o c c u r  i n  t h e  n o n - r e s p o n d i n g  m i c e  b u t  n o t  i n  
r a b b i t s  i n  w h i c h  t h e  m a c r o p h a g e s  m a y  p r e s e n t  d i f f e r e n t  a n t i g e n i c  d e t e r m i n ­
a n t s  t o  t h e  i m m u n o - c o m p e t e n t  c e l l s .
C h e m i c a l  m o d i f i c a t i o n  o f  5 - h a e m o l y s i n
S i n c e  n a t i v e  5 - h a e m o l y s i n  f a i l e d  t o  i n d u c e  a n  a c c e p t a b l e  im m u n e  
r e s p o n s e  i n  t h e  m o u s e ,  c h e m i c a l  t r e a t m e n t  o f  t h e  h a e m o l y s i n  w i t h  f o r m a l d e ­
h y d e ,  g l u t a r a l d e h y d e  o r  f o r m a l d e h y d e / a m i n o  a c i d  m i x t u r e s  w a s  e x a m i n e d  i n  a n  
a t t e m p t  t o  i n c r e a s e  i t s  i m m u n o g e n i c i t y .
T r e a t m e n t  o f  5 - h a e m o l y s i n  w i t h  f o r m a l d e h y d e  a t  3 7 ° C  a n d  a t  pH  5 
o r  pH  7 * 5  c a u s e d  c o m p l e t e  l o s s  o f  h a e m o l y t i c  a c t i v i t y  w i t h i n  2 4  h  o f  
i n c u b a t i o n .  H o w e v e r ,  u n d e r  a l k a l i n e  c o n d i t i o n s ,  so m e  a c t i v i t y  w a s  
r e t a i n e d  e v e n  a f t e r  7  d a y s  i n c u b a t i o n .  T h e  i n i t i a l  l o s s  o f  h a e m o l y t i c  
a c t i v i t y  a t  " z e r o  t i m e "  c o m p a r e d  w i t h  c o n t r o l  s a m p l e s  c a n  b e  e x p l a i n e d  b y  
t h e  r e a c t i o n  w h i c h  o c c u r r e d  w h i l s t  s e t t i n g  u p  t h e  d i a l y s i s  a n d  d u r i n g  t h e  
i n i t i a l  p e r i o d  o f  d i a l y s i s  ( M y e r s  a n d  H a r d m a n ,  1 9 7 1 ) .
E a t o n  ( 1 9 3 7 )  r e p o r t e d  t h a t  g r e a t e r  q u a n t i t i e s  o f  f o r m a l d e h y d e  w e r e  
n e e d e d  t o  c o n v e r t  d i p h t h e r i a  t o x i n  i n t o  t o x o i d  a t  a c i d  pH t h a n  a t  
a l k a l i n e  pH  w h i c h  i s  c o n t r a r y  t o  w h a t  w a s  f o u n d  h e r e .  H o w e v e r ,  i n  e x c e s s  
f o r m a l d e h y d e ,  t h e  r e a c t i o n  m a y  b e  r e v e r s i b l e  ( L i n g g o o d  e t  a l . ,  19 6 3 )  a n d  
m a y  a c c o u n t  f o r  t h e  s l o w e r  r a t e  o f  d e t o x i f i c a t i o n  u n d e r  a l k a l i n e  c o n d i t i o n s .
M a r k s  a n d  V a u g h a n  ( 1 9 5 0 )  r e p o r t e d  a  l o s s  o f  h a e m o l y t i c  a c t i v i t y  
w i t h i n  4 8 - 7 2  h  w h e n  5 - h a e m o l y s i n  w a s  t r e a t e d  w i t h  0 .5 %  f o r m a l d e h y d e  b u t ,  
u n f o r t u n a t e l y ,  t h e  pH  o f  t h e  r e a c t i o n  w a s  n o t  r e c o r d e d .
T h e  i m p o r t a n c e  o f  pH  i n  t h e  r e a c t i o n  o f  f o r m a l d e h y d e  w i t h  t o x i n s  
a n d  t h e  r e s u l t i n g  p r o p e r t i e s  h a s  b e e n  r e p o r t e d  f o r  t h e  t o x i n  o f  t h e  
P a l e s t i n e  v i p e r ,  Y i p e r a  p a l e s t i n a e .  N e u r o t o x i c  a n d  a n t i g e n i c  a c t i v i t i e s
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o f  t h e  t o x i n  w e r e  r e t a i n e d  a t  a c i d i c  pH b u t  l o s t  a t  a l k a l i n e  pH  w h i l e  
t h e  h a e m o r r h a g i c  p r o p e r t y  o f  t h e  t o x i n  w a s  d e s t r o y e d  o v e r  a  pH r a n g e  o f  
5 .5  t o  9 * 2  ( M o r o z - P e r l m u t t e r  e t  a l . ,  19 6 5 ) .
T h e  a n t i g e n i c  a c t i v i t y  o f  a l l  f o r m a l d e h y d e - t r e a t e d  6 - h a e m o l y s i n  
p r e p a r a t i o n s  w a s  r e t a i n e d  a n d  a l l  p r o d u c e d  a  l i n e  o f  i d e n t i t y  w i t h  n a t i v e  
6 - h a e m o l y s i n  a g a i n s t  a n t i - 6 - h a e m o l y s i n  a n t i b o d y  ( F i g  7 ) *  O t h e r  w o r k e r s  
a l s o  f a i l e d  t o  d e t e c t  a n y  d i f f e r e n c e s  i n  a n t i g e n i c  s p e c i f i c i t y  o f  BSA 
( H a b e e b ,  19 6 9 )  o r  s t a p h y l o c o c c a l ,  e x f o l i a t i n  A a n d  B ( K o n d o  e t  a l . ,  1 9 7 6 )  
a f t e r  t r e a t m e n t  w i t h  f o r m a l d e h y d e .  D e s t r u c t i o n  o f  a n t i g e n i c  d e t e r m i n a n t s  
b y  f o r m a l d e h y d e  h a s  b e e n  r e p o r t e d  w i t h  d i p h t h e r i a  t o x i n  ( R i t t e n b e r g  £ t  a l . ,
1 9 7 6 )  b u t  n o t  f o u n d  b y  o t h e r  w o r k e r s  ( B a z a r a l  e t  a l . ,  1 9 7 3 ) *  H o w e v e r ,  
d e s t r u c t i o n  o f  n a t i v e  d e t e r m i n a n t s  i s  p H - d e p e n d e n t  s i n c e  t h e r e  i s  a  g r e a t e r  
l o s s  w i t h  i n c r e a s i n g  pH  ( W a r r e n  e t  a l , ,  1 9 7 3 *  1 9 7 5 ) *  T h e s e  r e s u l t s  w e r e  
o b t a i n e d  f r o m  q u a n t i t a t i v e  p r e c i p i t i n  t e s t s  o f  t o x o i d s  w i t h  a n t i b o d y  t o  
n a t i v e  e n t e r o t o x i n s .  S i n c e  t h i s  t e s t  i s  m o r e  s e n s i t i v e  t h a n  g e l  d i f f u s i o n  
i t  i s  p o s s i b l e  t h a t  so m e  n a t i v e  d e t e r m i n a n t s  m a y  h a v e  b e e n  d e s t r o y e d  i n  
t h i s  s t u d y .  I n d e e d ,  t h e  p r e c i p i t i n  r e a c t i o n  w i t h  s a m p l e s  t r e a t e d  a t  pH 9 * 5  
w a s  f r e q u e n t l y  w e a k e r  t h a n  t h a t  o b t a i n e d  w i t h  t h e  o t h e r  t o x o i d s .  T h i s  i s  
t h e r e f o r e  i n  a g r e e m e n t  w i t h  t h e  w o r k  o f  E a t o n  ( 1 9 3 7 )  t h a t ,  i n  a l k a l i n e  
c o n d i t i o n s  a n d  i n  e x c e s s  f o r m a l d e h y d e ,  t h e r e  i s  a  l o s s  i n  f l o c c u l a t i n g  
a b i l i t y  o f  t o x i n .
A n t i s e r a  r a i s e d  a g a i n s t  t h e  t o x o i d s  i n  b o t h  t h e  r a b b i t  a n d  t h e  
m o u s e  c o n t a i n e d  a n t i b o d i e s  d i r e c t e d  a g a i n s t  n e w  a n t i g e n i c  d e t e r m i n a n t s  n o t  
f o u n d  i n  n a t i v e  6 - h a e m o l y s i n  ( F i g  1 3 ) •  T h i s  i s  p r o b a b l y  d u e  t o  t h e  i n t r a ­
m o l e c u l a r  c r o s s - l i n k i n g  c a u s e d  b y  f o r m a l d e h y d e  ( G i l l  e t  a l . ,  19 6 8 ) .  A l s o ,  
i f  t h e  d e s t r u c t i o n  o f  n a t i v e  d e t e r m i n a n t s  a n d  t h e  c r e a t i o n  o f  n e w  a n t i g e n i c  
d e t e r m i n a n t s  o c c u r r e d  a t  d i f f e r e n t  r a t e s ,  i t  i s  p o s s i b l e  t h a t  t h e  a n t i b o d y  
r e s p o n s e  a g a i n s t  t h e  n a t i v e  d e t e r m i n a n t s  w o u l d  b e  w e a k e r  ( S c h i r m a c h e r  a n d
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W i g z e l l ,  1 9 7 4 » N a o r  a n d  G a l i l i ,  1 9 7 7 ;  O n i c a ,  L e n k e i  a n d  G h e t i e ,  1 9 7 8 )  
o r  o f  l o w e r  a v i d i t y  ( s t e w a r d  e_t a l . ,  19 7 4 )  t h a n  t h a t  d i r e c t e d  a g a i n s t  
t h e  n e w  d e t e r m i n a n t s .  T h i s  w o u l d  e x p l a i n  t h e  i n a b i l i t y  o f  n a t i v e  6 -  
h a e m o l y s i n  t o  p r e c i p i t a t e  w i t h  c e r t a i n  m o u s e  a n t i - t o x o i d  a n t i s e r a  o n  
i m m u n o d i f f u s i o n  ( F i g  l l ) .  H o w e v e r ,  s i n c e  d i f f e r e n c e s  i n  a n t i b o d y  
a v i d i t y  c a n  o c c u r  b e t w e e n  i n d i v i d u a l  m i c e  ( S t e w a r d  £ t  a l . , 1 9 7 4 )  a n d  & - 
h a e m o l y s i n  i s  m o r e  i m m u n o g e n i c  i n  t h e  r a b b i t  ( B i r k b e c k  a n d  W h i t e l a w ,
19 7 9 ) f t h e  r e s p o n s e  a g a i n s t  t h e  n a t i v e  d e t e r m i n a n t s  w o u l d  b e  g r e a t e r  i n  
t h e  r a b b i t  a n d  i n  c e r t a i n  m i c e  a n d  t h e r e f o r e  d e t e c t a b l e  b y  i m m u n o d i f f u s i o n  
( F i g  1 1 ) .
T r e a t m e n t  o f  6 - h a e m o l y s i n  w i t h  g l u t a r a l d e h y d e  c a u s e d  a  r a p i d  
l o s s  o f  h a e m o l y t i c  a c t i v i t y .  S i n c e  g l u t a r a l d e h y d e  i s  a  b i f u n c t i o n a l  
a l d e h y d e  i t s  m e c h a n i s m  o f  r e a c t i o n  i s  p r o b a b l y  a n a l o g o u s  t o  t h a t  o f  
f o r m a l d e h y d e  a t  e a c h  f u n c t i o n a l  g r o u p ,  b u t  t h e  r e a c t i o n  o c c u r s  m o r e  
r a p i d l y  ( H a b e e b  a n d  H i r a m o t o ,  19 6 8 ; H a b e e b ,  1 9 6 9 )  a n d  t h e  b i n d i n g  t o  
p r o t e i n s  a n d  i n t r o d u c t i o n  o f  c r o s s - l i n k a g e s  i s  g r e a t e r  t h a n  w i t h  f o r m a l ­
d e h y d e  (B o w e s  a n d  C a t e r ,  19 6 6 ) .  A d e c r e a s e  i n  a n t i g e n i c  a c t i v i t y  w a s  
f o u n d  ( R a p p a p o r t  e t  a l . ,  19 7 4 )  a n d ,  a f t e r  i n c u b a t i o n  f o r  7  d a y s ,  o n l y  
s a m p l e s  t r e a t e d  a t  pH  9 * 5  r e t a i n e d  a n t i g e n i c  a c t i v i t y  ( F i g  2 1 ) .  T h i s  
m a y  b e  d u e  t o  t h e  p o l y m e r i s a t i o n  o f  g l u t a r a l d e h y d e  i n  a l k a l i n e  c o n d i t i o n s  
w h i c h  a f f e c t s  i t s  e f f i c i e n c y  a s  a  c r o s s - l i n k i n g  r e a g e n t  (B o w e s  a n d  C a t e r ,
19 6 6 ) .  T h e  d e s t r u c t i o n  o f  n a t i v e  d e t e r m i n a n t s ,  t h e r e f o r e ,  m a y  n o t  o c c u r  
a p p r e c i a b l y  u n d e r  a l k a l i n e  c o n d i t i o n s .  S i m i l a r l y ,  u n d e r  a c i d  o r  
n e u t r a l  c o n d i t i o n s ,  f o r m a l d e h y d e  e x i s t s  a s  a  p o l y m e r  b u t  i s  d e p o l y m e r i s e d  
b y  c h a n g i n g  t o  a l k a l i n e  c o n d i t i o n s  ( T o m iy a m a ,  1 9 3 5 ) -  T h i s  w o u ld  
s i m i l a r l y  a c c o u n t  f o r  t h e  a c t i v i t i e s  o f  t h e  f o r m a l d e h y d e - t r e a t e d  
p r e p a r a t i o n s .
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T h e  a d d i t i o n  o f  t y r o s i n e ,  g l y c i n e  o r  l e u c i n e  d u r i n g  " t o x o i d i n g "  
d i d  n o t  s i g n i f i c a n t l y  a l t e r  t h e  r e a c t i o n  o f  f o r m a l d e h y d e  w i t h  5 - h a e m o l y s i n .  
T h e  a n t i g e n i c  a c t i v i t y  o f  5 - h a e m o l y s i n  w a s  r e t a i n e d  i n  a l l  p r e p a r a t i o n s  
s in d ,  a t  pH 5 o r  PH 7 « 5 f  h a e m o l y t i c  a c t i v i t y  w a s  l o s t .  T h e  m a i n  d i f f e r e n c e  
b e t w e e n  5 - h a e m o l y s i n  t r e a t e d  w i t h  f o r m a l d e h y d e  a l o n e  o r  w i t h  f o r m a l d e h y d e /  
a m i n o  a c i d  m i x t u r e s  w a s  t h e  c o m p l e t e  l o s s  o f  h a e m o l y t i c  a c t i v i t y  a f t e r  
i n c u b a t i o n  f o r  7  d a y s  a t  pH  9 * 5  w i t h  g l y c i n e  o r  l e u c i n e .  F o r m a l d e h y d e  
m a y  p r e f e r e n t i a l l y  r e a c t  w i t h  t h e s e  f r e e  a m i n o  a c i d s  ( F r e n c h  a n d  E d s a l l ,  
1 9 4 5 )  a n d ,  t h e r e f o r e ,  t h e  r e v e r s i b l e  r e a c t i o n  o c c u r r i n g  u n d e r  a l k a l i n e  
c o n d i t i o n s  d u e  t o  e x c e s s  f o r m a l d e h y d e  ( a s  p o s t u l a t e d  a b o v e )  m a y  n o t  o c c u r  
d u e  t o  t h i s  " m o p p i n g  u p ” e f f e c t  o f  t h e  a m i n o  a c i d s .  I n  t h i s  w a y ,  
d e t o x i f i c a t i o n  c o u l d  o c c u r  m o r e  r a p i d l y .
T h e  p r i m a r y  r e a c t i o n  o f  f o r m a l d e h y d e  w i t h  p r o t e i n s  o c c u r s  a t  
l y s y l  r e s i d u e s  ( F r a e n k e l - C o n r a t  a n d  O l c o t t ,  1 9 4 8 )  b u t  m e t h y l e n e  b r i d g e s  
m a y  a l s o  b e  f o r m e d  b e t w e e n  l y s i n e  a n d  t y r o s i n e ,  h i s t i d i n e  o r  t r y p t o p h a n  
r e s i d u e s  ( F r a e n k e l - C o n r a t  a n d  O l c o t t ,  1 9 4 8 ;  B l a s s ,  B i z z i n i  a n d  R a y n a u d ,
19 6 7 )  a n d  o t h e r  a m i n o  g r o u p s  ( D u n l o p ,  M a r i n i  a n d  M a r t i n ,  1 9 7 1 ) *  H o w e v e r ,  
s i n c e  5 - h a e m o l y s i n  l a c k s  t y r o s i n e  a n d  h i s t i d i n e  ( K r e g e r  e t  a l , ,  1 9 7 1 >  
H e a t l e y ,  1 9 7 1 »  K a n t o r  e t  a l . ,  1 9 7 2 ;  W h i t e l a w ,  1 9 7 8 ) ,  t h e  r e a c t i o n  o f
5 - h a e m o l y s i n  w i t h  f o r m a l d e h y d e  c a n  b e  r e g a r d e d  a s  o c c u r r i n g  b e t w e e n  
l y s i n e  a n d  t r y p t o p h a n ,  a n d  p o s s i b l y  a l s o  a s p a r a g i n e  a n d  g l u t a m i n e  
r e s i d u e s .  T h e  r e a c t i o n  w i t h  t r y p t o p h a n  r e s i d u e s  o c c u r s  m a i n l y  i n  
a l k a l i n e  c o n d i t i o n s  ( F r a e n k e l - C o n r a t  e t  a l . ,  1 9 4 7 ) .
T r e a t m e n t  o f  5 - h a e m o l y s i n  w i t h  f o r m a l d e h y d e  o r  g l u t a r a l d e h y d e  
c a u s e d  a  g r a d u a l  l o s s  i n  p r o t e i n  c o n c e n t r a t i o n  w i t h  i n c r e a s i n g  
i n c u b a t i o n  t i m e s .  T h i s  l o s s  w a s  e x t e n s i v e  u n d e r  a c i d  c o n d i t i o n s ,  w h i l e ,
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a t  pH  9 , 5 ,  t h e r e  w a s  l i t t l e  d e c r e a s e  i n  t h e  p r o t e i n  c o n c e n t r a t i o n  o f
5 - h a e m o l y s i n .  I t  w a s  i n i t i a l l y  c o n s i d e r e d  t h a t  t h e  a p p a r e n t  l o s s  o f  
p r o t e i n  h y  t h e  F o l i n  a s s a y  w a s  d u e  t o  a n  a l t e r e d  r e a c t i v i t y  c a u s e d  b y  
t h e  m o d i f i c a t i o n  o f  t h e  t r y p t o p h a n  r e s i d u e s .  H o w e v e r ,  t h e r e  w a s  a l s o  
a  l o s s  i n  t h e  t o t a l  n i t r o g e n  c o n t e n t  o f  t h e s e  p r e p a r a t i o n s  w h i c h  
p a r a l l e l e d  t h e  l o s s  o f  m e a s u r a b l e  p r o t e i n .  S i n c e  t h e  d e c r e a s e  i n  
p r o t e i n  c o n c e n t r a t i o n  w a s  g r e a t e r  t h a n  t h e  d e c r e a s e  i n  n i t r o g e n  c o n t e n t ,  
f o r m a l d e h y d e  m a y  h a v e  i n f l u e n c e d  t h e  a s s a y  s y s t e m ,  b u t  t h e  r e s u l t s  
n e v e r t h e l e s s  i n d i c a t e  t h a t  t h e r e  w a s  a  g e n u i n e  l o s s  o f  p r o t e i n .
T h e  l o s s  o f  p r o t e i n  o c c u r r e d  d u r i n g  t h e  i n c u b a t i o n  p e r i o d  o f
5 - h a e m o l y s i n  w i t h  f o r m a l d e h y d e  s i n c e  t h e r e  w a s  n o  s i g n i f i c a n t  d e c r e a s e  
i n  t h e  p r o t e i n  c o n c e n t r a t i o n s  o f  p r e p a r a t i o n s  b e f o r e  o r  a f t e r  t h e  
d i a l y s i s  a n d  c e n t r i f u g a t i o n  s t e p s .  T h e  r e a s o n  f o r  t h i s  l o s s  o f  p r o t e i n  
w a s  n o t  i n v e s t i g a t e d ,  h o w e v e r ,  o n e  e x p l a n a t i o n  m a y  b e  t h a t  t h e  h a e m o ­
l y s i n  h a d  a d s o r b e d  t o  t h e  g l a s s  s u r f a c e  o f  t h e  t e s t  t u b e s  d u r i n g  
i n c u b a t i o n .  H e a t l e y  ( 1 9 7 1 )  r e p o r t e d  t h a t  d i l u t e  s o l u t i o n s  o f  5 - h a e m o ­
l y s i n  ( a b o u t  2  H U /m l)  a d s o r b e d  q u i c k l y  a n d  s t r o n g l y  t o  g l a s s .  I f  t h i s  
o c c u r r e d  i n  t h e s e  e x p e r i m e n t s ,  t h e n  t h e  pH  o f  t h e  r e a c t i o n  o f  f o r m a l d e h y d e  
w i t h  5 - h a e m o l y s i n  i s  a n  i m p o r t a n t  f a c t o r  i n  t h e  a b i l i t y  o f  t h e  h a e m o l y s i n  
t o  a d s o r b  t o  g l a s s .  T h e  a l t e r a t i o n  i n  t h e  o v e r a l l  c h a r g e  o f  5 - h a e m o ­
l y s i n  d u e  t o  m o d i f i c a t i o n  o f  l y s y l  r e s i d u e s  p r o b a b l y  d o e s  n o t  i n f l u e n c e  
t h e  b i n d i n g  o f  5 - h a e m o l y s i n  t o  g l a s s  s i n c e  t h e  p i  o f  a l l  t o x o i d s 1 w a s  
v e r y  s i m i l a r .  H o w e v e r ,  v a r y i n g  d e g r e e s  o f  c r o s s - l i n k i n g  a t  d i f f e r e n t  
p H * s  m a y  i n f l u e n c e  t h e  a d s o r p t i o n  o f  5 - h a e m o l y s i n  t o  g l a s s .  F o r  
e x a m p l e ,  i f  t h e r e  i s  a  g r e a t e r  d e g r e e  o f  c r o s s l i n k i n g  i n  a l k a l i n e  
c o n d i t i o n s  t h i s  m a y  p r e v e n t  t h e  b i n d i n g  o f  t h e  h a e m o l y s i n  t o  g l a s s .  T h e
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c r o s s l i n k i n g  r e a c t i o n  o f  f o r m a l d e h y d e  w i t h  t r y p t o p h a n  r e s i d u e s  m a y  
c a u s e  t h i s  ( F r a e n k e l - C o n r a t  _ e t a l . ,  1 9 4 7 ) *  H o w e v e r ,  a s  m e n t i o n e d  
e a r l i e r ,  t h e  c r o s s l i n k i n g  e f f i c i e n c y  o f  g l u t a r a l d e h y d e  i s  d e c r e a s e d  
u n d e r  a l k a l i n e  c o n d i t i o n s  (B o w e s  a n d  C a t e r ,  19 6 6 )  a n d  t h e r e f o r e  so m e  
o t h e r  f a c t o r s  m u s t  h e  i n v o l v e d  e i t h e r  i n  t h e  a d s o r p t i o n  o f  6 - h a e m o l y s i n  
t o  g l a s s  o r  c a u s i n g  t h e  l o s s  o f  p r o t e i n .
T h e  u l t r a v i o l e t  a b s o r p t i o n  s p e c t r u m  o f  f o r m a l d e h y d e - t r e a t e d  
p r e p a r a t i o n s  i n d i c a t e d  a  l o s s  o f  t h e  s m a l l  p e a k  a t  2 9 1  nm  ( F i g  1 4 ) .
T h i s  m a y  b e  d u e  t o  r e a c t i o n  o f  f o r m a l d e h y d e  w i t h  t r y p t o p h a n  r e s i d u e s .  
H o w e v e r ,  t h e  s l i g h t  i n c r e a s e  i n  a b s o r p t i o n  a t  265  nm  w i t h  pH  5 s a m p l e s  
m a y  b e  c a u s e d  b y  t h e  r e a c t i o n  o f  t h e  f o r m a l d e h y d e  w i t h  l y s i n e  r e s i d u e s  
( K o r n  e t  a l . ,  1 9 7 2 ;  O n i c a ,  1 9 7 8 ) *
I m m u n o g e n i c i t y  o f  c h e m i c a l l y  m o d i f i e d  6 - h a e m o l y s i n
T r e a t m e n t  o f  6 - h a e m o l y s i n  w i t h  f o r m a l d e h y d e  a t  pH  5 g a v e  a  
p r o d u c t  w i t h  e n h a n c e d  i m m u n o g e n i c i t y .  A n i n c r e a s e  i n  i m m u n o g e n i c i t y  h a s  
b e e n  r e p o r t e d  a f t e r  f o r m a l d e h y d e  t r e a t m e n t  o f  s t a p h y l o c o c c a l  e n t e r o t o x i n s  
( W a r r e n  e t  a l . , 1 9 7 3 » 1 9 7 5 ) *  H o w e v e r ,  u n l i k e  t h e  r e s u l t s  o f  t h e s e  
w o r k e r s ,  t h e  p r e p a r a t i o n  t r e a t e d  a t  pH 7 « 5  w a s  l e s s  i m m u n o g e n i c  t h a n  t h e  
p r e p a r a t i o n  t r e a t e d  a t  pH  5»  T h e  f a i l u r e  o f  f o r m a l d e h y d e  t o  i n c r e a s e  t h e
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i m m u n o g e n i c i t y  o f  6 - h a e m o l y s i n  u n d e r  a l k a l i n e  c o n d i t i o n s  c o n f i r m s  t h e  
f i n d i n g s  o f  o t h e r  w o r k e r s  u s i n g  d i p h t h e r i a  t o x i n  ( E a t o n ,  1 9 5 7 ) »  s n a k e  
t o x i n s  ( M o r o z - P e r l m u t t e r  e t  a l . ,  19 6 3 ) ,  s t a p h y l o c o c c a l  e n t e r o t o x i n s  
( W a r r e n  e t  a l . ,  1 9 7 3 »  1 9 7 5 )  a n d . s t a p h y l o c o c c a l  e x f o l i a t i n  A a n d  B (K o n d o  
j e t  a l . ,  1 9 7 6 ) .  A g r e a t e r  d e s t r u c t i o n  o f  n a t i v e  d e t e r m i n a n t s  m a y  a c c o u n t  
f o r  t h e  d e c r e a s e d  i m m u n o g e n i c i t y  o f  t h e s e  p r e p a r a t i o n s  ( W a r r e n  e t  a l . ,
1 9 7 3 )  a n d  t h e r e f o r e  t h e r e  m a y  n o t  b e  t h e  c o r r e c t  n u m b e r  o f  a n t i g e n i c  
d e t e r m i n a n t s  p r e s e n t  t o  i n d u c e  a n  im m u n e  r e s p o n s e  ( D e s a y m a r d  a n d  F e l d m a n n ,  
1 9 7 5 ;  D e s a y m a r d  a n d  H o w a r d ,  1 9 7 5 ?  D i n t z  e t  a l , ,  1 9 7 6 ) .
V a r i o u s  e x p e r i m e n t s  w e r e  p e r f o r m e d  t o  t r y  a n d  e x p l a i n  t h e  
i n c r e a s e d  i m m u n o g e n i c i t y  o f  t h e  f o r m a l d e h y d e - t r e a t e d  p r e p a r a t i o n s .  P o l y ­
m e r i s a t i o n  c a u s e d  b y  f o r m a l d e h y d e  t r e a t m e n t  h a s  b e e n  c o n s i d e r e d  a s  t h e  
c o n t r i b u t i n g  f a c t o r  i n  t h e  e n h a n c e d  i m m u n o g e n i c i t y  o f  s t a p h y l o c o c c a l  e n t e r o ­
t o x i n s  ( W a r r e n  e t  a l . ,  1 9 7 3 »  1 9 7 5 ) *  H o w e v e r ,  e x t e n s i v e  c r o s s l i n k i n g  
g i v i n g  l a r g e  p o l y m e r s  w a s  n o t  e v i d e n t  i n  t h e  s o l u b l e  f r a c t i o n s  u s e d  f o r  
t h e  i m m u n i s a t i o n  o f  m i c e .  O t h e r  w o r k e r s  a l s o  f a i l e d  t o  d e t e c t  p o l y m e r ­
i s a t i o n  o f  s t a p h y l o c o c c a l  a - h a e m o l y s i n  ( B e r n h e i m e r  e t  a l . ,  19 6 8 )  o r  BSA 
( H a b e e b ,  1 9 6 9 )  a f t e r  t r e a t m e n t  w i t h  f o r m a l d e h y d e .  T h i s  m a y  b e  d u e  t o  n o t  
o n l y  t h e  pH o f  t h e  r e a c t i o n  ( W a r r e n  e t  a l . ,  1 9 7 3 >  1 9 7 5 )  D u t  a l s o  t o  t h e  
c o n c e n t r a t i o n  o f  f o r m a l d e h y d e  a n d  t o x i n  u s e d  ( M u r p h y ,  19 6 7 ) .
T h e  r e a c t i o n  w i t h  f o r m a l d e h y d e  r e s u l t e d  i n  a n  i n c r e a s e d  e l e c t r o ­
p h o r e t i c  m o b i l i t y  ( F i g  1 5 )  a n d  r e d u c e d  i s o e l e c t r i c  p o i n t  ( F i g  1 6 )  o f  
6 - h a e m o l y s i n .  T h i s  i s  p r o b a b l y  d u e  t o  t h e  r e a c t i o n  w i t h  f r e e  a m i n o  
g r o u p s  ( M u r p h y ,  1 9 6 7 ;  H a b e e b ,  19 6 9 ) .  H o w e v e r ,  t h i s  i n c r e a s e  i n  n e g a t i v e  
c h a r g e  i s  u n l i k e l y  t o  a f f e c t  t h e  i m m u n o g e n i c i t y  o f  t h e  p r o t e i n  ( M a u r e r ,
1 9 6 4 ;  R e i c h l i n  e t  a l . ,  1 9 7 0 ) .
T h e  e n h a n c e d  i m m u n o g e n i c i t y  o f  6 - h a e m o l y s i n  t r e a t e d  w i t h  f o r m a l ­
d e h y d e  m a y  b e  e x p l a i n e d  b y  i t s  r e d u c e d  a f f i n i t y  f o r  l e c i t h i n  ( F i g  1 7 ) .
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D u r i n g  i m m u n i s a t i o n , t h i s  w o u l d  l e a v e  6 - h a e m o l y s i n  f r e e  t o  s t i m u l a t e  a n  
im m u n e  r e s p o n s e  r a t h e r  t h a n  b e i n g  b o u n d  t o  l i p o p r o t e i n s  o r  c e l l  m e m b r a n e  
p h o s p h o l i p i d s .  A l s o ,  f o r m a l d e h y d e  r e n d e r e d  6 - h a e m o l y s i n  r e s i s t a n t  t o  
t r y p t i c  d i g e s t i o n ,  p r o b a b l y  d u e  t o  t h e  c r o s s l i n k i n g  e f f e c t  o f  f o r m a l d e h y d e  
( P a p p e n h e i m e r  e t  a l . ,  1 9 7 2 ;  B a z a r a l  e t  a l . ,  1 9 7 5 ) *  T h i s  s t a b i l i t y  m a y  
r e n d e r  t h e  p r o t e i n  r e s i s t a n t  t o  p r o t e o l y s i s  b y  o t h e r  e n z y m e s  ( F r a e n k e l -  
C o n r a t  a n d  O l c o t t ,  1 9 4 8 ;  E a t o n ,  1 9 5 7 )  w h i c h  m a y  c a u s e  m e t a b o l i c  i n e r t n e s s  
o r  d i m i n i s h e d  r e n a l  e x c r e t i o n  ( C r u m p t o n ,  1 9 7 4 ) *  H o w e v e r ,  r e s i s t a n c e  t o  
b o t h  l e c i t h i n  i n h i b i t i o n  a n d  t r y p t i c  d i g e s t i o n  w a s  f o u n d  i n  a l l  t o x o i d  
p r e p a r a t i o n s  a n d  t h e r e f o r e  so m e  o t h e r  f a c t o r s  m u s t  b e  i n v o l v e d  t o  e x p l a i n  
t h e  i n c r e a s e d  i m m u n o g e n i c i t y  o f  t h e  pH 5 t r e a t e d  p r e p a r a t i o n s .  A n 
i m p o r t a n t  p o i n t  i s ,  h o w e v e r ,  t h e  r e s i s t a n c e  t o  t r y p t i c  d i g e s t i o n  o f  6 - h a e m o -  
l y s i n  t r e a t e d  a t  pH  5 i n  t h e  a b s e n c e  o f  f o r m a l d e h y d e .  I f  a c i d i t y  
i n f l u e n c e s  t h e  s t r u c t u r e  o f  6 - h a e m o l y s i n  i n  s u c h  a  w a y  a s  t o  r e n d e r  t h e  
s u s c e p t i b l e  s i t e s  i n a c c e s s i b l e  t o  t h e  e n z y m e ,  t h e n  f u r t h e r  t r e a t m e n t  w i t h  
f o r m a l d e h y d e  m a y  r e s u l t  i n  6 - h a e m o l y s i n  b e i n g  e x t r e m e l y  r e s i s t a n t  t o  
m e t a b o l i c  d i g e s t i o n .
A n i n c r e a s e d  r i g i d i t y  o f  6 - h a e m o l y s i n  d u e  t o  f o r m a t i o n  o f  c r o s s ­
l i n k a g e s  ( E a t o n ,  1 9 5 7 )  m a y  a l s o  e x p l a i n  t h e  i n c r e a s e  i n  i m m u n o g e n i c i t y  
( H a u r o w i t z ,  1 9 5 2 ;  d e  W e e k ,  1 9 7 4 ) •  I f  l i t t l e  c r o s s - l i n k i n g  o c c u r r e d  a t  
pH  9 * 5  t h i s  w o u l d  l e a v e  t h e  p r o t e i n  i n  a  f l e x i b l e  c o n f o r m a t i o n  ( C o l a c i c c o  
e t  a l . ,  1 9 7 7 )  w h i c h  m a y  n o t  b e  s u i t a b l e  f o r  i m m u n i s i n g  p u r p o s e s .  H o w e v e r ,  
a s  s t a t e d  e a r l i e r ,  t h e  f o r m a t i o n  o f  c r o s s - l i n k a g e s  m a y  o c c u r  m o r e  r e a d i l y  
u n d e r  a l k a l i n e  c o n d i t i o n s ,  t h e r e f o r e  r i g i d i t y  o f  t h e  m o l e c u l e  m a y  n o t  b e  
a n  i m p o r t a n t  f a c t o r  h e r e .
I n  a d d i t i o n  t o  a n  i n c r e a s e  i n  t h e  t i t r e  o f  a n t i - 6 - h a e m o l y s i n  
a n t i b o d i e s  p r o d u c e d ,  t h e  e n h a n c e d  r e s p o n s e  t o  6 - h a e m o l y s i n  a l s o  r e s u l t e d  
f r o m  a n  i n c r e a s e  i n  t h e  n u m b e r  o f  r e s p o n d i n g  m i c e .  T h e r e  a r e  t h e r e f o r e
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s t r o n g  i m p l i c a t i o n s  t h a t  g e n e t i c  f a c t o r s  m a y  b e  i m p o r t a n t  i n  t h e  e n h a n c e d  
i n m r u n o g e n i c i t y .  T h e  r e s u l t s  o f  t h e  p r e s e n t  s t u d y  a r e  i n  a g r e e m e n t  w i t h  
t h o s e  o f  N u t t  e t  a l .  ( 1 9 7 4 )  i n  t h a t  t h e  m i c e  a p p e a r e d  t o  h a v e  t h e
p o t e n t i a l  t o  m a k e  a n  im m u n e  r e s p o n s e  a g a i n s t  6 - h a e m o l y s i n  b u t  m a y  n o t  b e
a b l e  t o  e x p r e s s  t h a t  p o t e n t i a l .  H o w e v e r ,  b y  t r e a t i n g  t h e  h a e m o l y s i n  w i t h  
f o r m a l d e h y d e  a t  pH 5  t h e  a n t i b o d y  p r o d u c t i o n  w a s  a f f e c t e d  i n  s u c h  a  w a y  
t h a t  t h e  p h e n o t y p i c  e x p r e s s i o n  o f  s p e c i f i c  a n t i b o d y  w a s  c a r r i e d  o u t .  
W h e t h e r  t h e  i n c r e a s e d  r e s p o n s e  i s  d u e  t o  a  s e l e c t i v e  i n c r e a s e  i n  im m u n o ­
c o m p e t e n t  B c e l l  p r e c u r s o r s  ( S h e a r e r  e t  a l . ,  1 9 7 1 ) »  T - h e l p e r  c e l l s  
( D e n n e r t  a n d  T u c k e r ,  1 9 7 2 ;  K a h a n  e t  a l . ,  1 9 7 6 )  o r  m e r e l y  a n  i n c r e a s e d
a f f i n i t y  f o r  B c e l l s  ( P a r i s h  a n d  A d a ,  1 9 7 2 )  r e m a i n s  t o  b e  i n v e s t i g a t e d .
T h e  c r o s s l i n k i n g  c a u s e d  b y  f o r m a l d e h y d e  h o w e v e r ,  m a y  m a s k  o r  d e s t r o y  a  
s u p p r e s s o r  d e t e r m i n a n t  o n  t h e  n a t i v e  h a e m o l y s i n  ( A d o r i n i  e t  a l , ,  1 9 7 9 )  an d . 
t h e r e f o r e  o t h e r  d e t e r m i n a n t s  w o u l d  b e  f r e e  t o  i n d u c e  t h e  p r o l i f e r a t i o n  o f  
T - h e l p e r  c e l l s  ( Y o w e l l  e t  a l . ,  1 9 7 9 ) *
I m m u n i s a t i o n  o f  m i c e  w i t h  6 - h a e m o l y s i n  t r e a t e d  w i t h  f o r m a l d e h y d e /  
a m i n o  a c i d  m i x t u r e s  p r o d u c e d  a  s i m i l a r  r e s p o n s e  a s  f o u n d  i n  m i c e  i m m u n i s e d  
w i t h  6 - h a e m o l y s i n  t r e a t e d  w i t h  f o r m a l d e h y d e  a l o n e .  O n l y  p r e p a r a t i o n s  
t r e a t e d  a t  pH  5 o r  pH 7 * 5  i n d u c e d  t h e  p r o d u c t i o n  o f  d e t e c t a b l e  a n t i - 6 -  
h a e m o l y s i n  a n t i b o d y .
D e l t a - h a e m o l y s i n  t r e a t e d  w i t h  g l u t a r a l d e h y d e  f a i l e d  t o  s t i m u l a t e  
a  d e t e c t a b l e  im m u n e  r e s p o n s e  t o  t h e  h a e m o l y s i n .  L o s s  o r  d e c r e a s e  i n  
im m u n o g e n i c  a c t i v i t y  o f  c h o l e r a  t o x i n  ( S a l e t t i  a n d  R i c c i ,  1 9 7 4 a ) ,  s h e e p  
e r y t h r o c y t e s  a n d  s p l e e n  c e l l s  ( R a m o s ,  Z a v a l a  a n d  H o e c k e r ,  1 9 7 9 )  h a s  b e e n  
f o u n d  a f t e r  t r e a t m e n t  w i t h  g l u t a r a l d e h y d e .  R a m o s  e t  a l .  ( 19 7 9 )  h a v e  
s u g g e s t e d  t h a t  t h e  r e a s o n  f o r  t h i s  d e c r e a s e  i n  i m m u n o g e n i c i t y  m a y  b e  d u e  
t o  e i t h e r  1 )  a  d e l a y  i n  t h e  d i g e s t i o n  o f  t h e  t o x o i d  b y  m a c r o p h a g e s  w h i c h  
m a y  d i s r u p t  t h e  p r o p e r  t i m e - s e q u e n c e  o f  t h e  p r o c e s s e s  r e q u i r e d  f o r  a
c o m p l e t e  i n d u c t i o n  o f  a n  im m u n e  r e s p o n s e  o r  2 )  a  d e c r e a s e  i n  t h e  n u m b e r  
o f  n a t i v e  d e t e r m i n a n t s  r e m a i n i n g  o n  t h e  s u r f a c e  o f  t h e  m o l e c u l e .
E r y t h r o c y t e s  t r e a t e d  w i t h  g l u t a r a l d e h y d e  o r  f o r m a l d e h y d e  i n d u c e d  
a  v e r y  p o o r  p r i m a r y  r e s p o n s e  i n  m i c e  b u t  i n d u c e d  a  h i g h  s e c o n d a r y  r e s p o n s e ,  
i m p l y i n g  t h a t  t h e  t r e a t e d  c e l l s  w e r e  p o t e n t  m e m o ry  i n d u c e r s  ( D e n n e r t  a n d  
T u c k e r ,  1 9 7 2 ;  K a h a n  e t  a l . ,  1 9 7 6 ;  R a m o s  e t  a l . ,  1 9 7 9 ) *  H o w e v e r ,  
p r o d u c t i o n  o f  a  s e c o n d a r y  r e s p o n s e  d e p e n d e d  u p o n  t h e  t i m i n g  o f  t h e  s e c o n d  
c h a l l e n g e  w i t h  a n t i g e n  a n d ,  i f  g i v e n  t o o  l a t e ,  i n h i b i t o r y  h u m o r a l ,  f a c t o r ( s )  
d e c r e a s e d  t h e  c a p a c i t y  o f  t h e  p r i m e d  m i c e  t o  m o u n t  a  s e c o n d a r y  r e s p o n s e  
( K a h a n  e t  a l . ,  1 9 7 6 ) .  T h e  p r o d u c t i o n  o f  so m e  " i n h i b i t o r "  m a y  t h e r e f o r e  
a c c o u n t  f o r  t h e  n e c e s s i t y  o f  t h r e e  p r i m i n g  a n d  t h r e e  b o o s t i n g  i n j e c t i o n s  t o  
g i v e  a  m ax im u m  a n t i b o d y  r e s p o n s e  t o  f o r m a l d e h y d e - t r e a t e d  6 - h a e m o l y s i n : 
i f  o n l y  o n e  p r i m a r y  a n d  o n e  b o o s t e r  i n j e c t i o n  w a s  g i v e n  t h e  i n h i b i t o r  m a y  
h a v e  p r e v e n t e d  i m m u n o c o m p e t e n t  c e l l s  f r o m  b e i n g  s t i m u l a t e d  b y  a n t i g e n  
w h e r e a s ,  w h e n  t h r e e  i n j e c t i o n s  w e r e  a d m i n i s t e r e d ,  t h e  s t i m u l u s  o n  t h e  
i m m u n o c o m p e t e n t  c e l l s  w o u l d  b e  t o o  h i g h  f o r  t h e  i n h i b i t o r  t o  h a v e  a n y  
e f f e c t  o n  a n t i b o d y  p r o d u c t i o n .  A l s o ,  i f  t h e  i n h i b i t o r  i s  r e g a r d e d  a s  
h a v i n g  a  s p e c i f i c  h a l f - l i f e ,  t h e n  t h e  t i m i n g  o f  t h e  b o o s t e r  i n j e c t i o n s  m a y  
a l s o  b e  c r i t i c a l :  a f t e r  t h r e e  w e e k s  i n h i b i t o r  w o u l d  s t i l l  b e  p r e s e n t  b u t
a b s e n t  a f t e r  f i v e  w e e k s .  I f  t h e  a b o v e  p r o p o s a l  i s  c o r r e c t  t h e n  t h i s  
w o u l d  e x p l a i n  t h e  d i f f e r e n c e s  i n  t h e  im m u n e  r e s p o n s e  t o  6 - h a e m o l y s i n  w i t h  
d i f f e r e n t  t i m e  s c h e d u l e s .
E n h a n c e d  V a s c u l a r  P e r m e a b i l i t y
S i n c e  f o r m a l d e h y d e  h a d  a l t e r e d  c e r t a i n  p h y s i c a l  a n d  b i o l o g i c a l  
p r o p e r t i e s  o f  6 - h a e m o l y s i n ,  t h e  i n  v i v o  a c t i v i t y  o f  6 - h a e m o l y s i n  w a s  
s t u d i e d  a n d  t h e  e f f e c t  o f  f o r m a l d e h y d e ,  a n d  o t h e r  t r e a t m e n t s ,  o n  t h i s  
a c t i v i t y  w a s  i n v e s t i g a t e d .
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T h e  v a s c u l a r  p e r m e a b i l i t y  e n h a n c i n g  e f f e c t  o f  6 - h a e m o l y s i n  w a s  
o b s e r v e d  o p t i m a l l y  b y  i n t r a v e n o u s  i n j e c t i o n  o f  P o n t a m i n e  S k y  B l u e  d y e  1  h
a f t e r  i n j e c t i o n  o f  h a e m o l y s i n  i n t o  t h e  s k i n  o f  r a b b i t s .  I f  d y e  w a s
i n j e c t e d  a f t e r  2  h  o r  l a t e r  t h e  b l u e  z o n e s  f a d e d  u n t i l ,  a f t e r  24 h ,  o n l y  
h a r d  e r y t h e m a t o u s  l e s i o n s  w e r e  p r e s e n t  w h i c h  w e r e  d e v o i d  o f  a n y  b l u i n g .
T h e s e  r e s u l t s  d i f f e r  f r o m  t h o s e  o f  O ’ B r i e n  a n d  K a p r a l  ( 1 9 7 6 )  w h o  o b t a i n e d
m a x i m a l  r e s u l t s  a f t e r  6  h .  T h e s e  d i f f e r e n c e s  m a y  h a v e  b e e n  d u e  t o  t h e
d i f f e r e n t  a n i m a l  m o d e l s  e m p l o y e d .  H o w e v e r ,  a l t h o u g h  C r a i g  ( 1 9 7 1 )  n o t e d  
d i f f e r e n c e s  i n  t h e  s i z e  o f  t h e  r e s u l t i n g  z o n e s  a f t e r  a d m i n i s t r a t i o n  o f  e q u a l  
q u a n t i t i e s  o f  c h o l e r a  t o x i n  i n t o  g u i n e a  p i g s  a n d  r a b b i t s ,  t h e r e  w a s  n o  
e v i d e n c e  t h a t  t h e  r e s p o n s e  i n  g u i n e a  p i g s  t o o k  l o n g e r  t o  o c c u r  t h a n  i n  
r a b b i t s  ( i . e .  1 8 - 2 4  h ) .  N e v e r t h e l e s s ,  s i n c e  t h e  m e c h a n i s m  o f  i n d u c t i o n  
o f  EV P b y  6 - h a e m o l y s i n  m a y  d i f f e r  f r o m  t h a t  o f  c h o l e r a  t o x i n  ( O ’ B r i e n  a n d  
K a p r a l ,  1 9 7 7 ) ,  a n i m a l  v a r i a t i o n  m a y  b e  m o r e  s i g n i f i c a n t  i n  t h i s  c a s e .
A n o t h e r  p o s s i b i l i t y  i s  t h a t  t h e  p r e p a r a t i o n  u s e d  h e r e  d i f f e r e d  i n  a c t i v i t y  
o r  p h y s i c a l  s t a t e  f r o m  t h a t  o f  O ’ B r i e n  a n d  K a p r a l  ( 1 9 7 6 )  d u e  t o  d i f f e r e n t  
p u r i f i c a t i o n  t e c h n i q u e s  ( K a p r a l  a n d  M i l l e r ,  1 9 7 1 ) .
Tw o s k i n  p e r m e a b i l i t y  f a c t o r s  h a v e  b e e n  f o u n d  i n  c u l t u r e  f i l t r a t e s  
o f  S a l m o n e l l a  t y p h i m u r i u m  ( S a n d e f u r  a n d  P e t e r s o n ,  1 9 7 6 ) .  A r a p i d  a c t i n g  
f a c t o r  h a d  a  c r i t i c a l  b l u i n g  t i m e  o f  1 h  a f t e r  c o m p l e t i o n  o f  s k i n  s i t e s ,  
h a d  n o  a s s o c i a t e d  i n d u r a t i o n  a n d  w a s  s u g g e s t e d  t o  b e  o r  a s s o c i a t e d  w i t h  
e n d o t o x i n  ( P e t e r s o n  a n d  S a n d e f u r ,  1 9 7 9 ) .  A d e l a y e d  f a c t o r  w a s  a l s o  i s o l a t e d ,  
a f t e r  c h r o m a t o g r a p h y  o f  t h e  c r u d e  c u l t u r e  s u p e r n a t a n t  f l u i d  o n  S e p h a d e x  
G 1 0 0 ,  w h i c h  c a u s e d  a  m a r k e d  i n d u r a t i o n  o f  r a b b i t  s k i n  w i t h i n  1 8  h  a n d  w a s  
a c c o m p a n i e d  b y  b l u i n g .  T h i s  f a c t o r  w a s  v e r y  s i m i l a r  t o  c h o l e r a  t o x i n  i n  
b o t h  p h y s i c a l  a n d  a n t i g e n i c  p r o p e r t i e s  ( S a n d e f u r  a n d  P e t e r s o n ,  1 9 7 7 ;
P e t e r s o n  a n d  S a n d e f u r ,  1 9 7 9 ) .  I t  w a s  s u g g e s t e d  t h a t  t h e  e f f e c t s  o f  t h e  
d e l a y e d  f a c t o r  w e r e  b l o c k e d  o r  m a s k e d  b y  a n  i n h i b i t o r - l i k e  s u b s t a n c e
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p r e s e n t  i n  t h e  c r u d e  c u l t u r e  f i l t r a t e s  ( S a n d e f u r  a n d  P e t e r s o n ,  1 9 7 6 ) .
T h e  d a t a  p r e s e n t e d  b y  O 'B r i e n  a n d  K a p r a l  ( 1 9 7 6 )  s h o w  t h a t ,  a l t h o u g h  t h e  
m ax im u m  EV P a c t i v i t y  d e v e l o p e d  b y  6  h  p o s t  i n o c u l a t i o n ,  t h e r e  w a s  a n  e a r l y  
r e s p o n s e  a t  J>0  m i n  -  2  h  b e f o r e  t h e  d e v e l o p m e n t  o f  t h i s  m ax im u m  a c t i v i t y .
I n  t h i s  s t u d y ,  t h e  r e s p o n s e  t o  6 - h a e m o l y s i n  w a s  o f  a  s i m i l a r  d e g r e e  a n d  
t i m e - c o u r s e  t o  t h i s  e a r l y  r e s p o n s e  f o u n d  b y  O 'B r i e n  a n d  K a p r a l  ( 1 9 7 6 ) .  
W h e t h e r  6 - h a e m o l y s i n  e x i s t s  i n  tw o  o r  m o r e  d i f f e r e n t  p h y s i c a l  s t a t e s  
( p o s s i b l y  d e p e n d i n g  o n  t h e  m e t h o d  o f  p u r i f i c a t i o n )  w h i c h  m a y  h a v e  d i f f e r e n t  
b i o l o g i c a l  a c t i v i t i e s ,  r e m a i n s  t o  b e  i n v e s t i g a t e d .
A n o t h e r  i n t e r e s t i n g  o b s e r v a t i o n  b y  t h e s e  w o r k e r s  w h i c h  i s  a n a l o g o u s  
t o  t h e  r e s u l t s  i n  t h e  p r e s e n t  w o r k ,  w a s  t h e  t h e r m o s t a b i l i t y  (4  h  a t  1 0 0 ° C )  
( S a n d e f u r  a n d  P e t e r s o n ,  1 9 7 6 )  a n d  t h e  r e s i s t a n c e  t o  e n z y m i c  d i g e s t i o n  
( P e t e r s o n  a n d  S a n d e f u r ,  1 9 7 9 )  o f  t h e  r a p i d  f a c t o r .  T h e  e n h a n c e d  v a s c u l a r  
p e r m e a b i l i t y  a c t i v i t y  o f  6 - h a e m o l y s i n  w a s  r e t a i n e d  a f t e r  h e a t i n g  f o r  1 0  h  
a t  1 0 0 ° C  a n d  a f t e r  t r y p t i c  d i g e s t i o n ,  w h i l e  l e c i t h i n  o n l y  r e d u c e d ,  b u t  
d i d  n o t  a b o l i s h ,  t h e  EV P a c t i v i t y  o f  t h e  h a e m o l y s i n .  O 'B r i e n  a n d  K a p r a l
( 1 9 7 6 )  o b t a i n e d  a  g r e a t e r  r e d u c t i o n  i n  EV P a c t i v i t y  a f t e r  t r e a t m e n t  w i t h  
l e c i t h i n  t h a n  w a s  f o u n d  i n  t h i s  i n v e s t i g a t i o n ,  a l t h o u g h  t h e  l o w e r  d o s e s  o f  
6 - h a e m o l y s i n  r e q u i r e d  f o r  a c t i v i t y  m a y  a c c o u n t  f o r  t h i s  d i f f e r e n c e .
H o w e v e r ,  i f  t h e  h y p o t h e s i s  o f  tw o  s e p a r a t e  f a c t o r s  h o l d s  t r u e ,  t h e  d e l a y e d  
f a c t o r  o f  O 'B r i e n  a n d  K a p r a l  m a y  b e  m o r e  s u s c e p t i b l e  t o  i n h i b i t i o n  b y  
l e c i t h i n .
A n i m a l - t o - a n i m a l  v a r i a t i o n  w a s  f o u n d  h e r e ,  a n d  a l s o  b y  O 'B r i e n  
a n d  K a p r a l  ( 1 9 7 6 ) .  C r a i g  ( 1 9 7 1 )  f o u n d  r a b b i t  p a i r s  v a r i e d  1 6 - f o l d  i n  
s u s c e p t i b i l i t y  t o  c h o l e r a  t o x i n .  H o w e v e r ,  i n  t h i s  s t u d y ,  c o m p a r i s o n s  
w e r e  m a d e  o n  e a c h  i n d i v i d u a l  r a b b i t  t o  o v e r c o m e  t h i s  p r o b l e m .
D e l t a - h a e m o l y s i n  ( 6 2 . 5  | i g  -  1  m g ) w a s  f o u n d  t o  g i v e  a  l i n e a r
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l o g  d o s e / r e s p o n s e  c u r v e .  F ro m  t h e  r e s u l t s  o f  O 'B r i e n  a n d  K a p r a l  ( 1 9 7 6 )  
i t  a p p e a r e d  t h a t  t h e i r  p r e p a r a t i o n  w a s  m o r e  a c t i v e  t h a n  t h e  o n e  u s e d  h e r e ,  
b u t  a n i m a l  v a r i a t i o n  m a y  b e  a  c o m p l i c a t i n g  f a c t o r  a s  f o u n d  b y  C r a i g  ( 1 9 7 1 )  
w i t h  c h o l e r a  t o x i n .
U n l i k e  c h o l e r a  t o x i n  ( C r a i g ,  1 9 6 6 ) ,  f o r m a l d e h y d e  t r e a t m e n t  o f
5 - h a e m o l y s i n  d i d  n o t  e l i m i n a t e  a l l  EVP a c t i v i t y  ( T a b l e s  2 2 ,  2 3 ) .  I t  i s  
p o s s i b l e  t h a t  a  l o n g e r  i n c u b a t i o n  p e r i o d  i s  r e q u i r e d  t o  l o s e  EV P a c t i v i t y  
t h a n  h a e m o l y t i c  a c t i v i t y .  S i l v e r m a n ,  E s p e s e t h  a n d  S c h a n t z  ( 19 6 9 )  f o u n d  
f o r m a l d e h y d e  t r e a t m e n t  o f  s t a p h y l o c o c c a l  e n t e r o t o x i n  B  a l t e r e d  t h e  e m e t i c ,  
l e t h a l  a n d  p y r o g e n i c  a c t i v i t i e s  o f  t h e  t o x i n  a t  d i f f e r e n t  r a t e s .
T h e  p o s s i b l e  r e a s o n  f o r  t h e s e  d i f f e r e n c e s  i s  t h a t  t h e  a m i n o  a c i d s  a f f e c t e d  
b y  f o r m a l d e h y d e  ( i . e .  l y s i n e  a n d  t r y p t o p h a n )  m a y  n o t  b e  s o  i m p o r t a n t  i n  
E V P a n d  a n t i g e n i c  a c t i v i t i e s  a s  i n  t h e  h a e m o l y t i c  a c t i v i t y  o f  t h e  
h a e m o l y s i n .
C o m p l e t e  n e u t r a l i s a t i o n  o f  EVP a c t i v i t y  w a s  n o t  o b t a i n e d  w i t h  
a n t i - 5 - h a e m o l y s i n  a n t i b o d y .  T h i s  m a y  b e  e x p l a i n e d  b y  t h e  h i g h  c o n c e n ­
t r a t i o n s  o f  6 - h a e m o l y s i n  r e q u i r e d  t o  p r o d u c e  a  m e a s u r a b l e  r e s p o n s e  a n d  
i n s u f f i c i e n t  a n t i b o d y  f o r  n e u t r a l i s a t i o n .  T h i s  i s  e n d o r s e d  b y  t h e  f a c t  
t h a t  t h e  h a e m o l y t i c  a c t i v i t y  w a s  a l s o  p r e s e n t  a f t e r  a d d i t i o n  o f  a n t i b o d y .  
H o w e v e r ,  t h e  r e a s o n  w h y  i n c r e a s i n g  c o n c e n t r a t i o n s  o f  5 - h a e m o l y s i n  w a s  
a s s o c i a t e d  w i t h  d e c r e a s i n g  EV P a c t i v i t y  i n  t h e  p r e s e n c e  o f  a  c o n s t a n t  
a m o u n t  o f  a n t i b o d y ,  i s  a t  p r e s e n t  u n k n o w n .
T h e  EVP a c t i v i t y  o f  5 - h a e m o l y s i n  w a s  n o t  a  n o n - s p e c i f i c  r e s p o n s e  
a s  s h o w n  b y  t h e  i n a b i l i t y  o f  s e r u m  p r o t e i n s  t o  p r o d u c e  a  r e s p o n s e .
H o w e v e r ,  t h e  p o s s i b i l i t y  t h a t  a  f a c t o r  o t h e r  t h a n  6 - h a e m o l y s i n  i s  
r e s p o n s i b l e  f o r  E V P a c t i v i t y  c a n n o t  b e  d i s r e g a r d e d .  T h e  m o s t  p o s i t i v e  
e v i d e n c e  t h a t  6 - h a e m o l y s i n  p r o d u c e d  t h i s  i n  v i v o  r e s p o n s e  c o m e s  f r o m  t h e  
r e s u l t s  s h o w i n g  t h e  EV P a c t i v i t y  t o  b e  a s s o c i a t e d  w i t h  t r y p t i c  p e p t i d e s
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w h i c h  l a c k e d  b o t h  h a e m o l y t i c  a n d  a n t i g e n i c  a c t i v i t i e s .  I t  i s ,  h o w e v e r ,  
r e c o g n i s e d  t h a t  t h e  s t u d y  o f  t h e s e  p e p t i d e  f r a g m e n t s  o f  6 - h a e m o l y s i n  i s  
o f  a  p r e l i m i n a r y  n a t u r e  a n d  s e v e r a l  l i m i t a t i o n s  m u s t  b e  t a k e n  i n t o  a c c o u n t  
s u c h  a s  t h e  s e n s i t i v i t y  o f  t h e  s e p a r a t i o n  t e c h n i q u e  a n d  t h e  p o s s i b l e  
p r e s e n c e  o f  a r t e f a c t s ,  e t c .  A l s o ,  i t  r e m a i n s  t o  b e  i n v e s t i g a t e d  w h e t h e r  
t h e  a c t i o n  o f  t h e  p e p t i d e  f r a g m e n t s  o f  6 - h a e m o l y s i n  i s  s p e c i f i c  o r  m a y  b e  
m e d i a t e d  b y  a  w i d e  v a r i e t y  o f  s m a l l  p e p t i d e s .  N e v e r t h e l e s s ,  t h e  r e s u l t s  
w e r e  r e p r o d u c i b l e  a n d  t h e r e f o r e  p r o v i d e  a  b a s i s  f o r  f u r t h e r  e x p e r i m e n t s .
T h e  i n c r e a s e d  v a s c u l a r  p e r m e a b i l i t y  c a u s e d  b y  V . c h o l e r a  e n t e r o -  
t o x i n  a n d  E .  c o l i  h e a t - l a b i l e  e n t e r o t o x i n  i s  a s s u m e d  t o  b e  a  cAMP 
m e d i a t e d  r e s p o n s e  i n  t h a t  t h e s e  t o x i n s  s t i m u l a t e  m u c o s a l  a d e n y l  c y c l a s e  
( C r a i g ,  1 9 6 5 ;  E v a n s  e t  a l . ,  1 9 7 2 ) .  H o w e v e r ,  u n l i k e  t h e s e  t o x i n s ,  
6 - h a e m o l y s i n  f a i l e d  t o  c a u s e  o t h e r  c A M P - m e d ia t e d  r e s p o n s e s  s u c h  a s  m o r p h o ­
g e n e s i s  a n d  s t e r o i d o g e n e s i s  i n  c u l t u r e d  t i s s u e  c e l l s ,  ( O ’ B r i e n  a n d  K a p r a l ,
1 9 7 7 )  a l t h o u g h  i t  d i d  i n c r e a s e  cAMP l e v e l s  i n  g u i n e a  p i g  i l e u m  ( O 'B r i e n  
a n d  K a p r a l ,  1 9 7 6 ) .  T h e r e f o r e ,  6 - h a e m o l y s i n  m a y  e l e v a t e  cAMP l e v e l s  b y  
a  m e c h a n i s m  d i f f e r e n t  f r o m  t h a t  o f  c h o l e r a  o r  E .  c o l i  t o x i n s .
S t i m u l a t i o n  o f  a d e n y l  c y c l a s e  i s  a n  u n l i k e l y  m e c h a n i s m  o f  
i n c r e a s i n g  t h e  l e v e l s  o f  i n t r a c e l l u l a r  cAMP b y  6 - h a e m o l y s i n  s i n c e  b o t h  
m e l i t t i n  ( C o o k  a n d  W o l f f ,  1 9 7 7 )  a n d  n o n - i o n i c  d e t e r g e n t s  ( S u t h e r l a n d ,
R a i l  a n d  M e n o n ,  1 9 6 2 ;  L e v e y ,  1 9 7 0 ) ,  t h e  m e m b r a n e - d i s r u p t i n g  p r o p e r t i e s  o f  
w h i c h  a r e  s i m i l a r  t o  t h a t  o f  6 - h a e m o l y s i n ,  i n h i b i t  o r  d e c r e a s e  t h e  a c t i v i t y  
o f  a d e n y l  c y c l a s e  a n d  d i s r u p t  t h e  m e m b ra n e  i n t e g r i t y  r e q u i r e d  f o r  t h e  
e n z y m e  a c t i v i t y  ( E n g e l h a r d  e t  a l . ,  1 9 7 6 ) .  H o w e v e r ,  O 'B r i e n  a n d  K a p r a l  
( 1 9 7 7 )  h a v e  s u g g e s t e d  t h a t  t h e  e l e v a t i o n  i n  c e l l u l a r  cAMP i s  a  s e c o n d a r y  
r e s p o n s e  t o  6 - h a e m o l y s i n ,  w h i c h  p r i m a r i l y  a l t e r s  t h e  m o v e m e n t  o f  i o n s  
a c r o s s  t h e  m u c o s a ,  a n d  t h e  EV P a c t i v i t y  i s  a  r e f l e c t i o n  o f  a n  i n c r e a s e  i n  
i n t e r c e l l u l a r  l e a k a g e  ( O ' B r i e n  £ t  a l . ,  1 9 7 8 ) .
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S t r u e t u r a l - f u n c t i o n a l  r e l a t i o n s h i p  o f  5 - h a e m o l y s i n
T a b l e  2 2  l i s t s  t h e  e f f e c t s  o f  v a r i o u s  t r e a t m e n t s  o n  t h e  h a e m o l y t i c ,  
E V P a n d  a n t i g e n i c  a c t i v i t i e s  o f  6 - h a e m o l y s i n .  S i n c e  h a e m o l y t i c  a n d  
a n t i g e n i c  a c t i v i t i e s  m a y  b e  l o s t  i n d e p e n d e n t l y  o f  EVP a c t i v i t y  ( a s  w i t h  
l e c i t h i n  a n d  t r y p s i n  t r e a t m e n t s )  w h i l e  h a e m o l y t i c  a c t i v i t y  c a n  a l s o  b e  l o s t  
i n d e p e n d e n t l y  o f  a n t i g e n i c  a c t i v i t y  ( a s  i n  h e a t i n g  a n d  f o r m a l d e h y d e  
t r e a t m e n t s ) ,  t h e n  t h e s e  f i n d i n g s  s t r o n g l y  s u g g e s t  t h a t  d i f f e r e n t  m e c h a n i s m s  
a n d  a r e a s  o f  t h e  m o l e c u l e  m a y  b e  i n v o l v e d  i n  d i f f e r e n t  f u n c t i o n s .
T h e  EV P a c t i v i t y  w a s  a s s o c i a t e d  w i t h  t r y p t i c  p e p t i d e s  w h i c h  
l a c k e d  h a e m o l y t i c  a n d  a n t i g e n i c  a c t i v i t i e s .  A f a i r l y  r i g o r o u s  t r e a t m e n t  
w a s  c a r r i e d  o u t ,  i . e .  1 0 : 1  r a t i o  o f  t o x i n : e n z y m e  f o r  2  h ,  a n d  y e t  a n  
i n c r e a s e d  EV P a c t i v i t y  w a s  r e c o r d e d ,  w h i c h  s u g g e s t s  t h a t  t h e  f r a g m e n t s  
c o n t a i n i n g  EV P a c t i v i t y  w e r e  r e s i s t a n t  t o  t r y p t i c  d i g e s t i o n .  S i x  p e p t i d e s  
w e r e  i d e n t i f i e d  i n  t h i s  s t u d y  w i t h  a b s o r b a n c e  a t  w h i l e  K a n t o r  e t  a l .
( 1 9 7 2 )  s e p a r a t e d  e i g h t  p e p t i d e s  b y  e l e c t r o p h o r e s i s  a n d  c h r o m a t o g r a p h y .
S i n c e  t h e  a m i n o  a c i d  c o m p o s i t i o n  o f  t h e  p r e p a r a t i o n  u s e d  w a s  s i m i l a r  t o  
t h a t  o f  K a n t o r  e t  a l .  ( 1 9 7 2 )  ( W h i t e l a w ,  1 9 7 8 ) t i t  i s  p o s s i b l e ,  a s  s u g g e s t e d  
e a r l i e r ,  t h a t  t h e  d i f f e r e n c e s  o b s e r v e d  m a y  b e  d u e  t o  t h e  d i f f e r e n c e s  i n  
t h e  s e n s i t i v i t y  o f  t h e  s e p a r a t i o n  a n d  d e t e c t i o n  t e c h n i q u e s  e m p l o y e d .
S i n c e  6 - h a e m o l y s i n  l a c k s  a r g i n i n e  r e s i d u e s  ( K r e g e r  e t  a l . ,  1 9 7 1 ;  
H e a t l e y ,  1 9 7 1 ;  K a n t o r  e t  a l , ,  1 9 7 2 ;  W h i t e l a w ,  1 9 7 8 )  c l e a v a g e  w o u l d  b e  
r e s t r i c t e d  t o  l y s i n e  r e s i d u e s .  H o w e v e r ,  l o w  l e v e l  t r y p t i c  c l e a v a g e  a t  
a s p a r a g i n e  r e s i d u e s  m a y  a l s o  o c c u r  ( C a s e y  a n d  L a n g ,  1 9 7 6 ;  R i c e ,  W a t t s  
a n d  B r o w n ,  1 9 7 9 ) *  D e l t a - h a e m o l y s i n  m a y  t h e r e f o r e  c o n t a i n  a  u n i q u e  
s e q u e n c e  o f  a m i n o  a c i d  r e s i d u e s  w h i c h  l a c k s  l y s i n e  o r  a s p a r a g i n e  r e s i d u e s  
( i . e .  r e s i s t a n t  t o  t r y p t i c  d i g e s t i o n )  a n d  w h i c h  i s  i n v o l v e d  i n  t h e  EVP 
a c t i v i t y  o f  t h e  h a e m o l y s i n .  T h e  r e a s o n  f o r  s o  m a n y  f r a g m e n t s  h a v i n g
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EVT a c t i v i t y  m a y  b e  d u e  t o  e i t h e r  v a r i o u s  c l e a v a g e  p r o d u c t s  c o n t a i n i n g  
t h i s  u n i q u e  s e q u e n c e  o f  a m i n o  a c i d s  o r  t h e  i n a b i l i t y  o f  t h e  s e p a r a t i o n  
t e c h n i q u e  t o  r e s o l v e  i n d i v i d u a l  p e p t i d e s .  M u l l e r - E b e r h a r d  ( 1 9 7 5 )  h a s  
r e p o r t e d  t h a t  a  s m a l l  s e g m e n t  o f  b o t h  C ^ a  a n d  a n a p h y l a t o x i n s  i s  
i n v o l v e d  i n  t h e  e x p r e s s i o n  o f  t h e  b i o l o g i c a l  a c t i v i t y  o f  t h e s e  p r o t e i n s .  
R e m o v a l ,  o f  t h e  C O O H - t e r m i n a l  a r g i n i n e  r e s i d u e ,  i n  e i t h e r  p r o t e i n ,  b y  
c a r b o x y p e p t i d a s e  B c a u s e d  a  t o t a l  l o s s  o f  b i o l o g i c a l  a c t i v i t y .
P e p t i d e  d i g e s t i o n  h a s  b e e n  e m p l o y e d  b y  s e v e r a l  w o r k e r s  t o  
d e t e r m i n e  t h e  s t r u c t u r e - f u n c t i o n a l  r e l a t i o n s h i p  o f  v a r i o u s  t o x i n s .
W a ta n a b e  a n d  K a t o  ( 1 9 7 8 )  i s o l a t e d  a  l e t h a l  f r a g m e n t  f r o m  s t a p h y l o c o c c a l  
a - h a e m o l y s i n  b y  t r y p t i c  d i g e s t i o n .  T h i s  w a s  d e v o i d  o f  h a e m o l y t i c  a c t i v i t y  
a n d  h a d  v e r y  l i t t l e  d e r m o n e c r o t i c  a c t i v i t y .  S i m i l a r l y ,  p a p a i n  d i g e s t i o n  
o f  t e t a n u s  t o x i n  g a v e  tw o  f r a g m e n t s  w h i c h  w e r e  a n t i g e n i c a l l y  d i s t i n c t  a n d  
y e t  b o t h  w e r e  a t o x i c  ( H e l t i n g  a n d  Z w i s l e r ,  1 9 7 7 a ) .  H o w e v e r ,  t h e  m a j o r  
p e p t i d e  ( F r a g m e n t  C )  c o n t a i n e d  t h e  b i n d i n g  s i t e  f o r  g a n g l i o s i d e s  a n d  
t h e r e f o r e  a n t i - f r a g m e n t  C a n t i b o d y  w a s  s u f f i c i e n t  t o  n e u t r a l i s e  t h e  l e t h a l  
e f f e c t  o f  t e t a n u s  t o x i n  i n  v i v o  s i n c e  b i n d i n g  t o  b r a i n  r e c e p t o r s  i s  t h e  
n e c e s s a r y  p r i m a r y  s t e p  r e q u i r e d  f o r  e x p r e s s i o n  o f  t o x i c i t y  ( H e l t i n g  a n d  
Z w i s l e r ,  1 9 7 7 ^ ) *
B i n d i n g  o f  5 - h a e m o l y s i n  t o  e r y t h r o c y t e s  a n d  l e c i t h i n  n o t  o n l y  
c a u s e d  l y s i s  o f  e r y t h r o c y t e s  b u t  a l s o  a  l o s s  o f  a n t i g e n i c  a c t i v i t y .
H o w e v e r ,  o n  t r e a t m e n t  w i t h  f o r m a l d e h y d e ,  t h e  h a e m o l y t i c  a c t i v i t y  w a s  l o s t  
b u t  t h e  a n t i g e n i c  a c t i v i t y  w a s  r e t a i n e d .  T h e  a m p h i p a t h i c  p o l y p e p t i d e ,  
b e e  m e l i t t i n ,  s h a r e s  m a n y  p r o p e r t i e s  w i t h  6 - h a e m o l y s i n  ( F r e e r  a n d  
A r b u t h n o t t ,  1 9 7 6 )  a n d  t h e  i n i t i a l  b i n d i n g  t o  m e m b r a n e s  i s  t h o u g h t  t o  b e  
m e d i a t e d  b y  i o n i c  i n t e r a c t i o n  f o l l o w e d  b y  p o s t - b i n d i n g  c o n f o r m a t i o n a l  
c h a n g e s  r e s u l t i n g  i n  m e m b r a n e  p e n e t r a t i o n  ( D a w s o n  e t  a l . ,  1 9 7 8 ) .  I t  i s  
p o s s i b l e ,  t h e r e f o r e ,  t h a t  t h e  b i n d i n g  o f  6 —h a e m o l y s i n  t o  e r y t h r o c y t e
m e m b r a n e s  m a y  i n v o l v e  a n  i n i t i a l  i o n i c  i n t e r a c t i o n  w i t h  t h e  m e m b r a n e  
s u r f a c e  w h i c h  c a u s e s  so m e  c o n f o r m a t i o n a l  c h a n g e  i n  t h e  h a e m o l y s i n  
r e s u l t i n g  i n  p e n e t r a t i o n  o f  t h e  b i l a y e r  ( C o l a c i c c o  e t  a l . ,  1 9 7 7 ) .  I n  
t h i s  w a y ,  e n t r y  o f  5 - h a e m o l y s i n  i n t o  t h e  m e m b r a n e  w o u l d  n o t  o n l y  c a u s e  
l y s i s  o f  t h e  c e l l  b u t  m a y  a l s o  r e n d e r  t h e  a n t i g e n i c  d e t e r m i n a n t s  
u n a v a i l a b l e  f o r  r e a c t i o n  w i t h  s p e c i f i c  a n t i b o d y .  I f  l y s i n e  o r  t r y p t o p h a n  
r e s i d u e s  a r e  c r i t i c a l  t o  t h e  i n i t i a l  b i n d i n g  o f  h a e m o l y s i n  t o  e r y t h r o c y t e  
m e m b r a n e s ,  t h e n  f o r m a l d e h y d e  t r e a t m e n t  o f  t h e  h a e m o l y s i n  m a y  p r e v e n t  t h i s  
b i n d i n g  d u e  t o  a l t e r a t i o n  o f  t h e s e  r e s i d u e s .  T h e  a n t i g e n i c  d e t e r m i n a n t s  
w o u l d  t h e r e f o r e  b e  f r e e  t o  p r e c i p i t a t e  w i t h  a n t i —5 - h a e m o l y s i n  a n t i s e r u m .
T h e  r e s u l t s  t h e r e f o r e  s u g g e s t  t h a t  l y s i n e  a n d  p e r h a p s  t r y p t o p h a n  
r e s i d u e s  a r e  i m p o r t a n t  i n  t h e  b i n d i n g  o f  6 - h a e m o l y s i n  t o  e r y t h r o c y t e s .  
S e v e r a l  t r e a t m e n t s  h a v e  b e e n  e m p l o y e d  t o  d e t e r m i n e  t h e  a m i n o  a c i d  
r e s i d u e s  i n v o l v e d  i n  t h e  b i o l o g i c a l  a c t i v i t i e s  o f  p r o t e i n s .  T e t r a n i t r o -  
m e t h a n e  i s  h i g h l y  s p e c i f i c  f o r  t y r o s i n e  r e s i d u e s  ( K o n d o  e t  a l . ,  1 9 7 6 ;  
B e u g n i e r  a n d  Z a n e n ,  1 9 7 7 )  a n d  r e d u c t i v e  m e t h y l a t i o n  a n d  c a r b a m y l a t i o n  a r e  
s p e c i f i c  f o r  l y s i n e  r e s i d u e s  ( M e a n s  a n d  F e e n y ,  1 9 6 8 ;  R o b i n s o n  e t  a l . ,
1 9 7 5 ?  B e u g n i e r  a n d  Z a n e n ,  1 9 7 7 ) *  T h e  l e s s  s p e c i f i c  t r e a t m e n t s  o f  
d i a z o t i z a t i o n  a n d  f o r m a l d e h y d e  h a v e  a l s o  b e e n  e m p l o y e d  t o  d e t e r m i n e  t h e  
a m i n o  a c i d s  o r  t h e  d i f f e r e n t  s i t e s  i n v o l v e d  i n  d i f f e r e n t  f u n c t i o n s  
( H a b e r m a n n ,  1 9 7 3  > K o n d o  e t  a l . ,  1 9 7 6 ) .  B y  u s i n g  e i t h e r  o n e  o r  s e v e r a l  o f  
t h e  a b o v e  t e c h n i q u e s  i t  h a s  b e e n  d i s c o v e r e d  t h a t
1 )  t y r o s i n e  r e s i d u e s ,  a t  l e a s t ,  a r e  e s s e n t i a l  f o r  t h e  e x f o l i a t i n  o f  
s t a p h y l o c o c c i  t o  m a n i f e s t  o r  m a i n t a i n  i t s  e x f o l i a t i v e  a c t i v i t y  (K o n d o  
e t  a l . ,  1 9 7 6 )
2 )  t h e  e n z y m i c  s i t e  o f  d i p h t h e r i a  t o x i n  c o n t a i n s  o n e  e s s e n t i a l  t y r o s i n e  
r e s i d u e  i m p l i c a t e d  i n  t h e  b i n d i n g  o f  n i c o t i n a m i d e  a d e n i n e  d i n u c l e o t i d e  a n d  
a t  l e a s t  o n e  l y s i n e  r e s i d u e  i s  n o t  i m p l i c a t e d  i n  t h e  d i n u c l e o t i d e  b i n d i n g
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( B e u g n i e r  a n d  Z a n e n ,  1 9 7 7 )  a n d
3 )  d i f f e r e n t  s i t e s  o f  t h e  t e t a n u s  t o x i n  m o l e c u l e  a x e  i m p l i c a t e d  i n  t h e  
b i n d i n g  p r o c e s s  t o  b r a i n  m a t t e r ,  t o x i c i t y ,  a n d  i m m u n o g e n i c i t y  
( K r y z h a n o u s k y ,  1 9 7 3 ;  H a b e r m a n n ,  1 9 7 3 ?  R o b i n s o n  e t  a l . ,  1 9 7 5 ) *  H o w e v e r ,  
t h e  e x c e l l e n t  r e s e a r c h  p r o g r a m m e  c a r r i e d  o u t  b y  A t a s s i  ( 1 9 7 5 »  1 9 7 8 ) ,  w h i c h  
i n c l u d e d  i m m u n o c h e m i c a l  a n a l y s i s  o f  b o t h  m o d i f i e d  c h e m i c a l  d e r i v a t i v e s  a n d  
p e p t i d e  f r a g m e n t s  o f  p r o t e i n s ,  h a s  r e s u l t e d  i n  t h e  p r o d u c t i o n  o f  a  p r e c i s e  
a n d  c o m p l e t e  m a p  o f  t h e  a n t i g e n i c  s t r u c t u r e  o f  s p e r m - w h a l e  m y o g l o b i n  a n d  
h e n  e g g - w h i t e  l y s o z y m e .
C o m p a r i s o n  o f  6 - h a e m o l y s i n s  f r o m  d i f f e r e n t  s t r a i n s  o f  S .  a u r e u s
S i n c e  t h e  p r e v i o u s  s t u d i e s  h a d  i n d i c a t e d  t h a t  d i f f e r e n t  s i t e s  o f  
t h e  6 - h a e m o l y s i n  m o l e c u l e  f r o m  s t r a i n  10 34 5  m a y  b e  i n v o l v e d  i n  h a e m o l y t i c ,  
a n t i g e n i c  a n d  E V P a c t i v i t i e s ,  p r e l i m i n a r y  i n v e s t i g a t i o n s  i n t o  p o s s i b l e  
d i f f e r e n c e s  b e t w e e n  6 - h a e m o l y s i n s  p r o d u c e d  b y  d i f f e r e n t  s t r a i n s  o f  
S«  a u r e u s  w e r e  c a r r i e d  o u t .  H i g h  t i t r e s  o f  a -  a n d  6 - h a e m o l y s i n s  w e r e  
p r o d u c e d  b y  t h e  h u m a n  s t r a i n s ,  c o n f i r m i n g  p r e v i o u s  f i n d i n g s  t h a t  a -  a n d  
6 - h a e m o l y s i n s  a r e  f r e q u e n t l y  a s s o c i a t e d  w i t h  s t r a i n s  f r o m  h u m a n  o r i g i n  
( E l e k  a n d  L e v y ,  1 9 5 0 ;  F r a s e r ,  19 6 4 ) .  H o w e v e r ,  u n l i k e  t h e  r e p o r t s  o f  
o t h e r  w o r k e r s  ( E l e k  a n d  L e v y ,  1 9 5 0 ;  F r a s e r ,  19 6 4 )  t h e  a n i m a l  s t r a i n s  
p r o d u c e d  l i t t l e  o r  n o  (B—h a e m o l y s i n  a n d  s e v e r a l  o f  t h e  c a n i n e  s t r a i n s  
p r o d u c e d  f a i r l y  h i g h  a - h a e m o l y s i n  t i t r e s .  T h e  r e a s o n  f o r  t h e s e  d i f f e r e n c e s  
m a y  b e  t h e  c u l t u r a l  c o n d i t i o n s  e m p l o y e d .  S h a r m a  a n d  H a q u e  ( 1 9 7 3 )  f o u n d  
t h a t  a e r a t i o n  b y  s h a k i n g  w a s  i n h i b i t o r y  t o  ( 3 - h a e m o l y s i n  p r o d u c t i o n  i n  
s y n t h e t i c  m e d iu m  w h ile  t h e  p r o d u c t i o n  o f  a - h a e m o l y s i n  d e p e n d s  o n  t h e  g r o w t h  
r a t e  o f  t h e  o r g a n i s m s  ( A r b u t h n o t t ,  1 9 7 0 ) .  A h i g h  g r o w t h  r a t e  i s  
a c c o m p a n i e d  b y  a  l o w e r  a —h a e m o l y s i n  p r o d u c t i o n  w h i l e  t h e  r e v e r s e  i s  t r u e  
f o r  a  l o w e r  g r o w t h  r a t e  ( C o l e m a n  a n d  A b b a s - A l i ,  1 9 7 7 ) .
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I n  m o s t  c a s e s ,  g r o w t h  i n  CCY m e d iu m  w a s  a c c o m p a n i e d  b y  a  l o w e r  
h a e m o l y s i n  p r o d u c t i o n .  H o w e v e r ,  w i t h  t h e  c a n i n e  s t r a i n  7O67I / L ,  t h e r e  
w a s  a n  i n c r e a s e  i n  a - ,  (B- a n d  6 - h a e m o l y s i n  p r o d u c t i o n  w h e n  t h e  o r g a n i s m  
w a s  g r o w n  i n  CCY m e d i u m .  T h e  f i n d i n g  t h a t  d i f f e r e n t  c u l t u r a l  c o n d i t i o n s  
m a y  b e  r e q u i r e d  b y  d i f f e r e n t  s t r a i n s  o f  S .  a u r e u s  f o r  h a e m o l y s i n  p r o d u c t i o n  
i s  s u p p o r t e d  b y  T u r n e r  ( 1 9 7 8 b )  w h o  f o u n d  t h a t  6 - h a e m o l y s i n  p r o d u c t i o n  
d e p e n d e d  o n  t h e  c o m p o s i t i o n  a n d  v o lu m e  o f  m e d iu m  a n d  a l s o  o n  t h e  s t r a i n  o f  
S .  a u r e u s  e m p l o y e d .
T h e  s t r a i n  i s o l a t e d  f r o m  a  c a s e  o f  b o v i n e  m a s t i t i s  ( 6 9 9 3 1 )  d i d  
n o t  p r o d u c e  a n y  h a e m o l y s i n s  a l t h o u g h  t h e  c u l t u r a l  c o n d i t i o n s  e m p l o y e d  m a y  
n o t  h a v e  b e e n  s u i t a b l e  f o r  h a e m o l y s i n  p r o d u c t i o n  b y  t h i s  s t r a i n .  N e v e r ­
t h e l e s s ,  p r o d u c t i o n  o f  h a e m o l y s i n s  i n  v i v o  m a y  n o t  b e  a  p r e r e q u i s i t e““ —■ »
f a c t o r  f o r  t h e  v i r u l e n c e  o f  s t r a i n s  c a u s i n g  b o v i n e  m a s t i t i s  ( A n d e r s o n ,  1 9 7 6 ) .
C o n t r a r y  t o  t h e  w o r k  o f  T u r n e r  ( 1 9 7 8 a ) ,  a n t i g e n i c  d i f f e r e n c e s  
b e t w e e n  c r u d e  c u l t u r e  s u p e r n a t e s  o f  c a n i n e  s t r a i n s  a n d  p u r i f i e d  6 - h a e m o l y s i n  
w e r e  n o t  d e t e c t e d  o n  g e l  d i f f u s i o n  a g a i n s t  a n t i - p u r i f i e d  6 - h a e m o l y s i n .  
S i m i l a r l y ,  a l l  h u m a n  s t r a i n s  ( e x c e p t  s t r a i n  L S 2 6 )  p r o d u c e d  a  6 - h a e m o l y s i n  
w h i c h  w a s  a n t i g e n i c a l l y  i d e n t i c a l  t o  p u r i f i e d  ( 10 3 4 5 )  6 - h a e m o l y s i n .
H o w e v e r ,  s e v e r a l  o f  t h e  c a n i n e  s t r a i n s  g a v e  a  s p l i t  l i n e  o f  i d e n t i t y  w i t h  
p u r i f i e d  6 - h a e m o l y s i n .  S o m e t i m e s  t h i s  w a s  m i s t a k e n  f o r  a  s p u r r i n g  
r e a c t i o n  ( u s u a l l y  i n  u n s t a i n e d  p r e p a r a t i o n s )  b u t ,  b y  a b s o r p t i o n  o f  t h e  
a n t i s e r a  w i t h  e i t h e r  t h e  c r u d e  c a n i n e  c u l t u r e  s u p e r n a t e  o r  w i t h  p u r i f i e d  
6 - h a e m o l y s i n ,  i t  w a s  s h o w n  t h a t  t h e s e  c a n i n e  6 - h a e m o l y s i n s  w e r e  a n t i g e n i c a l l y  
i n d i s t i n g u i s h a b l e  f r o m  t h a t  o f  s t r a i n  1 0 3 4 5 *  T u r n e r  ( 1 9 7 8 a )  a l s o  r e p o r t e d  
tw o  p r e c i p i t i n  l i n e s  w i t h  c r u d e  c u l t u r e  s u p e r n a t e s  o f  b o v i n e  s t r a i n s  b u t ,  
u n l i k e  t h e  f i n d i n g s  i n  t h i s  s t u d y ,  o n l y  o n e  o f  t h e s e  l i n e s  g a v e  i d e n t i t y  
w i t h  p u r i f i e d  6 - h a e m o l y s i n .  T u r n e r  s u g g e s t e d  t h a t  t h i s  s e c o n d  p r e c i p i t i n  
l i n e  m a y  h a v e  b e e n  c a u s e d  b y  t h e  p r e s e n c e  o f  p r o t e i n  A i n  t h e  c r u d e  
c u l t u r e  s u p e r n a t e s .  S i n c e  b o t h  p r e c i p i t i n  l i n e s  f o u n d  i n  t h i s  s t u d y
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g a v e  a  r e a c t i o n  o f  i d e n t i t y  w i t h  p u r i f i e d  5 - h a e m o l y s i n  i t  i s  p o s s i b l e  
t h a t  t h e y  w e r e  c a u s e d  b y  d i f f e r e n t  a g g r e g a t e d  f o r m s  o f  t h e  h a e m o l y s i n  
( K a n t o r  e t_  a l . , 1 9 7 2 ) .  T u r n e r  ( 1 9 7 8 a )  d i d  n o t  r e p o r t  s p l i t  p r e c i p i t i n  
l i n e s  w i t h  a n y  o f  h i s  c a n i n e  c r u d e  c u l t u r e  s u p e r n a t e s .  H o w e v e r ,  h e  f a i l e d  
t o  t e s t  t h e  c r u d e  s u p e r n a t e s  a g a i n s t  a n t i s e r a  a b s o r b e d  w i t h  e i t h e r  c r u d e  
o r  p u r i f i e d  5 - h a e m o l y s i n  w h i c h  w o u l d  h a v e  p r o v e d  t h a t  t h e s e  s t r a i n s  d i d  
p r o d u c e  a n  i m m u n o l o g i c a l l y  d i s t i n c t  h a e m o l y s i n .
T h e  h u m a n  s t r a i n ,  L S 2 6 ,  p r o d u c e d  5 - h a e m o l y s i n  w h i c h  p r e c i p i t a t e d  
w i t h  a n t i b o d i e s  i n  a n t i - p u r i f i e d  5 - h a e m o l y s i n  a n t i s e r u m  w h i c h  w e r e  d i r e c t e d  
a g a i n s t  a n t i g e n i c  s i t e s  n o t  p r e s e n t  o n  t h e  h o m o l o g o u s  h a e m o l y s i n .  T h i s  
r e a c t i o n  o c c u r r e d  w i t h  s e v e r a l  a n t i - 5 - h a e m o l y s i n  a n t i s e r a .  T h e s e  r e s u l t s  
s u g g e s t  t h a t  h i d d e n  a n t i g e n i c  d e t e r m i n a n t s  a r e  " e x p o s e d "  d u r i n g  i m m u n i s a t i o n  
w i t h  5 - h a e m o l y s i n  w h i c h  i n d u c e  s p e c i f i c  a n t i b o d y  f o r m a t i o n .  D e t e c t i o n  o f  
a n t i b o d i e s  d i r e c t e d  a g a i n s t  b u r i e d  d e t e r m i n a n t s  h a s  b e e n  s h o w n  u s i n g  
p r o t e o l y t i c  p e p t i d e s  o f  HSA ( L a  P r e s l e  a n d  D u r i e u x ,  1 9 5 8 )  a n d  BSA ( i s h i z a k a ,  
C a m p b e l l  a n d  I s h i z a k a ,  I 9 6 0 ) .  E x p o s u r e  o f  t h e s e  b u r i e d  d e t e r m i n a n t s  i n  
v i v o  m a y  b e  d u e  t o  a g g r e g a t i o n ,  c o n f o r m a t i o n a l  c h a n g e s  o r  l o c a l  e n z y m i c  
r e a c t i o n s  ( G o e t z l  a n d  P e t e r s ,  1 9 7 2 ) .
T h e r e f o r e ,  d u r i n g  p r o d u c t i o n  o f  5 - h a e m o l y s i n ,  i n  s t r a i n  L S 2 6 ,  t h e  
p r o t e i n  m a y  b e  a s s e m b l e d  a n d  s e c r e t e d  i n  s u c h  a  w a y  a s  t o  u n c h a r a c t e r i s t ­
i c a l l y  e x p o s e  t h e s e  h i d d e n  d e t e r m i n a n t s  w h i c h  w o u l d  t h e r e f o r e  b e  f r e e  t o  
p r e c i p i t a t e  w i t h  s p e c i f i c  a n t i b o d y .
T h e  g e n e r a l  m e c h a n i s m  o f  p r o t e i n  s e c r e t i o n  h a s  b e e n  r e p o r t e d  b y  
B l o b e l  a n d  D o b b e r s t e i n  ( 1 9 7 5 )  w h i l e  G e r d a  a n d  K r e i l  ( 1 9 7 7 )  h a v e  d e s c r i b e d  
t h e  m o d e  o f  s e c r e t i o n  o f  m e l i t t i n .  A s  m e n t i o n e d  e a r l i e r ,  5 - h a e m o l y s i n  
s h a r e s  m a n y  p r o p e r t i e s  w i t h  m e l i t t i n  a n d  t h e r e f o r e  i t  m a y  a l s o  b e  s e c r e t e d  
b y  c e l l s  i n  a  s i m i l a r  w a y .  T h e r e f o r e ,  s e c r e t i o n  o f  5 - h a e m o l y s i n  m a y  
i n v o l v e  s y n t h e s i s  o f  a  s i g n a l  s e q u e n c e  o f  a  f e w  a m i n o  a c i d s  w h i c h  i n t e r a c t s
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w i t h  t h e  m e m b r a n e  a n d  i n  s o m e  w a y  a l l o w s  t h e  t r a n s l o c a t i o n  o f  t h e  r e s t  
o f  t h e  p e p t i d e  a c r o s s  t h e  m e m b r a n e  a s  i t  i s  s y n t h e s i s e d .  T h e  p r o - h a e m o l y s i n  
s e c r e t e d  m a y  b e  i n  a n  i n a c t i v e  f o r m  w h i c h  r e q u i r e s  so m e  e n z y m i c  c l e a v a g e  
t o  p r o d u c e  a n  a c t i v e  6 - h a e m o l y s i n .  I f  t h i s  p r o - s e q u e n c e  o f  a m i n o  a c i d s  
i s  c l e a v e d  a t  d i f f e r e n t  p o i n t s ,  t h e n  i t  m a y  r e s u l t  i n  a n  a l t e r e d  
c o n f o r m a t i o n  w h i c h  c o u l d  " e x p o s e ” t h e  n o r m a l l y  h i d d e n  a n t i g e n i c  d e t e r m i n a n t s .  
T h e  r e s u l t s  o f  s t r a i n  L S 2 6  c o u l d ,  h o w e v e r ,  a l s o  b e  e x p l a i n e d  i f  s t r a i n  1 0 5 4 5  
c o n t a i n e d  a  c e r t a i n  p e r c e n t a g e  o f  o r g a n i s m s  w h i c h  p r o d u c e d  t h i s  a t y p i c a l  
f o r m  o f  6 - h a e m o l y s i n  a n d  t h e r e f o r e  t h e  a n t i s e r a  r a i s e d  a g a i n s t  t h e  h a e m o l y s i n  
w o u l d  c o n t a i n  a  s m a l l  p r o p o r t i o n  o f  a n t i b o d i e s  d i r e c t e d  a g a i n s t  t h e  " h i d d e n "  
d e t e r m i n a n t s .  N o r m a l l y  t h e s e  m a y  n o t  b e  i d e n t i f i e d  d u e  t o  t h e  l a c k  o f  
s u f f i c i e n t  a n t i g e n  b u t  i f ,  a s  i n  t h e  c a s e  o f  s t r a i n  L S 2 6 ,  a  g r e a t e r  
p r o p o r t i o n  o f  c e l l s  p r o d u c e d  t h i s  a t y p i c a l  h a e m o l y s i n ,  t h e n  t h e r e  i s  a  
b e t t e r  c h a n c e  f o r  t h e s e  d i f f e r e n t  a n t i g e n i c  d e t e r m i n a n t s  t o  b e  i d e n t i f i e d .  
T h i s  m a y  a l s o  e x p l a i n  w h y ,  a f t e r  r e c u l t i v a t i o n  o f  t h e  o r g a n i s m ,  t h e  
h a e m o l y s i n  p r o d u c e d  w a s  a n t i g e n i c a l l y  i d e n t i c a l  t o  p u r i f i e d  6 - h a e m o l y s i n  
s i n c e  p r o d u c t i o n  o f  t h e  a n t i g e n i c a l l y  d i s t i n c t  f o r m  m a y  b e  e x t r e m e l y  
s e n s i t i v e  t o  c u l t u r a l  c o n d i t i o n s  ( T u r n e r ,  1 9 7 8 t> )*  e x a m p l e ,  c u l t u r a l
c o n d i t i o n s  m a y  a f f e c t  t h e  a c t i v i t y  o f  t h e  e n z y m e  i n v o l v e d  i n  c l e a v a g e  o f  
t h e  p r o - s e q u e n c e .
T h e  i m m u n o e l e c t r o p h o r e s i s  o f  c r u d e  s u p e r n a t e s  r e v e a l e d  t h a t  
s e v e r a l  s t r a i n s  h a d  gin i n c r e a s e d  e l e c t r o p h o r e t i c  m o b i l i t y  c o m p a r e d  w i t h  
s t r a i n  1 0 5 4 5 *  T h i s  i n d i c a t e d  t h a t  t h o s e  s t r a i n s  p r o d u c e d  a  h a e m o l y s i n  
w i t h  gin i n c r e a s e d  s u r f a c e  c h a r g e .  H o w e v e r ,  b y  i s o e l e c t r i c  f o c u s i n g  i n  
t h e  T a l b o t  a n d  C a i e  a p p a r a t u s ,  t h e  p i  o f  t h e  d i f f e r e n t  h a e m o l y s i n s  w e r e  
v e r y  s i m i l a r  t o  t h a t  o f  s t r a i n  1 0 5 4 5 *  T h e  d i f f e r e n t  e l e c t r o p h o r e t i c  
m o b i l i t i e s  m a y  t h e r e f o r e  b e  d u e  t o  d i f f e r e n c e s  i n  m o l e c u l a r  s i z e .  A b a s i c  
c o m p o n e n t  o f  p i  8 w a s  a l s o  i d e n t i f i e d  i n  s t r a i n  ZM . H o w e v e r ,  s i n c e  tw o
c o m p o n e n t s  w e r e  n o t  f o u n d  o n  i m m u n o e l e c t r o p h o r e s i s ,  a d s o r p t i o n  o f  t h e  
h a e m o l y s i n  t o  a m p h o l i n e s  (C a n n  a n d  S t i m p s o n ,  1 9 7 7 ;  J o n s s o n  e t  a l , ,  1 9 7 8 )  
o r  so m e  p H - d e p e n d e n t  c o n f o r m a t i o n a l  t r a n s i t i o n  ( S t i m p s o n  a n d  C a n n ,  1 9 7 7 ;  
P o r c e l l i ,  S m a l l  a n d  B r e w e r ,  1 9 7 8 )  m a y  a c c o u n t  f o r  t h e  b a s i c  c o m p o n e n t .
I s o e l e c t r i c  f o c u s i n g  i n  p o l y a c r y l a m i d e  g e l s  c o n f i r m e d  p r e v i o u s  
f i n d i n g s  t h a t  d i f f e r e n t  s t r a i n s  o f  S .  a u r e u s  d i f f e r  i n  t h e  n u m b e r  o f  
e x t r a c e l l u l a r  p r o d u c t s  r e l e a s e d  ( W a d s t r o m  e t  a l . ,  1 9 7 4 ) *  F o r  e x a m p l e ,  
s t r a i n  L S 2 5  p r o d u c e d  4 - 5  b a n d s  w h i l e  s t r a i n  7 0 5 4 4  p r o d u c e d  2 0 - 2 6  b a n d s .
T h e  tw o  c l o s e l y  a s s o c i a t e d  b a n d s  o f  p u r i f i e d  6- h a e m o l y s i n  a r e  p r o b a b l y  
n o t  d u e  t o  d i f f e r e n t  c o n f o r m a t i o n s  o f  t h e  m o l e c u l e  s i n c e  f o c u s i n g  w a s  
c a r r i e d  o u t  i n  9M u r e a  w h i c h  s h o u l d  r e d u c e  t h e  i n f l u e n c e  o f  c o n f o r m a t i o n a l  
a l t e r a t i o n s  ( Z e c h e l ,  1 9 7 7 ) *  A d s o r p t i o n  t o  a m p h o l i n e s  m a y  t h e r e f o r e  
e x p l a i n  t h i s  d o u b l e  b a n d i n g  ( C a n n  a n d  S t i m p s o n ,  1 9 7 7 ;  J o n s s o n  e t  a l . ,  1 9 7 8 ) .
A t t e m p t s  t o  p u r i f y  so m e  o f  t h o s e  c r u d e  p r e p a r a t i o n s  p r o v e d  
u n s u c c e s s f u l .  A p a r t  f r o m  s t r a i n  L S 2 8 ,  n o n e  o f  t h e  s t r a i n s  g r o w n  i n  
5 0 0  m l v o l u m e s  o f  B e r n h e i m e r 1s  y e a s t  d i f f u s a t e  m e d iu m  p r o d u c e d  h i g h  t i t r e s  
o f  6 - h a e m o l y s i n .  T h e s e  r e s u l t s  a r e  i n  a g r e e m e n t  w i t h  t h o s e  o f  T u r n e r  
( 1 9 7 8 b )  w ho  f o u n d  t h a t  t h e  v o lu m e  o f  t h e  m e d iu m  c a n ,  t o  a  g r e a t  e x t e n t ,  
i n f l u e n c e  t h e  a m o u n t  o f  6 - h a e m o l y s i n  p r o d u c e d .  T u r n e r  ( 1 9 7 8 a )  a l s o  
r e p o r t e d  t h e  i n a b i l i t y  t o  p u r i f y  6 - h a e m o l y s i n  f r o m  a  c a n i n e  s o u r c e  b y  
h y d r o x y l a p a t i t e ,  w h i c h  w a s  f o u n d  w i t h  s t r a i n  L S 2 8 .  D e s o r p t i o n  o f  t h e  
h a e m o l y s i n  f r o m  h y d r o x y l a p a t i t e  d i d  n o t  o c c u r  a f t e r  w a s h i n g  i n  1M p h o s p h a t e  
b u f f e r  pH  7 * 2  o r  w i t h  1M N aH ^P O ^  pH 4 * 5 *  T h e  p i  o f  6 - h a e m o l y s i n  f r o m  
s t r a i n  L S 2 8  w a s  v e r y  s i m i l a r  t o  t h a t  o f  s t r a i n  1 0 3 4 5  a n d  s o  a  s t r o n g e r  
b i n d i n g  o f  t h e  h a e m o l y s i n  t o  h y d r o x y l a p a t i t e  c a n n o t  b e  e x p l a i n e d  b y  a n  
i n c r e a s e d  c h a r g e .  H o w e v e r ,  i t  i s  p o s s i b l e  t h a t  c o n f o r m a t i o n a l  a l t e r a t i o n s  
m a y  i n f l u e n c e  t h e  b i n d i n g  o f  t h e  h a e m o l y s i n .
P u r i f i c a t i o n  o f  6 - h a e m o l y s i n  b y  a f f i n i t y  c h r o m a t o g r a p h y  i n d i c a t e d
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t h a t  t h e  h a e m o l y s i n  c o u l d  b e  s u c c e s s f u l l y  r e m o v e d  f r o m  c r u d e  c u l t u r e  
s u p e r n a t e s  u s i n g  t h i s  t e c h n i q u e .  P r e l i m i n a r y  e x p e r i m e n t s  s h o w e d  t h a t  o n l y  
38%  o f  t o t a l  h a e m o l y s i n  a p p l i e d  t o  t h e  c o lu m n  c o u l d  b e  d e - s o r b e d  a n d  t h e  
e l u t e d  s a m p l e  c o n t a i n e d  l i t t l e  h a e m o l y t i c  a c t i v i t y .  T h e s e  r e s u l t s  a r e  
s i m i l a r  t o  t h o s e  r e p o r t e d  b y  H e a t l e y  a n d  G l a d s t o n e  ( 1 9 7 7 ) .  D e s o r p t i o n  o f  
6 - h a e m o l y s i n  f r o m  s t r a i n  L S 2 6  w a s  s u c c e s s f u l  w i t h  c a r b o n a t e / b i c a r b o n a t e  
b u f f e r  a t  pH  1 1 .  T h e  e l u t e d  m a t e r i a l  r e t a i n e d  i t s  a n t i g e n i c  p r o p e r t i e s  
( F i g  t* 0 )  a l t h o u g h  i t s  h a e m o l y t i c  a c t i v i t y  w a s  d e c r e a s e d .  F u r t h e r  
e x p e r i m e n t s  w i t h  t h i s  t e c h n i q u e  w e r e  a b a n d o n e d  d u e  t o  t h e  l o s s  o f  a d s o r b i n g  
c a p a c i t y  o f  t h e  c o l u m n  a n d  t h e  i n a b i l i t y  t o  r e c o v e r  h a e m o l y t i c a l l y  a c t i v e  
m a t e r i a l .
T h e  i n a b i l i t y  t o  o b t a i n  p u r i f i e d  6 - h a e m o l y s i n  f r o m  d i f f e r e n t  
s t r a i n s  o f  S . a u r e u s  w a s  d i s a p p o i n t i n g  s i n c e  i t  w a s  e n v i s a g e d  t h a t  t h o s e  
p r e p a r a t i o n s  w o u l d  h a v e  b e e n  u s e f u l  t o  d e t e r m i n e  d i f f e r e n c e  i n  im m u n o g e n i c  
p r o p e r t i e s  o f  t h e  h a e m o l y s i n s .  H o w e v e r ,  m i c e  w e r e  i m m u n i s e d  w i t h  c r u d e  
p r e p a r a t i o n s  w h i c h  h a d  b e e n  t r e a t e d  w i t h  f o r m a l d e h y d e  a t  pH 5 ^ o r  7  d a y s  t o  
i n v e s t i g a t e  t h e  p r o b l e m .  O n l y  tw o  o u t  o f  s e v e n  c r u d e  s u p e r n a t e s  i n d u c e d  
t h e  p r o d u c t i o n  o f  a n t i - 6 - h a e m o l y s i n  a n t i b o d i e s .  H o w e v e r ,  a l l  a n t i s e r a  
c o n t a i n e d  a n t i b o d i e s  a g a i n s t  e a c h  h o m o l o g o u s  t o x o i d .  T h r e e  o f  t h e  c r u d e  
p r e p a r a t i o n s  h a d  l o s t  t h e i r  a n t i g e n i c  a c t i v i t y  a g a i n s t  a n t i - 6 - h a e m o l y s i n  
a n t i s e r a  w h i c h  c o u l d  e x p l a i n  t h e i r  i n a b i l i t y  t o  s t i m u l a t e  a n t i - 6 - h a e m o l y s i n  
a n t i b o d y  p r o d u c t i o n .  H o w e v e r ,  t h e  p r o b l e m  o f  a n t i g e n i c  c o m p e t i t i o n  
( L i a c o p o u l o s  a n d  B e n - E f r a i n ,  1 9 7 5 ) ,  d u e  t o  t h e  p r e s e n c e  o f  m a n y  a n t i g e n i c  
s p e c i e s  i n  t h e  c r u d e  p r e p a r a t i o n s ,  m a y  e x p l a i n  b o t h  t h e  i n a b i l i t y  o f  
s t r a i n s  L S 7  a n d  L S 26 t o  i n d u c e  a n t i - 6 - h a e m o l y s i n  a n t i b o d y  p r o d u c t i o n  a n d  
a l s o  t h e  w e a k  r e s p o n s e s  o b t a i n e d  w i t h  s t r a i n s  L S 2 8  a n d  ZM. S i n c e  m o r e  
f o r m a l d e h y d e  i s  r e q u i r e d  t o  t o x o i d  a  c r u d e  p r e p a r a t i o n  t h a n  a  p u r i f i e d  
p r e p a r a t i o n ,  d u e  t o  t h e  i n f l u e n c e  o f  o t h e r  p r o t e i n s  i n  t h e  m e d iu m  
( W a d s w o r t h  e t  a l . ,  1 9 3 7 ) ,  a  l o n g e r  i n c u b a t i o n  p e r i o d  m a y  b e  r e q u i r e d  t o
p r o d u c e  a  b e t t e r  im m u n o g e n .  T h e  i m p o r t a n c e  o f  t h e  l e n g t h  o f  i n c u b a t i o n  
t i m e  a n d  t h e  r e s u l t i n g  i m m u n o g e n i c i t y  w a s  s h o w n  w i t h  p u r i f i e d  6 - h a e m o l y s i n  
( F i g 0! ) .  T h i s  a l s o  e x p l a i n s  t h e  l o w  r e s u l t s  o b t a i n e d  w i t h  s t r a i n s  L S 2 8  
a n d  ZM.
P o s s i b l e  a r e a s  f o r  f u t u r e  r e s e a r c h
T h e  p r e s e n t  w o r k  h a s  o u t l i n e d  c o n d i t i o n s  s u i t a b l e  f o r  t h e  
s u c c e s s f u l  i m m u n i s a t i o n  o f  m i c e  a g a i n s t  s t a p h y l o c o c c a l  6 - h a e m o l y s i n  w h i c h  
m a y  p r o v e  u s e f u l  i n  d e t e r m i n i n g  a  r o l e  f o r  6 - h a e m o l y s i n  i n  t h e  v i r u l e n c e  
o f  S .  a u r e u s .  A d la m  e t  a l .  ( 1 9 7 7 )  h a v e  s h o w n  t h a t  i m m u n i s a t i o n  w i t h  
a l p h a - t o x o i d  c a n  m o d i f y  t h e  o u t c o m e  o f  e x p e r i m e n t a l l y  i n d u c e d  s t a p h y l o ­
c o c c a l  m a s t i t i s  i n  r a b b i t s .  I n  a  s i m i l a r  m a n n e r ,  t h e  e f f e c t  o f  i m m u n i s a ­
t i o n  w i t h  ' d e l t a - t o x o i d '  o n  e x p e r i m e n t a l l y  i n d u c e d  i n f e c t i o n s  i n  m i c e  m a y  
b e  i n v e s t i g a t e d .  T h e  s t u d y  o f  s k i n  n e c r o s i s  i n  m i c e  m a y  b e  i m p o r t a n t  
i n  t h i s  r e s p e c t  s i n c e  V a n  d e r  V i j v e r  £ t  a l .  ( 1 9 7 5 ^ )  h a v e  s h o w n  m u t a n t  
s t r a i n s ,  l a c k i n g  6 - h a e m o l y s i n ,  h a d  a  r e d u c e d  d e r m o n e c r o t i c  a c t i v i t y .  
P u r i f i e d  6 - h a e m o l y s i n  f r o m  d i f f e r e n t  s t r a i n s  o f  S .  a u r e u s  w o u l d  a l s o  b e  
u s e f u l  i n  s u c h  e x p e r i m e n t s ,  s i n c e  t h e  e f f e c t  o f  i m m u n i s a t i o n  o n  t h e  c o u r s e  
o f  i n f e c t i o n  m a y  d e p e n d  o n  t h e  s t r a i n  e m p l o y e d .  H o w e v e r ,  t h e  r e s u l t s  
o f  t h e  p r e s e n t  s t u d y  w e r e  d i s a p p o i n t i n g  d u e  t o  t h e  i n a b i l i t y  t o  p u r i f y  
t h e s e  d i f f e r e n t  h a e m o l y s i n s .  A m o r e  e x t e n s i v e  p r o g r a m m e  i s  t h e r e f o r e  
r e q u i r e d  t o  i n v e s t i g a t e  t h i s  p r o b l e m  o f  p u r i f i c a t i o n  b y  p o s s i b l y  i n v o l v i n g  
t h e  t e c h n i q u e s  o f  o t h e r  w o r k e r s  ( H e a t l e y ,  1 9 7 1 ;  K a n t o r  e t  a l . .  1 9 7 2 )  t o  
p u r i f y  6 - h a e m o l y s i n .  T h e  r e c e n t l y  d e s c r i b e d  s i n g l e - s t e p  p u r i f i c a t i o n  o f  
6 - h a e m o l y s i n  b y  h y d r o p h o b i c  i n t e r a c t i o n  c h r o m a t o g r a p h y  ( N o l t e  a n d  K a p r a l ,  
19 7 9 )  a l s o  m a y  b e  o f  u s e .
A d e t a i l e d  s t u d y  o f  t h e  g r o w t h  r e q u i r e m e n t s  o f  s t r a i n  L S 2 6  f o r  
t h e  p r o d u c t i o n  o f  t h e  " u n i q u e "  f o r m  o f  6 —h a e m o l y s i n  i s  a n o t h e r  a r e a  o f
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i n t e r e s t i n g  r e s e a r c h .  A p u r i f i e d  p r e p a r a t i o n  o f  t h i s  h a e m o l y s i n  c o u l d  
b e  e x p l o i t e d  i n  s e v e r a l  w a y s .  F o r  e x a m p l e ,  a m i n o  a c i d  a n a l y s i s  m a y  
p r o v i d e  s o m e  i n f o r m a t i o n  i n t o  t h e  m e t h o d  o f  r e l e a s e  o f  6 - h a e m o l y s i n  ( c f .
G e r d a  a n d  K r e i l ,  1 9 7 7 ) ,  a s  w o u l d  i n  v i v o  s t u d i e s  f o r  e n h a n c e d  v a s c u l a r  
p e r m e a b i l i t y  a c t i v i t y .  I f  t h e  ’ u n i q u e 1 a n t i g e n i c  d e t e r m i n a n t s  f o u n d  i n  
t h i s  h a e m o l y s i n  a r e  i n d e e d  d u e  t o  so m e  c o n f o r m a t i o n a l  a l t e r a t i o n  d u r i n g  
a s s e m b l y ,  a s  s u g g e s t e d  a b o v e ,  t h e n  t h e  s i t e  o f  t h e  m o l e c u l e  i n v o l v e d  i n  
EVP a c t i v i t y  m a y  b e  m a s k e d  b y  s u c h  a  c o n f o r m a t i o n a l  c h a n g e .
T h e  p r e s e n t  w o r k  h a s  s u g g e s t e d  t h a t  d i f f e r e n t  m e c h a n i s m s  a n d  
a r e a s  o f  t h e  m o l e c u l e  a r e  i n v o l v e d  i n  d i f f e r e n t  b i o l o g i c a l  a c t i v i t i e s  o f  
6 - h a e m o l y s i n .  F o r  e x a m p l e ,  a  r e q u i r e m e n t  f o r  l y s i n e  r e s i d u e s  i n  t h e  
b i n d i n g  o f  6 - h a e m o l y s i n  t o  l e c i t h i n  o r  e r y t h r o c y t e s  h a s  b e e n  i m p l i c a t e d  
w h i l e  t h e  EVP a c t i v i t y  o f  t h e  h a e m o l y s i n  m a y  n o t  r e l y  t o  s u c h  a  g r e a t  
e x t e n t  o n  t h e s e  r e s i d u e s .  T h e s e  r e s u l t s  c o u l d  b e  c o n f i r m e d  b y  e m p l o y i n g  
m o r e  s p e c i f i c  c h e m i c a l  m o d i f i c a t i o n  t e c h n i q u e s ,  s u c h  a s  r e d u c t i v e  
m e t h y l a t i o n  a n d  c a r b a m y l a t i o n ,  w h i c h  a r e  h i g h l y  s p e c i f i c  f o r  l y s i n e  r e s i d u e s .
S i m i l a r l y ,  t h e  s e p a r a t i o n  o f  t r y p t i c  f r a g m e n t s  b y  m o l e c u l a r  
e x c l u s i o n  c h r o m a t o g r a p h y  w a s  o n l y  a  p r e l i m i n a r y  i n v e s t i g a t i o n  a n d  t h e r e f o r e  
m o r e  s e n s i t i v e  s e p a r a t i o n  t e c h n i q u e s ,  s u c h  a s  i o n  e x c h a n g e  o r  p a p e r  
c h r o m a t o g r a p h y ,  m a y  p r o v i d e  a  m o r e  e f f i c i e n t  i s o l a t i o n  o f  t h e  f r a g m e n t s .  
P u r i f i c a t i o n  a n d  a m i n o  a c i d  a n a l y s i s  o f  s u c h  p e p t i d e s  w o u l d  b e  i m p o r t a n t  i n  
d e t e r m i n i n g  t h e  p o s i t i o n  a n d  c o m p o s i t i o n  o f  t h e  d i f f e r e n t  s i t e s  o f
6 - h a e m o l y s i n  i n v o l v e d  i n  h a e m o l y t i c ,  a n t i g e n i c  a n d  EV P a c t i v i t i e s .
A f u r t h e r  a r e a  o f  r e s e a r c h  r e g a r d i n g  t h e  EV P a c t i v i t y  o f
6 - h a e m o l y s i n  w o u l d  b e  t o  d e t e r m i n e  t h e  e f f e c t  o f  v a r i o u s  c h e m i c a l ,  t r e a t m e n t s  
o n  t h e  a b i l i t y  o f  6 - h a e m o l y s i n  t o  f o r m  i n d u r a t e d  l e s i o n s  a t  24 h .
P r e l i m i n a r y  s t u d i e s  ( n o t  s h o w n )  i n d i c a t e d  t h a t  f o r m a l d e h y d e - t r e a t e d  6 -  
h a e m o l y s i n  f a i l e d  t o  c a u s e  t h i s  r e s p o n s e  a t  24 h ,  w h i l e  c o n t r o l  s a m p l e s  d i d
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p r o d u c e  s u c h  l e s i o n s .  T h e r e f o r e ,  i t  i s  p o s s i b l e  t h a t  t h e  b l u i n g  a n d  
l e s i o n - f o r m i n g  r e s p o n s e s  o f  6 - h a e m o l y s i n  m a y  i n v o l v e  tw o  s e p a r a t e  
m e c h a n i s m s .
S h i e r  ( 1 9 7 9 )  h a s  r e c e n t l y  s u g g e s t e d  t h a t  6 - h a e m o l y s i n  m a y  i n t e r a c t  
w i t h  t h e  p l a s m a  m e m b r a n e  a n d  s t i m u l a t e  i n t r i n s i c  p h o s p h o l i p a s e  A2 a c t i v i t y  
l e a d i n g  t o  f o r m a t i o n  o f  t h e  l y t i c  a g e n t ,  l y s o l e c i t h i n ,  i n  t h e  m e m b r a n e .
T h e  e f f e c t  o f  f o r m a l d e h y d e  a n d  o t h e r  t r e a t m e n t s  o n  t h i s  s t i m u l a t i o n  b y  t h e  
h a e m o l y s i n  m a y  a l s o  p r o v i d e  i n f o r m a t i o n  o n  t h e  m e c h a n i s m  o f  a c t i o n  o f
6 - h a e m o l y s i n .
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o f  s t a p h y l o c o c c a l  t o x i n s  i n  r e l a t i o n  t o  T o x i c  E p i d e r m a l  N e c r o l y s i s  
( t h e  s c a l d e d - s k i n  s y n d r o m e ) .  B r i t i s h  J o u r n a l  o f  D e r m a t o l o g y .  8 6 ,
S u p p  8 ,  5 5 - 3 9 *
ARBUTHNOTT, J . P . ,  F R E E R , J . H .  a n d  M cN IV E N , A .C .  ( 1 9 7 3 )  P h y s i c a l
p r o p e r t i e s  o f  s t a p h y l o c o c c a l  a l p h a  t o x i n ,  a n d  a s p e c t s  o f  a l p h a  t o x i n  
m e m b r a n e  i n t e r a c t i o n s .  I n  " S t a p h y l o c o c c i  a n d  S t a p h y l o c o c c a l  i n f e c t i o n s "  
p 2 8 5 - 2 9 7 *  E d i t e d  b y  J .  J e l j a s z e w i c z ,  B a s e l ,  S .  K a r g e r .
ARBUTHNOTT, J . P . ,  B IL L C L IF F E , B .  a n d  THOMPSON, W .D . ( 1 9 7 4 )  I s o e l e c t r i c  
f o c u s i n g  s t u d i e s  o f  s t a p h y l o c o c c a l  e p i d e r m o l y t i c  t o x i n .  F . E . B . S .  
L e t t e r s ,  4 6 ,  9 2 - 9 5 *
A R V ID SO N , S . ,  HOLM E, T .  a n d  LINDHOLM , B .  ( 1 9 7 3 )  S t u d i e s  o n  e x t r a c e l l u l a r  
p r o t e o l y t i c  e n z y m e s  f r o m  S t a p h y l o c o c c u s  a u r e u s .  I  P u r i f i c a t i o n  a n d  
c h a r a c t e r i s a t i o n  o f  o n e  n e u t r a l  a n d  o n e  a l k a l i n e  p r o t e a s e .  B i o c h i m i c a  
e t  B i o p h y s i c a  A c t a .  5 0 2 ,  1 5 5 - 1 4 8 .
A T A S S I , M .Z .  ( l 9 7 5 )  A n t i g e n i c  s t r u c t u r e  o f  m y o g l o b i n  : T h e  c o m p l e t e  
i m m u n o - c h e m i c a l  a n a t o m y  o f  a  p r o t e i n  a n d  c o n c l u s i o n s  r e l a t i n g  t o  
a n t i g e n i c  s t r u c t u r e s  o f  p r o t e i n s .  I m m u n o c h e m i s t r y .  1 2 ,  425 - 4 5 8 .
A T A S S I , M .Z .  ( l 9 7 8 )  P r e c i s e  d e t e r m i n a t i o n  o f  t h e  e n t i r e  a n t i g e n i c  s t r u c t u r e  
o f  l y s o z y m e :  M o l e c u l a r  f e a t u r e s  o f  p r o t e i n  a n t i g e n i c  s t r u c t u r e s  a n d
p o t e n t i a l  o f  1 s u r f a c e - s t i m u l a t i o n 1 s y n t h e s i s  -  A p o w e r f u l  n e w  c o n c e p t  
f o r  p r o t e i n  b i n d i n g  s i t e s .  I m m u n o c h e m i s t r y ,  1 5 ,  909- 936 .
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A V IG A D , G . ( 1 9 7 6 )  M i c r o b i a l  p h o s p h o l i p a s e s .  I n  " M e c h a n i s m s  i n  B a c t e r i a l  
T o x i n o l o g y "  p 9 9 - l 6 7 «  E d i t e d ,  b y  A .W . B e r n h e i m e r ,  N ew  Y o r k ,  J o h n  W i l e y .
B A R T E L L , P . P . ,  O R R , T . E . ,  G E F F E N , A .  a n d  I O R I O ,  P .  ( 1 9 6 8 )  E x p e r i m e n t a l  
i n f e c t i o n  o f  m i c e  w i t h  S t a p h y l o c o c c u s  a u r e u s : E v i d e n c e  a g a i n s t  a l p h a
t o x i n  a n d  t h e  t e r m i n a l  s i z e  o f  t h e  b a c t e r i a l  p o p u l a t i o n  a s  d e t e r m i n a n t s  
o f  l e t h a l i t y .  J o u r n a l  o f  I n f e c t i o u s  D i s e a s e s .  1 1 8 ,  4 8 1 - 4 9 0 *
BAZARAL, M . ,  G O S C IE N S K I, P . J .  a n d  HAMBURGER, R . N .  ( 1 9 7 3 )  C h a r a c t e r i s t i c s  
o f  h u m a n  a n t i b o d y  t o  d i p h t h e r i a  t o x i n .  I n f e c t i o n  a n d  I m m u n i t y ,  2 >  
1 5 0 - 1 5 6 .
B E E L E Y , J . A . ,  STEV EN SO N , S .M .  a n d  B E E L E Y , J . G .  ( l 9 7 2 )  P o l y a c r y l a m i d e  g e l  
i s o e l e c t r i c  f o c u s i n g  o f  p r o t e i n s :  D e t e r m i n a t i o n  o f  i s o e l e c t r i c  p o i n t s  
u s i n g  a n  a n t i m o n y  e l e c t r o d e .  B i o c h i m i c a  e t  B i o p h y s i c a  A c t a ,  2 8 5 , 
2 9 5 - 5 0 0 .
BEN A CERRA F, B .  a n d  G ERM A IN , R . N .  ( 1 9 7 8 )  T h e  im m u n e  r e s p o n s e  g e n e s  o f  t h e  
m a j o r  h i s t o c o m p a t i b i l i t y  c o m p l e x .  I m m u n o l o g i c a l  R e v i e w s ,  5 8 ,  7 0 - 1 1 9 *
BEN A CERRA F, B .  a n d  K A T Z , D .H .  ( l 9 7 5 )  T h e  n a t u r e  a n d  f u n c t i o n  o f  h i s t o ­
c o m p a t i b i l i t y - l i n k e d  im m u n e  r e s p o n s e  g e n e s .  I n  " I m m u n o g e n e t i c s  a n d  
I m m u n o d e f i c i e n c y "  p l l 5 - 1 7 7 *  E d i t e d  b y  B .  B e n a c e r r a f ,  M T P .
BERG DO LL, M .S .  ( 19 6 7 )  T h e  s t a p h y l o c o c c a l  e n t e r o t o x i n s .  I n  " B i o c h e m i s t r y  
o f  so m e  f o o d b o r n e  m i c r o b i a l  t o x i n s "  p l - 2 5 .  E d i t e d  b y  R . I .  M a t e l e s  a n d  
G .N .  W o g a n ,  C a m b r i d g e ,  M . I . T .  P r e s s .
BERG DO LL, M .S .  ( 1 9 7 0 )  E n t e r o t o x i n s .  I n  " M i c r o b i a l  T o x i n s "  V o l  I I I  
p 2 6 5 - 5 2 6 .  E d i t e d  b y  S .  K a d i s ,  T . C .  M o n t i e  a n d  S . J .  A j l ,  N ew  Y o r k ,  
A c a d e m i c  P r e s s .
BERG DO LL, M .S .  ( l 9 7 2 )  T h e  e n t e r o t o x i n s  I n  " T h e  S t a p h y l o c o c c i "  p 5 0 1 - 5 5 1 .  
E d i t e d  b y  J . O .  C o h e n ,  L o n d o n ,  W i l e y - I n t e r s c i e n c e .
B ER N H EIM ER , A .W . ( 1 9 6 5 )  S t a p h y l o c o c c a l  a l p h a - t o x i n .  A n n a l s  o f  t h e  N ew  
Y o r k  A c a d e m y  o f  S c i e n c e ,  1 2 8 ,  1 1 2 - 1 2 5 .  ,
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B ER N H EIM ER , A .W . ( 1 9 6 8 )  C y t o l y t i c  t o x i n s  o f  b a c t e r i a l  o r i g i n .  T h e  n a t u r e  
a n d  p r o p e r t i e s  o f  c y t o l y t i c  p r o t e i n s  a x e  d i s c u s s e d  w i t h  e m p h a s i s  o n  
s t a p h y l o c o c c a l  a - t o x i n .  S c i e n c e .  1 5 9 .  8 4 7 - 8 5 1 .
BER N H EIM ER , A .W . ( 1 9 7 0 )  C y t o l y t i c  t o x i n s  o f  b a c t e r i a .  I n  " M i c r o b i a l
t o x i n s "  V o l  I  p l 8 5 - 2 1 2 .  E d i t e d  b y  S . J .  A j l ,  S .  K a d i s  a n d  T . C .  M o n t i e ,
N ew  Y o r k ,  A c a d e m i c  P r e s s .
B ER N H EIM ER , A .W . ( 1 9 7 4 )  I n t e r a c t i o n s  b e t w e e n  m e m b r a n e s  a n d  c y t o l y t i c  
b a c t e r i a l  t o x i n s .  B i o c h i m i c a  e t  B j o p h y s i c a  A c t a .  5 4 4 .  2 7 - 5 0 .
B ER N H EIM ER , A .W . a n d  SCHWARTZ, L . L .  ( l 9 6 l )  E x t r a c e l l u l a r  p r o t e i n s  o f
s t a p h y l o c o c c i .  P r o c e e d i n g s  o f  t h e  S o c i e t y  o f  E x p e r i m e n t a l  B i o l o g y  a n d  
M e d i c i n e .  1 0 6 ,  7 7 6 - 7 8 0 .
B ER N H EIM ER , A .W . a n d  SCHWARTZ, L . L .  ( 1 9 6 5 )  I s o l a t i o n  a n d  c o m p o s i t i o n  o f
s t a p h y l o c o c c a l  a l p h a - t o x i n .  J o u r n a l  o f  G e n e r a l  M i c r o b i o l o g y .  5 0 . 455- 468 .
B ER N H EIM ER , A .W . a n d  SCHWARTZ, L . L .  ( 1 9 6 4 ) L y s o s o m a l  d i s r u p t i o n  b y  b a c t e r i a l ,  
t o x i n s .  J o u r n a l  o f  B a c t e r i o l o g y .  8 7 , 1 1 0 0 - 1 1 0 4 .
BER N H EIM ER , A .W . ,  A V IG A D , L . S .  a n d  G RU SH O FF, P .  ( 19 6 8 )  L y t i c  e f f e c t s  o f  
s t a p h y l o c o c c a l  a - t o x i n  a n d  6 - h e m o l y s i n .  J o u r n a l  o f  B a c t e r i o l o g y .  96 .  
4 8 7 - 4 9 1 *
B ER N H EIM ER , A .W . ,  F R E E R , J . H . ,  L O M IN S K I, I .  a n d  S E S S A , G . ( l 9 6 8 )  S om e 
p r o p e r t i e s  o f  s t a p h y l o c o c c a l  a - t o x o i d .  J o u r n a l  o f  B a c t e r i o l o g y .  96 . 
1 4 2 9 - 1 4 3 0 .
B ER N H EIM ER , A .W . ,  K IM , K . S . ,  R EM SEN , C . C . ,  ANTANAVAGE, J .  a n d  WATSON, S .W . 
( l 9 7 2 )  F a c t o r s  a f f e c t i n g  i n t e r a c t i o n  o f  s t a p h y l o c o c c a l  a l p h a  t o x i n  w i t h  
m e m b r a n e s .  I n f e c t i o n  a n d  I m m u n i t y .  _6, 656- 6 4 2 .
B E U G N IE R , N . a n d  ZAN EN, J .  ( 1 9 7 7 )  D i p h t h e r i a  t o x i n :  T h e  e f f e c t  o f
n i t r a t i o n  a n d  r e d u c t i v e  m e t h y l a t i o n  o n  e n z y m i c  a c t i v i t y  a n d  t o x i c i t y .  
B i o c h i m i c a  e t  B j o p h y s i c a  A c t a .  4 9 0 .  2 2 5 - 2 5 4 *
B IG G E R , J . W . ,  BOLAND, C . R .  a n d  O 'M EA R A , R .A .Q .  ( 1 9 2 7 )  A n e w  m e t h o d  o f  
p r e p a r i n g  s t a p h y l o c o c c a l  h a e m o l y s i n .  J o u r n a l  o f  P a t h o l o g y  a n d  
B a c t e r i o l o g y .  5 0 .  2 7 1 - 2 7 7 .
B IR C H -H IR S C H F E L D ,  L .  ( 1 9 3 4 )  V e b e r  d i e  w i r k s a m k e i t  d e r  e x t r a k t e  v o n  a u f  
z e l l o p h a n a g a r  g e z u c h t e t e n  s t a p h y l o k o k k e n .  Z .  I m m u n i t a e t s f o r s c h . 
A l l e r g .  K l i n .  I m m u n o l . ,  8 1 .  2 6 0 - 2 8 5 .  ( c i t e d  b y  E l e k ,  1 9 5 9 ) *
B IR K B E C K , T . H .  a n d  S T E P H E N , J .  ( l 9 7 l )  I m m u n o c h e m i c a l  i s o l a t i o n  o f  
v a c c i n i a - v i r u s  a n t i g e n s .  I m m u n o c h e m i s t r y ,  8_, 1 0 2 9 - 1 0 5 9 *
B IR K B E C K , T . H .  a n d  W HITELAW , D .D .  ( l 9 7 6 )  I m m u n o g e n i c i t y  o f  s t a p h y l o c o c c a l  
d e l t a - h a e m o l y s i n .  P r o c e e d i n g s  o f  t h e  S o c i e t y  f o r  G e n e r a l  M i c r o b i o l o g y  
I t  1 2 .
B IR K B E C K , T . H .  a n d  W HITELAW , D .D .  ( l 9 7 9 )  I m m u n o g e n i c i t y  a n d  m o l e c u l a r  
c h a r a c t e r i z a t i o n  o f  s t a p h y l o c o c c a l  d e l t a - h a e m o l y s i n .  J o u r n a l  o f  
M e d i c a l  M i c r o b i o l o g y ,  i n  P r e s s .
B I Z Z I N I ,  B . ,  T U R P IN , A .  a n d  RAYNAUD, M . ( 1 9 7 3 )  I m m u n o c h e m i s t r y  o f  t e t a n u s  
t o x i n .  T h e  n i t r a t i o n  o f  t y r o s y l  r e s i d u e s  i n  t e t a n u s  t o x i n .  E u r o p e a n
J o u r n a l  o f  B i o c h e m i s t r y .  5 9 .  1 7 1 - 1 8 1 •
B L A S S , J . ,  B I Z Z I N I ,  M . a n d  RAYNAUD, M . ( 19 6 7 )  E t u d e s  s u r  l e  m e c h e n i s m e  
d e  l a  d e ' t o x i f i c a t i o n  d e s  t o x i n e s  p r o t e i q u e s  p a r  l e  f o r m o l .  B u l l e t i n
d e  l a  S o c i e t e  C h i m i q u e  d e  F r a n c e ,  1 0 .  3 9 5 7 - 3 9 6 5 *
B L O B E L , G . a n d  D O B B E R S T E IN , B .  ( l 9 7 5 )  T r a n s f e r  o f  p r o t e i n s  a c r o s s  
m e m b r a n e s .  N a s c e n t  i m m u n o g l o b u l i n  l i g h t  c h a i n s  o n  m e m b r a n e - b o u n d  
r i b o s o m e s  o f  m u r i n e  m y e l o m a .  J o u r n a l  o f  C e l l  B i o l o g y .  6 7 .  855- 8 5 1 . 
B O R E L , Y .  ( 1 9 7 6 )  I s o l o g o u s  I g G —i n d u c e d  i m m u n o l o g i c a l  t o l e r a n c e  t o  h a p t e n s  
A m o d e l  o f  s e l f  v e r s u s  n o n - s e l f  r e c o g n i t i o n .  T r a n s p l a n t a t i o n  R e v i e w s ,
2Lt > 2 2 -
BOW ES, J . H .  a n d  C A T E R , C .W . ( 19 6 6 )  T h e  r e a c t i o n  o f  g l u t a r a l d e h y d e  w i t h  
p r o t e i n s  a n d  o t h e r  b i o l o g i c a l  m a t e r i a l s .  J o u r n a l  o f  t h e  R o y a l  
M i c r o s c o p i c a l  S o c i e t y ,  8 5 ,  1 9 3 - 2 0 0 .
BRANDT, L .  a n d  SWAHN, B .  ( i 9 6 0 )  S u b a c u t e  b a c t e r i a l  e n d o c a r d i t i s  d u e  t o  
c o a g u l a s e - n e g a t i v e  S .  a l b u s .  A c t a  M e d i c a  S c a n d i n a v i c a ,  1 6 6 ,  1 2 5 - 1 3 2 ,  
B R E IG E R , L .  a n d  FR A E N K E L , C .  ( 1 8 9 0 )  B e r l i n e r  K l i n i s c h e  W o c h e n s c h r i f t ,  2 7 .  
2 4 1 - 2 4 6 .  ( c i t e d  i n  M c C a r t n e y  a n d  Ar b u t h n o t t ,  1 9 7 8 ) .
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B R O D IE , J . ,  G U T H R IE , W . a n d  SOM M ERVILLE, T .  ( l 9 5 8 )  A n  a t t e n u a t e d  v a r i a n t  
o f  S t a p h y l o c o c c u s  a u r e u s  w i t h  s p e c i f i c  i m m u n i s i n g  p r o p e r t i e s .  B r i t i s h  
J o u r n a l  o f  E x p e r i m e n t a l  P a t h o l o g y .  5 9 # 1 9 9 - 2 0 2 .
BUCKELEW, A .R .  a n d  C 0 L A C IC C 0 , G . ( l 9 7 l )  L i p i d  m o n o l a y e r s .  I n t e r a c t i o n s  
w i t h  s t a p h y l o c o c c a l  a - t o x i n .  B i o c h i m i c a  e t  B j o p h y s i c a  A c t a .  2 5 5 .  7 - 1 6 .
B U R N ET, P .M .  ( 1 9 2 9 )  T h e  e x o t o x i n s  o f  S t a p h y l o c o c c u s  p y o g e n e s  a u r e u s .
J o u r n a l  o f  P a t h o l o g y  a n d  B a c t e r i o l o g y .  5 2 . 7 1 7 - 7 5 4 *
B U R N ET, P .M .  ( 1 9 5 0 )  T h e  p r o d u c t i o n  o f  s t a p h y l o c o c c a l  t o x i n .  J o u r n a l  o f  
P a t h o l o g y  a n d  B a c t e r i o l o g y .  5 5 # 1 - 1 6 .
B U R N ET, F .M .  a n d  FE N N E R , P .  ( l 9 4 9 ) " T h e  p r o d u c t i o n  o f  a n t i b o d i e s " ,  2 n d  
E d i t i o n .  M e l b o u r n e ,  M a c M i l l a n .
BUSCHMANN, H . ,  K R A U S S L IC H , H . ,  M EYER, J . ,  RAD ZIKO W SKE, A . a n d  0S T E R K 0R N , K . 
( l 9 7 2 )  V a r i a t i o n  o f  t h e  im m u n e  r e s p o n s e  t o  s h e e p  e r y t h r o c y t e s  i n  
s e v e r a l  s t r a i n s  o f  m i c e  a n d  t h e i r  c r o s s e s .  M e d i c a l  M i c r o b i o l o g y  a n d  
I m m u n o l o g y ,  1 5 8 # 7 1 - 8 2 .
C A IR D , J . D .  a n d  W ISEM AN, G .M . ( l 9 7 0 )  P u r i f i c a t i o n  o f  t h e  d e l t a - t o x i n  o f  
S t a p h y l o c o c c u s  a u r e u s .  C a n a d i a n  J o u r n a l  o f  M i c r o b i o l o g y .  1 6 ,  7 0 5 - 7 0 8 .
CANN, J . R .  a n d  S T IM P S O N , D . L .  ( l 9 7 7 )  I s o e l e c t r i c  f o c u s i n g  o f  i n t e r a c t i n g  
s y s t e m s .  I  C a r r i e r  a m p h o l y t e - i n d u c e d  m a c r o m o l e c u l a r  i s o m e r i z a t i o n .  
B i o p h y s i c a l  C h e m i s t r y ,  ] _ 9 I O 5- H 4 .
C A SE Y , R .  a n d  LA N G , A . ( l 9 7 6 )  T r y p t i c  h y d r o l y s i s  a t  a s p a r a g i n e  r e s i d u e s  
i n  g l o b i n  c h a i n s .  B i o c h i m i c a  e t  B j o p h y s i c a  A c t a ,  4 5 4 # I 84- I 8 8 .
C A S S ID Y , P .  a n d  HARSHMAN, S .  ( l 9 7 6 a )  S t u d i e s  o n  t h e  b i n d i n g  o f  s t a p h y l o -  
1 2 5
c o c c a l  I - l a b e l l e d  a - t o x i n  t o  r a b b i t  e r y t h r o c y t e s .  B i o c h e m i s t r y ,
1 £ ,  2 5 4 8 - 2 5 5 5 .
C A S S ID Y , P .  a n d  HARSHMAN, S .  ( 1 9 7 6 b )  P u r i f i c a t i o n  o f  s t a p h y l o c o c c a l  
a l p h a - t o x i n  b y  a d s o r p t i o n  c h r o m a t o g r a p h y  o n  g l a s s .  I n f e c t i o n  a n d  
I m m u n i t y ,  1 5 ,  9 8 2 - 9 8 6 .
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CHAO, L .  ( 1 9 7 6 )  T h e  a s s a y  o f  s t a p h y l o c o c c a l  d e l t a - h a e m o l y s i n  w i t h  f i s h  
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EV A N S, D . J . ,  CHEW, L . C . ,  C U R L IN , G . T .  a n d  E V A N S, D .G .  ( l 9 7 2 )  S t i m u l a t i o n  
o f  a d e n y l  c y c l a s e  b y  E s c h e r i c h i a  c o l i  e n t e r o t o x i n .  N a t u r e  ( L o n d o n )
N ew  B i o l o g y ,  2 5 6 ,  1 3 7 - 1 3 8 .
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FA C K R E L L , H . B .  a n d  W ISEM AN, G .M . ( 1 9 7 4 )  I m m u n o g e n i c i t y  o f  t h e  5 - h a e m o l y s i n  
o f  S t a p h y l o c o c c u s  a u r e u s .  J o u r n a l  o f  M e d i c a l  M i c r o b i o l o g y ,  4 1 1 - 4 1 4 •  
F A C K R E L L , H . B ,  a n d  W ISEM AN, G .M . ( 1 9 7 6 a )  P r o d u c t i o n  a n d  p u r i f i c a t i o n  o f  
t h e  gam m a h a e m o l y s i n  o f  S t a p h y l o c o c c u s  a u r e u s  ' S m i t h  5 R 1 * J o u r n a l  o f  
G e n e r a l  M i c r o b i o l o g y ,  9 2 ,  1 - 1 0 .
FA C K R EL L , H . B .  a n d  W ISEM AN, G .M . ( 1 9 7 6 b )  P r o p e r t i e s  o f  t h e  gam m a h a e m o l y s i n  
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J o u r n a l  o f  P a t h o l o g y  a n d  B a c t e r i o l o g y , 8 4 ,  2 5 3 - 2 5 6 .
FR A EN K EL-C O N RA T, H . a n d  O LC O TT, H . S .  ( l 9 4 8 )  R e a c t i o n  o f  f o r m a l d e h y d e  w i t h  
p r o t e i n s .  V I  C r o s s - l i n k i n g  o f  a m i n o  g r o u p s  w i t h  p h e n o l ,  i m i d a z o l e  o r  
i n d o l e  g r o u p s .  J o u r n a l  o f  B i o l o g i c a l  C h e m i s t r y ,  1 7 4 ,  8 2 7 - 8 4 5 .
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f o r m a l d e h y d e  w i t h  p r o t e i n s .  IV  P a r t i c i p a t i o n  o f  i n d o l e  g r o u p s ,
G r a m i c i d i n .  J o u r n a l  o f  B i o l o g i c a l  C h e m i s t r y ,  1 6 8 ,  9 9 - 1 1 8 .
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F R E E R , J . H . ,  ARBUTHNOTT, J . P .  a n d  B IL L C L IF F E , B .  ( l 9 7 3 )  E f f e c t s  o f
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a n t i g e n ,  a  c r u c i a l  s t e p  i n  t h e  i n d u c t i o n  o f  t h e  p r i m a r y  r e s p o n s e .  
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FR E N C H , D . a n d  E D S A L L , J . T .  ( l 9 4 5 )  T h e  r e a c t i o n s  o f  f o r m a l d e h y d e  w i t h  a m i n o  
a c i d s  a n d  p r o t e i n s .  A d v a n c e s  i n  P r o t e i n  C h e m i s t r y ,  2 ,  2 7 7 - 3 3 5 *
F R O S T , P .  a n d  LA N C E, E .M .  ( l 9 7 8 )  O n t h e  m e c h a n i s m  o f  a c t i o n  o f  a d j u v a n t s .
I m m u n o l o g y ,  3 5 ,  63- 68 .
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G A R R ISO N , P . K .  a n d  FREEDMAN, L . R .  ( 1 9 7 0 )  E x p e r i m e n t a l  e n d o c a r d i t i s .  I  
S t a p h y l o c o c c a l  e n d o c a r d i t i s  i n  r a b b i t s  r e s u l t i n g  f r o m  p l a c e m e n t  o f  a  
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I I I  I n t e r n a t i o n a l  S y m p o s iu m  o f  S t a p h y l o c o c c u s  a n d  S t a p h y l o c o c c a l
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t h a n  w i t h  g l u t a m i n a m i d e .  P r o c e e d i n g s  o f  t h e  N a t i o n a l  A c a d e m y  o f  S c i e n c e s  
U S A , 2 4 ,  9 7 5 - 9 7 8 .
GERM A NIER, R . ,  F U R E R , E . ,  VARALLYAY, S .  a n d  IN D E R B IT Z IN , T .M . ( 1 9 7 6 )  
P r e p a r a t i o n  o f  a  p u r i f i e d  a n t i g e n i c  c h o l e r a  t o x o i d .  I n f e c t i o n  a n d  
I m m u n i t y , 1 3 ,  1 6 9 2 - 1 6 9 8 .
GERSHON, R . K .  ( 1 9 7 4 )  T  c e l l  c o n t r o l  o f  a n t i b o d y  p r o d u c t i o n .  C o n t e m p o r a r y  
T o p i c s  i n  I m m u n o b i o l o g y .  4 »  1 - 4 0 *
G I L L ,  T . J . ,  PA PER M A STER , D . S . ,  K U N Z, H .W . a n d  M ARFEY, P . S .  ( l 9 6 8 )  S t u d i e s  
o n  s y n t h e t i c  p o l y p e p t i d e  a n t i g e n s .  X IX  I m m u n o g e n i c i t y  a n d  a n t i g e n i c  
s i t e  s t r u c t u r e  o f  i n t r a m o l e c u l a r l y  c r o s s l i n k e d  p o l y p e p t i d e s .  J o u r n a l  
o f  B i o l o g i c a l  C h e m i s t r y ,  2 4 3 .  2 8 7 - 3 0 0 .
G LADSTONE, G . P .  ( l 9 6 6 )  S t a p h y l o c o c c a l ,  h a e m o l y s i n s .  P r Q s t e p y  M i k r o b i o l . ,
S ,  1 4 5 - 1 6 1 .
GLADSTONE, G . P .  a n d  G LEN C R O SS, E . J . G .  ( i 9 6 0 )  G r o w t h  a n d  t o x i n  p r o d u c t i o n  
o f  s t a p h y l o c o c c i  i n  c e l l o p h a n e  s a c s  i n  v i v o .  B r i t i s h  J o u r n a l  o f  
E x p e r i m e n t a l  P a t h o l o g y .  4 1 .  3 1 3 - 3 3 3 *
G LADSTONE, G . P .  a n d  VAN H EY N IN G EN , W .E .  ( l 9 5 7 )  S t a p h y l o c o c c a l  l e u c o c i d i n s .  
B r i t i s h  J o u r n a l  o f  E x p e r i m e n t a l  P a t h o l o g y .  3 8 ,  1 2 3 - 1 3 7 .
GLADSTONE, G . P .  a n d  Y O SH ID A , A . ( l 9 6 7 )  T h e  c y t o p a t h i c  a c t i o n  o f  p u r i f i e d  
s t a p h y l o c o c c a l  6- h a e m o l y s i n .  B r i t i s h  J o u r n a l  o f  E x p e r i m e n t a l  P a t h o l o g y , 
4 8 ,  1 1 - 1 9 *
GLADSTONE, G . P . ,  MUDD, S . ,  H O C H S T E IN , H .D .  a n d  LEN H ART, N .A .  ( 1 9 6 2 )  T h e  
a s s a y  o f  a n t i - s t a p h y l o c o c c a l  l e u c o c i d a l  c o m p o n e n t s  ( F  a n d  S )  i n  h u m a n  
s e r u m .  B r i t i s h  J o u r n a l  o f  E x p e r i m e n t a l  P a t h o l o g y ,  4 3 .  2 9 5 - 3 1 2 .
GLENNY, A . T .  a n d  H O P K IN S , B . E .  ( l 9 2 3 )  D i p h t h e r i a  t o x o i d  a s  a n  i m m u n i s i n g  
a g e n t .  B r i t i s h  J o u r n a l  o f  E x p e r i m e n t a l  P a t h o l o g y .  4 ,  2 8 3 - 2 8 8 .
GLENNY, A . T .  a n d  S T E V E N S , M .F .  ( l 9 3 5 )  S t a p h y l o c o c c u s  t o x i n s  a n d  a n t i t o x i n s .  
J o u r n a l  o f  P a t h o l o g y  a n d  B a c t e r i o l o g y ,  4 0 ,  2 0 1 - 2 1 0 .
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s e r u m  a l b u m i n  r e s u l t i n g  f r o m  p a r t i a l  o r  c o m p l e t e  r e d u c t i o n  a n d  a k y l a t i o n .  
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G O S H I, K . ,  C L U F F , L . E .  a n d  NORMAN, P . S .  ( 1 9 6 3 a )  S t u d i e s  o n  t h e  p a t h o g e n e s i s  
o f  s t a p h y l o c o c c a l  i n f e c t i o n .  V I  M e c h a n i s m  o f  i m m u n i t y  c o n f e r r e d  b y  
a n t i - a - h a e m o l y s i n .  J o h n s  H o p k i n s  H o s p i t a l  B u l l e t i n ,  1 1 2 ,  3 1 - 4 7 *
G O S H I, K . ,  S M IT H , E . W . , C L U F F , L . E .  a n d  NORMAN, P . S .  ( 1 9 6 3 b )  S t u d i e s  o n  
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a n i m a l s .  J o h n s  H o p k i n s  H o s p i t a l  B u l l e t i n ,  1 1 5 « 1 8 3 - 2 0 1 .
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3 - h a e m o l y s i n .  J o u r n a l  o f  B a c t e r i o l o g y . 9 7 * 1 0 2 6 - 1 0 3 2 .
GUY 0NN ET, F .  a n d  PL0M M ET, M . ( l 9 7 0 )  H e m o l y s i n e  gam m a d e  S t a p h y l o c o c c u s  
a u r e u s :  p u r i f i c a t i o n  e t  p r o p r i e t y ' s .  A n n a l e s  d e  l ' I n s t i t u t  P a s t e u r ,
1 1 8 ,  1 9 * 3 3  ( c i t e d  b y  T a y l o r  & B e r n h e i m e r ,  1 9 7 4 ) *
GUY 0NN ET, F . ,  PLOMMET, M . a n d  BO U ILLA N N E, C .  ( 19 6 8 )  P u r i f i c a t i o n  d e
1 * h e m o l y s i n e  gam m a d e  S t a p h y l o c o c c u s  a u r e u s .  C o m p t e s  R e n d u s  H e b d o m a d -  
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H A B EEB , A . F . S . A .  ( l 9 6 9 )  A s t u d y  o f  t h e  a n t i g e n i c i t y  o f  f o r m a l d e h y d e  -  a n d  
g l u t a r a l d e h y d e - t r e a t e d  b o v i n e  s e r u m  a l b u m i n  a n d  o v a l b u m i n - b o v i n e  s e r u m  
a l b u m i n  c o n j u g a t e .  J o u r n a l  o f  I m m u n o l o g y .  1 0 2 ,  4 5 7 - 4 6 5 *
H A B E EB , A . F . S . A .  a n d  HIRAM O TO, R .  ( 19 6 8 )  R e a c t i o n  o f  p r o t e i n s  w i t h
g l u t a r a l d e h y d e .  A r c h i v e s  o f  B i o c h e m i s t r y  a n d  B i o p h y s i c s .  1 2 6 ,  1 6 - 2 6 .  
HADERMANN, E .  ( l 9 7 3 )  D i s c r i m i n a t i o n  b e t w e e n  b i n d i n g  t o  C N S , t o x i c i t y  a n d  
i m m u n o g e n i c i t y  o f  d e r i v a t i v e s  o f  t e t a n u s  t o x i n .  M e d i c a l  M i c r o b i o l o g y  
a n d  I m m u n o l o g y ,  1 5 9 * 8 9 - 1 0 0 .
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c y t o s i s  o f  s t a p h y l o c o c c i .  B r i t i s h  J o u r n a l  o f  E x p e r i m e n t a l  P a t h o l o g y .
2 6 ,  2 0 9 -2 1 6 .
HALLANDER, H .O .  ( 1 9 6 8 )  C h a r a c t e r i s a t i o n  a n d  p a r t i a l  p u r i f i c a t i o n  o f
s t a p h y l o c o c c a l  d e l t a - l y s i n .  A c t a  P a t h o l o g i c a  M i c r o b i o l o g i c a  S c a n d i n -  
a v i c a ,  J2^f 586 -6 0 0 .
HALLANDER, H .O .  a n d  BEN G TSSO N , S .  ( l 9 6 7 )  S t u d i e s  o n  t h e  c e l l  t o x i c i t y  a n d  
s p e c i e s  s p e c i f i c i t y  o f  p u r i f i e d  s t a p h y l o c o c c a l  t o x i n s .  A c t a  
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HAUROW ITZ, F .  ( l 9 5 2 )  T h e  m e c h a n i s m  o f  i m m u n o l o g i c a l  r e s p o n s e .  C a m b r i d g e  
P h i l o s o p h i c a l  S o c i e t y  B i o l o g i c a l  R e v i e w s . 2 7 .  2 4 7 - 2 8 0 .
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H EA TLEY , N .G .  ( l 9 7 l )  A n e w  m e t h o d  f o r  t h e  p r e p a r a t i o n  a n d  so m e  p r o p e r t i e s  
o f  s t a p h y l o c o c c a l  d e l t a - h a e m o l y s i n .  J o u r n a l  o f  G e n e r a l  M i c r o b i o l o g y .
6 2 ,  2 6 9 - 2 7 8 .
H EA T LE Y , N .G .  ( l 9 7 7 )  P r o d u c t i o n  o f  a n t i b o d y  t o  s t a p h y l o c o c c a l  d e l t a -  
h a e m o l y s i n  i n  t h e  r a b b i t .  B r i t i s h  J o u r n a l  o f  E x p e r i m e n t a l  P a t h o l o g y .
2 8 ,  400- 408 .
H EA T LE Y , N .G .  a n d  G LADSTONE, G . P .  ( l 9 7 7 )  F u r t h e r  e v i d e n c e  f o r  t h e  a n t i g e n ­
i c i t y  o f  s t a p h y l o c o c c a l  d e l t a - h a e m o l y s i n .  B r i t i s h  J o u r n a l  o f  E x p e r i m e n t a l  
P a t h o l o g y ,  5 8 ,  4O8- 4H .
H E IN S , J . N . ,  S U R IA N O , J . R . ,  T A N IU C H I, H .  a n d  A N F IN S E N , C . B .  ( 19 6 7 ) 
C h a r a c t e r i s a t i o n  o f  a  n u c l e a s e  p r o d u c e d  b y  S t a p h y l o c o c c u s  a u r e u s .
J o u r n a l  o f  B i o l o g i c a l  C h e m i s t r y ,  2 4 2 ,  1 0 1 6 - 1 0 2 0 .
H E L T IN G , T . B . ,  Z W IS L E R , 0 .  ( 1 9 7 7 a )  S t r u c t u r e  o f  t e t a n u s  t o x i n .  I  B r e a k d o w n  
o f  t h e  t o x i n  m o l e c u l e  a n d  d i s c r i m i n a t i o n  b e t w e e n  p o l y p e p t i d e  f r a g m e n t s .  
J o u r n a l  o f  B i o l o g i c a l  C h e m i s t r y ,  2 5 2 , 1 8 7 - 1 9 5 *
H E L T IN G , T . B .  a n d  Z W IS L E R , 0 .  ( l 9 7 7 b )  S t r u c t u r e  o f  t e t a n u s  t o x i n .  I I  T o x i n  
b i n d i n g  t o  g a n g l i o s i d e .  J o u r n a l  o f  B i o l o g i c a l  C h e m i s t r y ,  2 5 2 .  1 9 4 - 1 9 8 .  
H E N D R IX , T . R .  ( l 9 7 l )  T h e  p a t h o p h y s i o l o g y  o f  c h o l e r a .  B u l l e t i n  o f  t h e  N ew  
Y o r k  A c a d e m y  o f  M e d i c i n e , 4 7 .  1 1 6 9 - 1 1 8 0 .
H I L L ,  M . J .  ( l 9 6 8 )  A s t a p h y l o c o c c a l  a g g r e s s i n .  J o u r n a l  o f  M e d i c a l  
M i c r o b i o l o g y ,  1_, 3 5 - 4 5 *
H I L L ,  M . J .  ( l 9 6 9 )  P r o t e c t i o n  o f  m i c e  a g a i n s t  i n f e c t i o n  b y  S t a p h y l o c o c c u s  
a u r e u s .  J o u r n a l  o f  M e d i c a l  M i c r o b i o l o g y ,  2_, 1 - 7 .
HOBART, M . J .  a n d  M cCO NN ELL, J .  ( 1 9 7 5 )  " T h e  im m u n e  s y s t e m ', ' a  c o u r s e  o n  t h e  
m o l e c u l a r  a n d  c e l l u l a r  b a s i s  o f  i m m u n i t y ,  O x f o r d ,  B l a c k w e l l  S c i e n t i f i c  
P u b l i c a t i o n s •
H 0 D G IN S , H .O .  a n d  RIDGW AY, G . J .  ( 19 6 4 )  P r e s e r v a t i o n  o f  t r o u t  a n d  s a l m o n  
e r y t h r o c y t e s  f o r  b l o o d  t y p i n g  b y  f r e e z i n g  w i t h  d i m e t h y l s u l p h o x i d e .
N a t u r e ,  2 0 1 ,  I 336- I 3 3 7 .
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HOFFMANN, E .M .  a n d  S T R E IT F E L D , M .M . ( 1 9 6 5 )  T h e  a n t i b i o t i c  a c t i v i t y
a s s o c i a t e d  w i t h  p r e p a r a t i o n s  o f  d e l t a - h a e m o l y s i n  o f  S t a p h y l o c o c c u s  a u r e u s . 
C a n a d i a n  J o u r n a l  o f  M i c r o b i o l o g y ,  1 1 ,  2 0 5 - 2 1 1 .
H O R N E, C .H .W . a n d  W H IT E , R . G .  ( 19 6 8 )  E v a l u a t i o n  o f  t h e  d i r e c  i n j e c t i o n  o f  
a n t i g e n  i n t o  a  p e r i p h e r a l  ly m p h  n o d e  f o r  t h e  p r o d u c t i o n  o f  h u m o r a l  
a n d  c e l l - m e d i a t e d  i m m u n i t y  i n  t h e  g u i n e a - p i g .  I m m u n o l o g y .  1 5 .  6 5 - 7 4 *
HOWARD, J . G .  a n d  M IT C H IS O N , N .A .  ( l 9 7 5 )  I m m u n o l o g i c a l  t o l e r a n c e .
P r o g r e s s  i n  A l l e r g y .  1 8 .  45- 96 .
HUMPHREY, J . H .  ( 1 9 7 6 )  S om e r e f l e c t i o n s  o n  p r i n c i p l e s  a n d  m e c h a n i s m s  o f  
i m m u n o l o g i c a l  t o l e r a n c e .  B r i t i s h  M e d i c a l  B u l l e t i n .  5 2 .  1 8 2 - 1 8 4 .
I P S E N , J .  ( 1 9 5 9 )  D i f f e r e n c e s  i n  p r i m a r y  a n d  s e c o n d a r y  i m m u n i z a b i l i t y  o f  
i n b r e d  m i c e  s t r a i n s .  J o u r n a l  o f  I m m u n o l o g y .  8 5 .  448- 4 5 7 .
IS H IZ A K A , T . ,  CAM PBELL, D .A .  a n d  IS H IZ A K A , K .  ( i 960)  I n t e r n a l  a n t i g e n i c  
d e t e r m i n a n t s  i n  p r o t e i n  m o l e c u l e s .  P r o c e e d i n g s  o f  t h e  S o c i e t y  f o r  
E x p e r i m e n t a l  B i o l o g y  a n d  M e d i c i n e . 1 0 5 .  5 - 9 .
JA C K SO N , A .W . ( 1 9 6 5 ) P u r i f i c a t i o n  o f  s t a p h y l o c o c c a l  b e t a —l y s i n .
C a n a d i a n  J o u r n a l  o f  B i o c h e m i s t r y  a n d  P h y s i o l o g y .  4 1 .  7 5 5 - 7 6 1 .
JA C K SO N , A .W . a n d  L IT T L E , R .M .  ( l 9 5 7 )  L e u c o c i d a l  e f f e c t  o f  s t a p h y l o c o c c a l  
d e l t a - l y s i n .  C a n a d i a n  J o u r n a l  o f  M i c r o b i o l o g y .  1 0 1 - 1 0 2 .
JA C K SO N , A .W . a n d  L IT T L E , R .M .  ( l 9 5 8 )  S t a p h y l o c o c c a l  t o x i n s .  I l l  P a r t i a l  
p u r i f i c a t i o n  a n d  so m e  p r o p e r t i e s  o f  6—l y s i n .  C a n a d i a n  J o u r n a l  o f  
M i c r o b i o l o g y .  4 ,  455 - 46I .
JA M E S , R . C .  a n d  M acL E O D , C . J .  ( l 9 6 l )  I n d u c t i o n  o f  s t a p h y l o c o c c a l  i n f e c t i o n s  
i n  m i c e  w i t h  s m a l l  i n o c u l a  i n t r o d u c e d  o n  s u t u r e s .  B r i t i s h  J o u r n a l  o f  
E x p e r i m e n t a l  P a t h o l o g y .  4 2 .  2 6 6 - 2 7 7 .
J A S I N ,  H . E .  ( l 9 7 2 )  H u m an  h e a t  l a b i l e  o p s o n i n s : e v i d e n c e  f o r  t h e i r
m e d i a t i o n  v i a  t h e  a l t e r n a t e  p a t h w a y  o f  c o m p l e m e n t  a c t i v a t i o n .  J o u r n a l  
o f  I m m u n o l o g y .  1 0 9 .  2 6 - 5 1 .
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JE L JA S Z E W IC Z , J ,  ( 1 9 6 0 a )  S t u d i e s  o n  s t a p h y l o c o c c a l  c o a g u l a s e s . V  Q u a n t i t a t i v e  
o b s e r v a t i o n s  c o n c e r n i n g  c o a g u l a s e  p r o d u c t i o n  b y  s t r a i n s  i s o l a t e d  f r o m  
v a r i o u s  s o u r c e s ,  M e d y c y n a  D o s w i a d c z a l n a  i  M i k r o b i o l o g i a ,  1 2 , 2 1 ,
JE L JA S Z E W iC Z , J ,  ( 1 9 6 0 b )  S t u d i e s  o n  s t a p h y l o c o c c a l  c o a g u l a s e s .  V I
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JE L JA S Z E W IC Z , J ,  (1 9 6 7 ) B i o l o g i c a l  a t t r i b u t e s  o f  s t a p h y l o c o c c a l  p r o d u c t s .  
P r o c e e d i n g s  o f  t h e  V t h  I n t e r n a t i o n a l  C o n g r e s s  o n  C h e m o t h e r a p y ;
M e d , A k a d .  V e r l a g ,  V i e n n a  p l - 1 6 .
JE L JA S Z E W IC Z , J .  ( 1 9 7 2 )  T o x i n s  ( H a e m o l y s i n s )  I n  " T h e  S t a p h y l o c o c c i "  
p 2 4 9 - 2 8 0 .  E d i t e d  b y  J . O .  C o h e n ,  L o n d o n ,  W i l e y  I n t e r s c i e n c e .
JE L JA S Z E W IC Z , J . ,  S Z M IG IE L S K I ,  S .  a n d  H R Y N IE W IC Z , W. ( 1 9 7 8 )  B i o l o g i c a l  
e f f e c t s  o f  s t a p h y l o c o c c a l  a n d  s t r e p t o c o c c a l  t o x i n s .  I n  " B a c t e r i a l  
t o x i n s  a n d  c e l l  m e m b r a n e s "  p l 8 5 - 2 2 7 .  E d i t e d  b y  J .  J e l j a s z e w i c z ,  L o n d o n ,  
A c a d e m i c  P r e s s .
J O L L E S , P .  a n d  P A R A F , A . ( 1 9 7 3 )  C h e m i c a l  a n d  b i o l o g i c a l  b a s i s  o f  a d j u v a n t s .  
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1* Yeast diffusate medium (Bernheimer and Schwartz, 1965)
Yeast extract diffusate 5200 ml
Bacto Casamino Acids (Difco) 64 g
Glucose 8 g
Nicotinic Acid 5«7 nig
Aneurine hydrochloride 0,4
The pH was adjusted to 7*1 with IN NaOH and the medium autoclaved at 
15 lb/in for 15 min.
Yeast extract diffusate
Yeast extract (Difco) 200 g
Distilled water 500 ml
Yeast extract was dissolved in distilled water by steaming and, after 
cooling was poured into a 50 cm length of 2,5/4” Visking dialysis tubing 
(Scientific Instrument Centre, London) previously soaked in 70% ethanol 
to minimise contamination. The dialysis sac was immersed in 1600 ml 
distilled water in a 5 1 beaker and stirred for 48 b at 4°C. The dialysis 
sac and contents were discarded and the diffusate was made up to 1600 ml 
with distilled water. Duplicate batches of diffusate were normally 
prepared to yield 5200 ml of diffusate.
"Antifoam" (l ml of a 1/20 dilution/500 ml culture media; Silcolapse 5000,
1.C.I, Stevenson, Ayrshire) was added to prevent frothing.
2. CCY medium (Gladstone and van Heyningen, 1957)
Bacto Casamino acids (Difco) 160 g
Yeast diffusate 1600 ml




0.52% (w/v) FeSO ,7H20
0.52% (w/v) citric acid
kh2p°4
Na„HP0. .12H.02 4  2





1 6 0  g
0 . 1 6  g
2Medium was autoclaved at 15 lb/in for 15 min.
Yeast diffusate




Suspension was dialysed (2.5/4" Visking tubing) against 1800 ml
distilled water at 4 C for 24 h with constant stirring.
APPENDIX II 
Buffers and diluents
1. Citrate/Dextrose/Sodium chloride solution, CDS. (Hodg ins and
Ridgway, 1964).
Glucose 2,05 g
Trisodium citrate 0,80 g
Sodium chloride O.4O g
Distilled water to 100 ml
2. Dulbeccofs A phosphate buffered saline, PBSA.
Phosphate buffered saline (Oxoid) 1 tablet
Distilled water 100 ml
2The buffer was autoclaved at 15 lb/in for 15 min.
3* Dulbecco^ A phosphate buffered saline 2, PBS2.
Sodium chloride 11*7 g
PBSA 1 1
Sodium azide (0.05%f w/v) was added to prevent contamination,
4* Potassium phosphate buffers (PB).
i) 1.0M phosphate (pH 7*4) buffer.
Stock solutions:
A: 1.0M solution of potassium dihydrogen orthophosphate
(13.6 g KH2P0^ in 100 ml distilled water).
B: 1.0M solution of potassium hydrogen orthophosphate
(17«4 g K2HP0^ in 100 ml distilled water).
Nineteen ml of solution A and 81 ml of solution B were mixed and the pH
adjusted by adding either stock solution until a pH of 7.4 was obtained.
A3
ii) 0.4M phosphate (pH 6*8) buffer.
Stock solutions were obtained by dilution of the above 1.0M stock 
solutions.
Approximately 45 nil of solution A and 55 ml solution B were mixed and
the pH adjusted to 6.8 by adding either stock solution.
iii) 0.01M phosphate (pH 6.8) was obtained by 1/40 dilution of the 
0.4M phosphate buffer.
5. Phosphate buffer, pH 5. 0.15M
A: 0.15M solution of potassium dihydrogen orthophosphate
(20.4 g KH2P0^ in 1 1 of distilled water)
B: 0.15M solution of disodium hydrogen orthophosphate
(26.7 g Na2HP0^.2H20 in 1 1 of distilled water.
Nine hundred and eighty-eight ml of solution A and 12 ml of solution B
were mixed and the pH adjusted to 5*0*
6. Phosphate buffer, pH 7*5. 0.15M
As 0.15M solution of sodium dihydrogen orthophosphate
(23*4 g Na^PO^.P^O in 1 1 of distilled water)
B: 0.15M solution of disodium hydrogen orthophosphate
(53.7 g Na2HP04.12H20 in 1 1 of distilled water)
One hundred and sixty ml of solution A and 840 ml of solution B were 
mixed and the pH adjusted to 7*5*
7* Sodium-carbonate/sodium bicarbonate buffer. pH 9.5. 0.05M
(Delory and King, 1945)
A: 0.1M solution of sodium carbonate
(28.62 g Na2C0^.10H20 in 1 1 of distilled water)
B: 0.1M solution of sodium bicarbonate
(8.4 g NaHCO^ in 1 1 of distilled water)
Forty ml of solution A and 60 ml of solution B were mixed and the pH
adjusted to 9*5* This solution was diluted 1:2 to give 0.05M buffer.
A4
A5
8. Bicarbonate buffer pH 10.6
Na2HC05 15 g
k2co5 170 g
Distilled water to 1 1, and the pH adjusted to 10,6 and 0.05% (w/v) 
sodium azide added.
9. Carbonate-bicarbonate buffer pH 11. 0.2M (Stephen et al., 1966)
As 0.2M solution of anhydrous sodium carbonate
(21.2 g Na2C0  ^in 1 1 of distilled water)
B: 0.2M solution of sodium bicarbonate
(16.8 g NaHCO^ in 1 1 of distilled water)
Four hundred and fifty ml of solution A and 15 ml of solution B were 
mixed and pH adjusted to 11 and 0.05% (w/v) sodium azide added.
10. Glycine HC1 buffer pH 2.2
A: 0.2M glycine solution (15*01 g/l) was adjusted to pH 2.2
with concentrated HC1 and 0.05% (w/v) sodium azide added,
11. Barbitone buffer, pH 8.6
Barbitone (diethylbarbituric acid) 1*84 g
Barbitone sodium 10*51 g
Distilled water to 1,000 ml.
12. Double strength barbitone buffer. pH 8*6
Barbitone sodium 24*74 g
Calcium lactate 1*54 g
Sodium azide 0.2 g
Distilled water 900 ml




i) CaCl2, 0,5M 2 litres
ii) Na2HP04, 0,5M 2 litres
iii) Phosphate buffers, pH 6,8 - see appendix II
iv) NaOH (40% w/w) 100 ml
Procedure
Calcium phosphate has been shown to exist in several crystalline 
forms including brushite and hydroxylapatite. Tiselius et al, (1956) 
showed that hydroxylapatite could be prepared from brushite. Brushite 
was prepared by allowing 2 litres of aqueous solutions of CaCl2 and Na2HP0^
to run at an equal flow rate (120 drops/min) into a glass beaker under
stirring. The supernatant was removed by decantation and the precipitate 
washed four times by decantation with distilled water, resuspended to 4 1 
with distilled water and 100 ml freshly prepared 40% (w/w) NaOH was added. 
The brushite was boiled under stirring for one hour and very fine material 
was removed by decantation. The precipitate was washed by decantation 
four times with distilled water, resuspended in 3 litres of 0.01M phosphate 
buffer (pH 6,8) and heated just to boiling. The supernatant was decanted 
and fresh phosphate buffer added and the suspension boiled for 5 min.
The supernatant was again decanted and the suspension boiled for 15 min, in 
fresh 0.01M buffer and then boiled twice in 0.001M phosphate buffer for 
15 min to convert the brushite to hydroxylapatite. The suspension was
stored in 0.001M phosphate buffer at 4°C.
APPENDIX I I I
Preparation of hydroxylapatite (Tiselius et al,, 1956)
A7
Reagents
Reagent A : 
Reagent B : 




for Protein Estimation (Lowry et al., 1951)
2% sodium carbonate (Na^CO^) in 0.1N sodium hydroxide.
1% copper sulphate (CuSO^.^HgO) in distilled water.
2% aqueous solution of potassium sodium tartrate.
Equal volumes of reagent B and C were mixed and 1 ml 
added to 50 ml of reagent A. The solution was 
discarded after one day.
Folin-Ciocalteau reagent (B.D.H., Poole, Dorset).
The Polin reagent was standardised by titration 
against IN NaOH using phenophthalein indicator and 







Sodium nitroprusside 10% (w/v)
Na^ [pe(CN)^No], 2^0 in distilled water
The protein solution (0.5 ml) was mixed with 0.5 ml of 
bicarbonate buffer pH 10.6 (Appendix II) and 2 drops of sodium nitro­
prusside indicator and was titrated with 0.00025N MMD. The titration 
was complete when the colour of the solution had changed from pink to 
yellow.
One ml of 0.00025N MMD is equivalent to 2.5 x 10~7 -SH groups 
and 1 mg/ml y-globulin is equal to 6.35 x 10*”^  moles. Therefore the 
number of -SH groups/mole in the immunosorbent preparation were calculated 
from the following equation:
ml MMD x 2.5 x 10~7 
-SH/mole = -------------------




Aqueous NH^ 7.1 ml
Distilled water to 100 ml.
APPENDIX VI




NjN'-bis-methylene acrylamide 0.8 g 
distilled water to 100 ml.
B. Tris-HCl 1.5M, pH 8.8
Tris (hydroxymethyl)aminomethane 18.15 S 
distilled water to 50 ml, pH adjusted to 8.8 
with IN HC1 and distilled water to 100 ml.
C. 10% SDS
Sodium dodecyl sulphate 10 g
distilled water to 100 ml
D. Tris/HCl. 0.5M. pH 6.8
Tris 6 g
Distilled water to 50 ml, pH adjusted with IN HC1
and distilled water to 100 ml.




Distilled water to 800 ml, pH adjusted and 
distilled water to 1 1 .
F. Ammonium persulphate (10%)
Ammonium persulphate 0.1 g
Distilled water to 1 ml
A10
G. Bromophenol blue (0.1%)
Bromophenol Blue 0,1 g
Dissolved in 100 ml 10*"^ M sodium azide (6,5 mg/l)
H. TEMED
N,N,N*,Nf-tetramethylethylenediamine
I • 2-Mercaptoethanol 
J. Glycerol
Stock solution Volume Final concentration 
(in sample)
D Tris/HCl pH 6.8, 0.5M 2.5 ml 0.0625M
C SDS (10%) 4.0 2%
J Glycerol 2.0 10%
I 3-mercaptoethanol 1.0 5%
G Bromophenol blue (0.1%) 0.2 0.001%
h 2o 0.3
10 ml
III. Separating gel - 10%
Stock solution Volume Final concentration
A Acrylamide/Bis 13.3 ml 10%
B Tris/HCl, pH 8.5 10.0 0.375M
C SDS (10%) 0.4 0.1%
H TEMED 0.04 0.1%




Stock solution Volume Final concentration
IV. Stacking gel
A Acrylamide/bis 2 ml 6%
D Tris HC1, pH 6.8 2.5 0.125M
C SDS (10%) 0.1 0.1%
H TEMED 0.01 0.1%














Polyacryalmide gels for isoelectric focusing 
Solutions
29*1% (w/v) Acrylamide 5 ml
0.9% (w/v) Bis 5 ml
Ampholines (pH 3*5-10) 0.5 ml
Ampholines (pH 3-5) 0.2 ml
Distilled water ) 18.3 ml
Sucrose ) 3*5 g
TEMED 20 Hi
O.OO&'Ww/v) Riboflavin 0.2 ml
Urea 16.2 g
Nonidet-P40 0.6 ml
The solutions were mixed in the order above and, after thorough 
degassing under reduced pressure, were polymerised between glass plates, 
separated by gaskets, using a fluorescent light source. After poly­
merisation, the top plate was gently removed and the bottom plate, 
containing the gel, was placed on the LKB 2117 Multiphor apparatus.
Staining of gels
Stain. Coomassie Brilliant Blue G250, Seva, (0.4 g) was dissolved in
200 ml distilled water and mixed with an equal volume of 2N H^SO,. The2 4
solution was left at room temperature for 3 h after which time it was 
filtered through Whatman No. 1 filter paper and the volume of the filtrate 
measured. Potassium hydroxide (lON) was added in a volume 1/9 of the 
filtrate volume and 100% (w/v) TCA was added to give a final concentration 
of 12%.
The gels were stained overnight and destained in tap water with 




Mycobacterium tuberculosis (Stewart-Tull and White, 1967) 4 mg
Bayol F 17 ml
Arlacel A 3 ml
The M, tuberculosis was mixed with the Bayol F using an MSE 100 watt 






Bromophenol blue 10 mg
Distilled water 100 ml
i Brilliant Blue (Weber and Osborn. 1969)
Coomassie Brilliant Blue 1,.25 g
50% methanol 454 ml
Glacial acetic acid 46 ml
A15




Borate succinate buffer 
36% aqueous formaldehyde
Delta-haemolysin (2 mg/ml) heated at 100°C for 10 h 
Sheep erythrocytes (fresh)
Borate-succinate buffer, pH 7«5« 0.15M
Solution A: 0.05M solution of sodium tetraborate
(19.0 g Na2B^0^.H20 dissolved in 1 1 distilled water) 
Solution Bs succinic acid, 0.05M
(5,9 g dissolved in 1 1 distilled water)
Sodium chloride
Horse serum (heat inactivated at 56°C for 45 min)
One 1 of A was mixed with solution B until pH 7-5 was reached. Sodium 
chloride was added to O.I4M and solution was mixed with 1% horse serum 
(final concentration).
Sheep blood was washed three times in PBS and the final 
suspension was adjusted to 4%. Fifty ml of PBS, containing 2.5 mg of 
tannic acid, was mixed with 50 ml of the 4% erythrocyte suspension and 
incubated at 37°C for 15 min. The erythrocytes were collected by gentle 
centrifugation (to prevent agglutination) at 100 g for 20 min and divided 
into two aliquots. Each aliquot was washed in PBS and one was used for 
antigen coating and the other was used as control cells. The test cells 
were resuspended in 10 ml PBS, mixed with 10 ml of 6-haemolysin (2 mg/ml)
APPENDIX X
Al6
and incubated at 37°C for JO min. Cells were collected by centrifugation 
(100 20 min) and resuspended in 20 ml borate-succinate buffer. Control
cells were also suspended in 20 ml borate-succinate buffer. Two ml of 
j6% formaldehyde was added to both cell suspensions, while stirring, over 
a period of JO min and the cells were allowed to settle overnight at 4°C.
A further 2 ml of formaldehyde was added and the cells allowed to re-settle 
at 4°C overnight. The supernatant was decanted off and the cells were 
resuspended in borate-succinate buffer with vigorous shaking. The cells 
were allowed to settle overnight and, after a final washing in borate- 
succinate buffer, the suspensions were adjusted to 1% (v/v) and 0.2% 
formaldehyde (final concentration) was added as a preservative. The cells 
were stored at 4°C.
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The results of Table 18 were analysed by the chi-square test 
using the Yates correction for continuity.
APPENDIX XI
Statistical Analysis of Table 18
Non-Responders Responders Total
Untreated haemolysin a b a + b
Treated haemolysin c , d c + d
Total a + c b + d N
2X =
N (|ad - bc| - n/2)2 
(a+b) (c+d)(a+c)(b+d)
There is one degree of freedom and tabulated chi-square values at 1 degree 
of freedom are:-
5.84 ; P = 0.05 
6.65 : P = 0.01 
7.88 = P = 0.005
(i) Analysis of native / F7.5 results
Non-Responders Responders Total
Native 62 18 80
F7.5 50 55 85
Total 112 51 165
• 2 165(2046 - 900 - 81.5)2X = ----------------80 x 85 x 112 x 51
= 4*2
2Calculated x value =4*9 which is greater than 5*84 and. therefore the 
variance between the number of responding mice to native and to F7.5
haemolysin is significant at the 5% probability level,
(ii) Analysis of native/F5 results
A18
Non-Responders Responders Total
Native 62 18 80
F5 29 47 76
Total 91 ON NJ1 156
• 2 156(2914 - 522 - 78) 2
X ~
80 x 76 x 91 x 65 
= 23.2
This value is much greater than 7*88 and therefore the variance between 
the number of responding mice to native or F5-haemolysin is highly 
significant at the 0,5% probability level.
The Reaction of Formaldehyde with Staphylococcal Delta-Haemolysin
Lorna E, T. Stearne and T. II, Birkbeck 
(Department of Microbiology, University of Glasgow,
The Alexander Stone Building, Garscube Estate,
Bearsden, Glasgow, G6l lQH),
Staphylococcal <f-baemolysin is cytolytic towards a wide range of 
different cell types (l), elevates cyclic AMP levels and inhibits water 
adsorption in the guinea pig ileum and causes increased vascular 
permeability in the skin (2,3). Delta-haemolysin also binds to phospho­
lipids (4) and lipoproteins (5). We have investigated the reaction of 
formaldehyde with <A-haemo lysin to form 'toxoids' for the immunisation of 
mice and to determine whether some of the above properties of i-haemolysin 
are mediated by common mechanisms,
Delta-haemolysin was treated with formaldehyde at pH 5* pH 7.5 or 
pH 9.5 for up to 7 days at 37°C; haemolytic activity was lost rapidly at 
pH 5 or pH 7.5 but more slowly at pH 9.5. All IICHO-treated preparations 
had an increased electrophoretic mobility at pH 8,6 with a concommitant 
decrease in isoelectric point, but soluble polymers of the basic subunit 
of^haemolysin were not detected by SDS-polyacrylamide gel electrophoresis. 
Delta-haemolysin treated with formaldehyde retained its antigenicity assessed 
by counter-immunoelectrophoresis and gel diffusion. This precipitinogenic 
activity of HCHO-treated A-haemolysin was not inhibited by lecithin or 
destroyed bv trypsin. Formaldehyde treatment also reduced (or abolished) 
the ability of <J-haeroo lysin to bind to erythrocytes. Haemolysin treated 
with HCHO for 7 days at pH 5 or pH 7.5 lost all detectable haemolytic 
activity but still induced increased vascular permeability in rabbit skin 
although to a lesser degree than native A-haemolysin,
-2 -
Native ^-haemolysin was poorly immunogenic in the mouse. However, 
on reaction with HCHO at pH 5» the immunogenicity of c5-haemo lysin was 
enhanced. Antisera to HCHO-treated haemolysin reacted with both native 
and HCHO-treated haemolysin on counter-immunoelectrophoresis. The enhanced 
immunogenicity of ^-haemolysin following reaction with HCHO may result 
from the reduced affinity for phospholipids rather than by polymerisation (6),
1. Wiseman, G.M, (1975) Bacteriological Reviews 22* 317.
2. Kapral, F.A,, O’Brien, A.D.j Ruff, P.P. and Drugen, W.J, (1976)
Infection and Immunity 1_3, 140,
3. O'Brien, A.D, and Kapral, F.A. (1976). Infection and Immunity 12_t 152.
4. Kapral, F.A, (1972). Proceedings of the Society for Experimental 
Biology and Medicine 114, 519.
5. Whitelaw, D.D. and Birkbeck, T.H. (1978). FEMS Microbiology Letters 
I t  335.
6. Warren, J.R. , Spero, L. and Metzger, J.F. (1973). Journal of 
Immunology 111, 885.
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